KRRO NASDAQ
Korro Bio, Inc.
1W: +40.9%
1M: +39.9%
3M: +32.1%
YTD: +65.2%
1Y: -65.1%
3Y: +6.4%
5Y: -96.1%
$13.30
+1.28 (+10.65%)
Weekly Expected Move ±17.9%
$8
$10
$12
$14
$16
Credit Risk of going bust: higher than 95% of companies Debt: 17.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.87 (down 93%), Korro Bio, Inc. would be worth roughly what it owes.
Total debt $42.2M against a stock market value of $195.9M.
Distance to default 0.57 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $21.1M (short-term plus half of long-term), stock volatility 179.9%; Altman Z'' -5.35. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.87 (down 93%), Korro Bio, Inc. would be worth roughly what it owes.
Total debt $42.2M against a stock market value of $195.9M.
Distance to default 0.57 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $21.1M (short-term plus half of long-term), stock volatility 179.9%; Altman Z'' -5.35. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
#398
of 1060
Biotechnology
Technical Signal Map
130 Bullish
45 Neutral
604 Bearish
KRRO
$180M
Korro Bio, Inc.
BULLISH
+84
SEPN
$1.9B
Septerna Inc
BULLISH
+100
COAG
$1.6B
Hemab Therapeutics Holdings, Inc. Common Stock
BULLISH
+100
VSTM
$910M
Verastem, Inc.
BULLISH
+100
SOLTF
$770M
Nxera Pharma Co., Ltd.
BULLISH
+100
PYPD
$110M
PolyPid Ltd.
BULLISH
+100
ANIX
$100M
Anixa Biosciences, Inc.
BULLISH
+100
GRDX
$40M
GridAI Technologies Corp.
BULLISH
+100
KLRA
$1.7B
Kailera Therapeutics, Inc.
BULLISH
+91
SPTX
$1.1B
Seaport Therapeutics, Inc. Common Stock
BULLISH
+91
SGP
$950M
SpyGlass Pharma, Inc. Common Stock
BULLISH
+91
ENTX
$510M
Entera Bio Ltd.
BULLISH
+91
ATNM
$50M
Actinium Pharmaceuticals, Inc.
BULLISH
+91
PRME
$670M
Prime Medicine, Inc.
BULLISH
+87
XFOR
$320M
X4 Pharmaceuticals, Inc.
BULLISH
+87
CING
$70M
Cingulate Inc.
BULLISH
+87
ESLA
$40M
Estrella Immunopharma, Inc.
BULLISH
+87
INDP
$360M
Indaptus Therapeutics, Inc.
BULLISH
+84
VIR
$1.8B
Vir Biotechnology, Inc.
BULLISH
+82
MAZE
$1.7B
Maze Therapeutics, Inc.
BULLISH
+78
ZIVO
$20M
ZIVO Bioscience, Inc.
BULLISH
+78
LBRX
$1.2B
LB Pharmaceuticals Inc Common Stock
BULLISH
+75
OABIW
$1.1B
OmniAb, Inc.
BULLISH
+75
RIGL
$900M
Rigel Pharmaceuticals, Inc.
BULLISH
+75
HURA
$140M
TuHURA Biosciences, Inc.
BULLISH
+75
MXCT
$140M
MaxCyte, Inc.
BULLISH
+75
IRLA
$30M
IRulya Therapeutics Inc.
BULLISH
+74
LYEL
$230M
Lyell Immunopharma, Inc.
BULLISH
+73
AGTX
—
Agentix Corp.
BULLISH
+73
NAUT
$410M
Nautilus Biotechnolgy, Inc.
BULLISH
+69
RARE
$1.5B
Ultragenyx Pharmaceutical Inc.
BULLISH
+68
XNCR
$1.9B
Xencor, Inc.
BULLISH
+66
TRAX
$1.6B
First Tracks Biotherapeutics Inc
BULLISH
+66
SLN
$930M
Silence Therapeutics plc
BULLISH
+66
PBYI
$570M
Puma Biotechnology, Inc.
BULLISH
+66
SGMT
$310M
Sagimet Biosciences Inc.
BULLISH
+66
HOWL
$50M
Werewolf Therapeutics, Inc.
BULLISH
+66
NNVC
$40M
NanoViricides, Inc.
BULLISH
+66
MBRX
$10M
Moleculin Biotech, Inc.
BULLISH
+66
AZTR
—
Azitra, Inc.
BULLISH
+66
NBTX
$1.5B
Nanobiotix S.A.
BULLISH
+62
BOLT
$10M
Bolt Biotherapeutics, Inc.
BULLISH
+62
BDRX
—
Biodexa Pharmaceuticals Plc
BULLISH
+62
CBDG
—
THC Farmaceuticals, Inc.
BULLISH
+60
NTLA
$1.6B
Intellia Therapeutics, Inc.
BULLISH
+59
PHAR
$710M
Pharming Group N.V.
BULLISH
+59
PCSA
$10M
Processa Pharmaceuticals, Inc.
BULLISH
+59
ICCC
$90M
ImmuCell Corporation
BULLISH
+58
PLUR
$10M
Pluri Inc.
BULLISH
+53
CASBF
$1.4B
CanSino Biologics Inc.
BULLISH
+52
REPL
$1.1B
Replimune Group, Inc.
BULLISH
+52
PPCB
—
Propanc Biopharma, Inc.
BULLISH
+52
HALB
—
Halberd Corporation
BULLISH
+51
ABSI
$1.6B
Absci Corporation
BULLISH
+50
CRMD
$610M
CorMedix Inc.
BULLISH
+50
DTIL
$180M
Precision BioSciences, Inc.
BULLISH
+50
NRXS
$90M
NeurAxis, Inc.
BULLISH
+50
OKYO
$70M
OKYO Pharma Limited
BULLISH
+50
XERS
$1.9B
Xeris Biopharma Holdings, Inc.
BULLISH
+49
ADCT
$180M
ADC Therapeutics S.A.
BULLISH
+49
SCNLF
$170M
Scancell Holdings plc
BULLISH
+49
ZEOX
$10M
Zeo ScientifiX, Inc.
BULLISH
+48
CLGN
—
CollPlant Biotechnologies Ltd.
BULLISH
+44
VOR
$990M
Vor Biopharma Inc.
BULLISH
+43
ALEC
$200M
Alector, Inc.
BULLISH
+43
ACUT
—
Accustem Sciences Inc.
BULLISH
+43
KNBIF
—
Kane Biotech Inc.
BULLISH
+43
RXRX
$2.0B
Recursion Pharmaceuticals, Inc.
BULLISH
+42
KROS
$220M
Keros Therapeutics, Inc.
BULLISH
+42
TXTM
$90M
ProText Mobility, Inc.
BULLISH
+42
IMCR
$1.6B
Immunocore Holdings plc
BULLISH
+41
DMAC
$470M
DiaMedica Therapeutics Inc.
BULLISH
+41
DMRA
$1.3B
Damora Therapeutics, Inc.
BULLISH
+40
MLTX
$1.0B
MoonLake Immunotherapeutics
BULLISH
+40
PDSB
$60M
PDS Biotechnology Corporation
BULLISH
+38
NYMXF
$10M
Nymox Pharmaceutical Corporation
BULLISH
+38
IPIX
—
Innovation Pharmaceuticals Inc.
BULLISH
+38
PULM
$10M
Pulmatrix, Inc.
BULLISH
+36
TCRT
$10M
Alaunos Therapeutics, Inc.
BULLISH
+35
EDIT
$370M
Editas Medicine, Inc.
BULLISH
+34
PEPG
$170M
PepGen Inc.
BULLISH
+33
NGNE
$370M
Neurogene Inc.
LEAN BULL
+27
BCYC
$250M
Bicycle Therapeutics plc
LEAN BULL
+27
LCTX
$250M
Lineage Cell Therapeutics, Inc.
LEAN BULL
+27
ABOS
$140M
Acumen Pharmaceuticals, Inc.
LEAN BULL
+27
IUGNF
$30M
Imugene Limited
LEAN BULL
+27
INFIQ
—
Infinity Pharmaceuticals, Inc.
LEAN BULL
+27
ARDS
—
Aridis Pharmaceuticals, Inc.
LEAN BULL
+27
BSSP
—
Baseline Productions, Inc.
LEAN BULL
+27
PTCHF
$390M
PureTech Health plc
LEAN BULL
+26
OBIO
$340M
Orchestra BioMed Holdings, Inc.
LEAN BULL
+26
ACOG
$130M
Alpha Cognition Inc
LEAN BULL
+26
CKDXF
$10M
Ceryvyn Therapeutics Ltd
LEAN BULL
+26
PRVCF
$10M
PreveCeutical Medical Inc.
LEAN BULL
+26
CYYNF
—
Cynata Therapeutics Limited
LEAN BULL
+26
EFTR
—
eFFECTOR Therapeutics, Inc.
LEAN BULL
+26
CALA
—
Calithera Biosciences, Inc.
LEAN BULL
+26
ENSC
$10M
Ensysce Biosciences, Inc.
LEAN BULL
+25
NTRR
—
Neutra Corp.
LEAN BULL
+20
STOK
$1.6B
Stoke Therapeutics, Inc.
LEAN BULL
+18
CCCC
$380M
C4 Therapeutics, Inc.
LEAN BULL
+18
ZURA
$320M
Zura Bio Limited
LEAN BULL
+18
BIVI
$10M
BioVie Inc.
LEAN BULL
+18
VSBC
$10M
VitaSpring Biomedical Co. Ltd.
LEAN BULL
+18
LOBEF
$10M
Lobe Sciences Ltd.
LEAN BULL
+18
PXMD
—
PaxMedica, Inc. Common Stock
LEAN BULL
+18
HEPA
—
Hepion Pharmaceuticals, Inc.
LEAN BULL
+18
VAXX
—
Vaxxinity, Inc.
LEAN BULL
+18
REVB
—
Revelation Biosciences, Inc.
LEAN BULL
+18
BTAX
—
Biostax Corp.
LEAN BULL
+18
ACHFF
$40M
Arch Biopartners Inc.
LEAN BULL
+17
PRLD
$210M
Prelude Therapeutics Incorporated
LEAN BULL
+16
BRVE
$1.5B
Braveheart Bio, Inc.
LEAN BULL
+15
SRZN
$190M
Surrozen, Inc.
LEAN BULL
+15
MDNAF
$20M
Medicenna Therapeutics Corp.
LEAN BULL
+15
ABPO
—
Abpro Holdings, Inc.
LEAN BULL
+15
CYDY
$380M
CytoDyn Inc.
LEAN BULL
+13
SPRB
$130M
Spruce Biosciences, Inc.
LEAN BULL
+13
OCEA
—
Ocean Biomedical, Inc.
LEAN BULL
+13
PVLA
$1.8B
Palvella Therapeutics, Inc.
LEAN BULL
+11
TYRA
$1.2B
Tyra Biosciences, Inc.
LEAN BULL
+11
PRTA
$420M
Prothena Corporation plc
LEAN BULL
+11
ENTA
$340M
Enanta Pharmaceuticals, Inc.
LEAN BULL
+11
GLSI
$240M
Greenwich LifeSciences, Inc.
LEAN BULL
+11
CLNN
$60M
Clene Inc.
LEAN BULL
+11
EHOS
—
Ehouse Global, Inc.
LEAN BULL
+11
CPMV
—
Mosaic ImmunoEngineering Inc.
LEAN BULL
+10
DNAG
—
DNAPrint Genomics, Inc.
LEAN BULL
+10
RBSH
—
Rebus Holdings, Inc.
LEAN BULL
+10
ONCSQ
—
OncoSec Medical Incorporated
LEAN BULL
+10
SRPT
$1.9B
Sarepta Therapeutics, Inc.
NEUTRAL
+9
ABVC
$30M
ABVC BioPharma, Inc.
NEUTRAL
+9
ANAB
$1.5B
AnaptysBio, Inc.
NEUTRAL
+8
STAB
—
Statera Biopharma, Inc.
NEUTRAL
+8
OBX
$10M
Obsidian Therapeutics Inc.
NEUTRAL
+6
GBIM
—
GlobeImmune, Inc.
NEUTRAL
+4
CNSP
$10M
CNS Pharmaceuticals, Inc.
NEUTRAL
+3
SABS
$260M
SAB Biotherapeutics, Inc.
NEUTRAL
+2
NWBO
$260M
Northwest Biotherapeutics, Inc.
NEUTRAL
+2
MLLCF
$150M
Molecular Partners AG
NEUTRAL
+2
HESG
—
Health Sciences Group, Inc.
NEUTRAL
+2
CTXR
$10M
Citius Pharmaceuticals, Inc.
NEUTRAL
+1
RCAR
—
RenovaCare, Inc.
NEUTRAL
+1
RGIN
—
Regenicin, Inc.
NEUTRAL
+1
NMTRQ
—
9 Meters Biopharma, Inc.
NEUTRAL
+1
CFRXQ
—
ContraFect Corp.
NEUTRAL
+1
LYCA
$1.6B
Lycia Therapeutics Inc.
N/A
0
CTY
$200M
City Therapeutics Inc.
N/A
0
IAM
$130M
Iambic Therapeutics Inc.
N/A
0
ATOS
$30M
Atossa Therapeutics, Inc.
NEUTRAL
0
LONA
$20M
LeonaBio, Inc.
NEUTRAL
0
ORGS
—
Orgenesis Inc.
NEUTRAL
0
JANX
$1.0B
Janux Therapeutics, Inc.
NEUTRAL
-1
ODTX
$940M
Odyssey Therapeutics, Inc.
NEUTRAL
-2
DRUG
$520M
Bright Minds Biosciences Inc.
NEUTRAL
-2
PHMMF
$1.6B
Pharma Mar, S.A.
NEUTRAL
-3
NMAD
$50M
NOMAD Power Solutions, Inc.
NEUTRAL
-4
KLDO
—
Kaleido Biosciences, Inc.
NEUTRAL
-5
CNBX
—
CNBX Pharmaceuticals Inc.
NEUTRAL
-5
CALC
—
CalciMedica, Inc.
NEUTRAL
-5
YARW
$180M
Yarrow Bioscience Inc
NEUTRAL
-6
ELUT
$40M
Elutia Inc
NEUTRAL
-6
GSTC
—
GlobeStar Therapeutics Corporation
NEUTRAL
-6
YDESW
—
YD Bio Limited Warrants
NEUTRAL
-6
BPTH
—
Bio-Path Holdings, Inc.
NEUTRAL
-6
RNXT
$60M
RenovoRx, Inc.
NEUTRAL
-7
USRM
—
U.S. Stem Cell, Inc.
NEUTRAL
-7
ZBIO
$1.8B
Zenas BioPharma, Inc.
NEUTRAL
-8
VCRE
$260M
Vicore Pharma Holding AB
NEUTRAL
-8
ENGNW
$10M
enGene Holdings Inc. Warrants
NEUTRAL
-8
PBLA
—
Panbela Therapeutics, Inc.
NEUTRAL
-8
NXTC
$20M
NextCure, Inc.
NEUTRAL
-9
EVAX
$20M
Evaxion Biotech A/S
NEUTRAL
-9
MRPI
—
Mera Pharmaceuticals, Inc.
NEUTRAL
-9
ATXI
—
Avenue Therapeutics, Inc.
NEUTRAL
-9
MBXBF
$30M
Microbix Biosystems Inc.
LEAN BEAR
-10
INRLF
$640M
Valneva SE
LEAN BEAR
-12
POLBF
$70M
Poolbeg Pharma PLC
LEAN BEAR
-12
CLYYF
$10M
Celyad Oncology S.A.
LEAN BEAR
-12
QPTFF
$10M
Quest PharmaTech Inc.
LEAN BEAR
-12
OKUR
$100M
OnKure Therapeutics, Inc.
LEAN BEAR
-14
SNGX
$10M
Soligenix, Inc.
LEAN BEAR
-14
ENDV
—
Endonovo Therapeutics, Inc.
LEAN BEAR
-14
APLMW
$170M
Apollomics, Inc.
LEAN BEAR
-15
ARMP
$140M
Armata Pharmaceuticals, Inc.
LEAN BEAR
-15
EQ
$80M
Equillium, Inc.
LEAN BEAR
-15
LEXX
$10M
Lexaria Bioscience Corp.
LEAN BEAR
-15
KPTI
$10M
Karyopharm Therapeutics Inc.
LEAN BEAR
-15
ADXN
—
Addex Therapeutics Ltd
LEAN BEAR
-15
SRBCF
—
Sirona Biochem Corp.
LEAN BEAR
-16
NKGN
—
NKGen Biotech, Inc.
LEAN BEAR
-16
REPCF
—
RepliCel Life Sciences Inc.
LEAN BEAR
-16
IMVIF
—
IMV Inc.
LEAN BEAR
-16
JUNS
—
Jupiter Neurosciences, Inc.
LEAN BEAR
-16
MCET
—
MultiCell Technologies, Inc.
LEAN BEAR
-16
SLGL
$230M
Sol-Gel Technologies Ltd.
LEAN BEAR
-17
MMIRF
$30M
MedMira Inc.
LEAN BEAR
-17
JBIO
$930M
Jade Biosciences, Inc.
LEAN BEAR
-18
CGEM
$880M
Cullinan Therapeutics, Inc.
LEAN BEAR
-18
ACRS
$550M
Aclaris Therapeutics, Inc.
LEAN BEAR
-18
IFRX
$230M
InflaRx N.V.
LEAN BEAR
-18
LADX
—
LadRx Corporation
LEAN BEAR
-18
LYRA
—
Lyra Therapeutics, Inc.
LEAN BEAR
-18
PARD
—
Poniard Pharmaceuticals, Inc.
LEAN BEAR
-18
ADRX
$1.9B
ADARx Pharmaceuticals, Inc.
LEAN BEAR
-20
AOBI
—
American Oriental Bioengineering, Inc.
LEAN BEAR
-20
HSTC
$210M
HST Global, Inc.
LEAN BEAR
-21
DBVT
$230M
DBV Technologies S.A.
LEAN BEAR
-22
RNA
$140M
Atrium Therapeutics, Inc.
LEAN BEAR
-22
ADAPY
$10M
Adaptimmune Therapeutics plc
LEAN BEAR
-22
PBIGF
$10M
Paradigm Biopharmaceuticals Limited
LEAN BEAR
-22
PREDQ
—
Predictive Discovery Limited
LEAN BEAR
-22
FPMI
—
FluoroPharma Medical, Inc.
LEAN BEAR
-22
GBLX
—
GB Sciences, Inc.
LEAN BEAR
-22
IMMB
—
Immunotech Laboratories, Inc.
LEAN BEAR
-22
FENC
$350M
Fennec Pharmaceuticals Inc.
LEAN BEAR
-23
INBX
$1.4B
Inhibrx Biosciences Inc.
LEAN BEAR
-24
KARD
$1.1B
Kardigan, Inc.
LEAN BEAR
-24
YDES
$350M
YD Bio Limited Ordinary Shares
LEAN BEAR
-24
FATE
$250M
Fate Therapeutics, Inc.
LEAN BEAR
-24
BDTX
$110M
Black Diamond Therapeutics, Inc.
LEAN BEAR
-24
NTHI
$90M
Neonc Technologies Holdings, Inc.
LEAN BEAR
-24
SGMOQ
$50M
Sangamo Therapeutics, Inc.
LEAN BEAR
-24
ENVB
$10M
Enveric Biosciences, Inc.
LEAN BEAR
-24
PZRXQ
—
PhaseRx, Inc.
LEAN BEAR
-24
NNLX
—
NanoLogix, Inc.
LEAN BEAR
-24
CLAZF
—
Claritas Pharmaceuticals, Inc.
LEAN BEAR
-24
NNBP
—
Nanobac Pharmaceuticals, Incorporated
LEAN BEAR
-24
FGHQF
$360M
Frontage Holdings Corporation
LEAN BEAR
-25
GWIN
$360M
Glorywin Entertainment Group, Inc.
LEAN BEAR
-25
KNTPF
$120M
Kintor Pharmaceutical Limited
LEAN BEAR
-25
LVCLF
$20M
Algorae Pharmaceuticals Limited
LEAN BEAR
-25
BCLI
$10M
Brainstorm Cell Therapeutics Inc.
LEAN BEAR
-25
FORU
—
ForU Holdings, Inc.
LEAN BEAR
-25
CHNXF
—
ChitogenX Inc.
LEAN BEAR
-25
HLSQ
—
Tessera Defense and Homeland Security Inc
LEAN BEAR
-25
CMND
—
Clearmind Medicine Inc.
LEAN BEAR
-25
VINC
—
Vincerx Pharma, Inc.
LEAN BEAR
-25
NURPF
$1.8B
Neuren Pharmaceuticals Limited
LEAN BEAR
-26
CUBT
—
Curative Biotechnology, Inc.
LEAN BEAR
-26
KZIA
$10M
Kazia Therapeutics Ltd ADR
LEAN BEAR
-27
LIANY
—
LianMedical
LEAN BEAR
-28
TSHA
$1.3B
Taysha Gene Therapies, Inc.
BEARISH
-31
ARVN
$470M
Arvinas, Inc.
BEARISH
-31
CAMP
$210M
CAMP4 Therapeutics Corporation
BEARISH
-31
PBMWW
—
Psyence Biomedical Ltd. Warrant
BEARISH
-31
TRVN
—
Trevena, Inc.
BEARISH
-31
CARM
—
Carisma Therapeutics, Inc.
BEARISH
-31
PKTX
—
ProtoKinetix, Incorporated
BEARISH
-31
INNMF
$30M
Amplia Therapeutics Limited
BEARISH
-32
IMUC
$10M
EOM Pharmaceuticals Holdings, Inc.
BEARISH
-32
AAGH
—
America Great Health
BEARISH
-32
BXRXQ
—
Baudax Bio, Inc.
BEARISH
-32
SNBIF
$1.3B
SanBio Company Limited
BEARISH
-33
OVID
$420M
Ovid Therapeutics Inc.
BEARISH
-33
RZLT
$370M
Rezolute, Inc.
BEARISH
-33
MDWD
$150M
MediWound Ltd.
BEARISH
-33
CSBR
$70M
Champions Oncology, Inc.
BEARISH
-33
MRKR
$20M
Marker Therapeutics, Inc.
BEARISH
-33
DTCFF
$20M
Defence Therapeutics Inc.
BEARISH
-33
XCUR
$10M
Exicure, Inc.
BEARISH
-33
VRCI
—
Verde Science, Inc.
BEARISH
-33
SNNAQ
—
Sienna Biopharmaceuticals, Inc.
BEARISH
-33
HLUN
—
HEALTHeUNIVERSE, Inc.
BEARISH
-33
NTII
—
Neurobiological Technologies, Inc.
BEARISH
-33
IBOGF
—
Universal Ibogaine Inc.
BEARISH
-33
CMRA
—
Comera Life Sciences Holdings, Inc.
BEARISH
-33
GLSHQ
—
Gelesis Holdings, Inc.
BEARISH
-33
PSYBF
—
PsyBio Therapeutics Corp
BEARISH
-33
TLOG
—
TetraLogic Pharmaceuticals Corporation
BEARISH
-33
MRZM
—
Marizyme, Inc.
BEARISH
-33
HAVLF
—
HAVN Life Sciences Inc.
BEARISH
-33
TRVI
$1.8B
Trevi Therapeutics, Inc.
BEARISH
-34
QURE
$1.6B
uniQure N.V.
BEARISH
-34
BPMUF
$960M
Basilea Pharmaceutica AG
BEARISH
-34
DNA
$670M
Ginkgo Bioworks Holdings, Inc.
BEARISH
-34
INKT
$50M
MiNK Therapeutics, Inc.
BEARISH
-34
CURX
$10M
Curanex Pharmaceuticals Inc Common Stock
BEARISH
-34
SYGGF
—
Synairgen plc
BEARISH
-34
RAPP
$1.2B
Rapport Therapeutics, Inc. Common Stock
BEARISH
-35
ATGGF
$140M
Actinogen Medical Limited
BEARISH
-35
NRXP
$110M
NRx Pharmaceuticals, Inc.
BEARISH
-35
SQZB
—
SQZ Biotechnologies Company
BEARISH
-35
MEOBF
$2.0B
Mesoblast Limited
BEARISH
-37
CEROW
—
CERo Therapeutics Holdings, Inc.
BEARISH
-39
BCRX
$1.9B
BioCryst Pharmaceuticals, Inc.
BEARISH
-40
APMD
$790M
Apnimed, Inc.
BEARISH
-40
STTK
$550M
Shattuck Labs, Inc.
BEARISH
-40
BNTC
$300M
Benitec Biopharma Inc.
BEARISH
-40
ELDN
$190M
Eledon Pharmaceuticals, Inc.
BEARISH
-40
CHRS
$160M
Coherus Oncology, Inc.
BEARISH
-40
FHTX
$120M
Foghorn Therapeutics Inc.
BEARISH
-40
MAIA
$70M
MAIA Biotechnology, Inc.
BEARISH
-40
AURX
$60M
Nuo Therapeutics, Inc.
BEARISH
-40
RNTX
$50M
Rein Therapeutics Inc.
BEARISH
-40
ELTX
$40M
Elicio Therapeutics, Inc.
BEARISH
-40
JSPR
$20M
Jasper Therapeutics, Inc.
BEARISH
-40
NCNA
$10M
NuCana plc
BEARISH
-40
GDTC
$10M
CytoMed Therapeutics Limited
BEARISH
-40
RLFTY
—
MindMaze Therapeutics Holding S.A.
BEARISH
-40
JAGX
—
Jaguar Health, Inc.
BEARISH
-40
HTDS
—
Hard to Treat Diseases Inc.
BEARISH
-40
ITMC
—
Itoco Inc.
BEARISH
-40
BIXT
—
Bioxytran, Inc.
BEARISH
-40
PPTDF
$870M
PeptiDream Inc.
BEARISH
-41
TRDA
$170M
Entrada Therapeutics, Inc.
BEARISH
-41
ERNA
—
Ernexa Therapeutics Inc.
BEARISH
-41
MRES
—
Institute of Biomedical Research Corp.
BEARISH
-41
CSPHF
$1.4B
CStone Pharmaceuticals
BEARISH
-42
DRTSW
$1.2B
Alpha Tau Medical Ltd.
BEARISH
-42
RLYB
$90M
Rallybio Corporation
BEARISH
-42
AEON
$10M
AEON Biopharma, Inc.
BEARISH
-42
LSTA
$10M
Lisata Therapeutics, Inc.
BEARISH
-42
PROT
—
Proteonomix, Inc.
BEARISH
-42
SIGY
—
Sigyn Therapeutics, Inc.
BEARISH
-42
ONCO
—
Onconetix, Inc.
BEARISH
-42
BRAXF
—
Braxia Scientific Corp.
BEARISH
-42
NBIO
—
Nascent Biotech, Inc.
BEARISH
-42
RNUGF
—
ReNeuron Group plc
BEARISH
-42
PFND
—
Pathfinder Cell Therapy, Inc.
BEARISH
-42
ADYX
—
Adynxx, Inc.
BEARISH
-42
CDXI
—
Cardax, Inc.
BEARISH
-42
SYVC
—
Synovics Pharmaceuticals, Inc.
BEARISH
-42
PANC
—
Panacos Pharmaceuticals, Inc.
BEARISH
-42
WHWK
$180M
Whitehawk Therapeutics Inc
BEARISH
-43
ATRA
$90M
Atara Biotherapeutics, Inc.
BEARISH
-43
HNSBF
$330M
Hansa Biopharma AB (publ)
BEARISH
-44
VICP
$10M
Vicapsys Life Sciences, Inc.
BEARISH
-44
VOGX
$260M
Vogenx Inc.
BEARISH
-45
CASIF
—
CASI Pharmaceuticals, Inc.
BEARISH
-46
IDRSF
$1.4B
Idorsia Ltd
BEARISH
-47
VBIZF
$400M
Viva Biotech Holdings
BEARISH
-47
RCKT
$250M
Rocket Pharmaceuticals, Inc.
BEARISH
-47
CRVS
$890M
Corvus Pharmaceuticals, Inc.
BEARISH
-48
SVRA
$870M
Savara Inc.
BEARISH
-48
IMRX
$240M
Immuneering Corporation
BEARISH
-48
PMN
$70M
ProMIS Neurosciences, Inc.
BEARISH
-48
IMTX
$1.1B
Immatics N.V.
BEARISH
-49
KURA
$850M
Kura Oncology, Inc.
BEARISH
-49
ATTO
$630M
Attovia Therapeutics, Inc.
BEARISH
-49
OCS
$490M
Oculis Holding AG
BEARISH
-49
DYAI
$20M
Dyadic International, Inc.
BEARISH
-49
DVHGF
$20M
Devonian Health Group, Inc.
BEARISH
-49
ALLR
$10M
Allarity Therapeutics, Inc.
BEARISH
-49
SCPS
—
Scopus BioPharma Inc.
BEARISH
-49
BITRF
—
Biotron Limited
BEARISH
-49
BIORQ
—
Biora Therapeutics, Inc.
BEARISH
-49
THER
—
Theralink Technologies, Inc.
BEARISH
-49
AURA
$650M
Aura Biosciences, Inc.
BEARISH
-50
TTRX
$310M
Turn Therapeutics Inc.
BEARISH
-50
ARCT
$280M
Arcturus Therapeutics Holdings Inc.
BEARISH
-50
SPHRY
$220M
Starpharma Holdings Limited
BEARISH
-50
BETRF
$110M
BetterLife Pharma Inc.
BEARISH
-50
NTRB
$70M
Nutriband Inc.
BEARISH
-50
HRGN
$30M
Harvard Apparatus Regenerative Technology Inc.
BEARISH
-50
PVCT
$20M
Provectus Biopharmaceuticals, Inc.
BEARISH
-50
APUS
—
Apimeds Pharmaceuticals US, Inc
BEARISH
-50
ERNAW
—
Ernexa Therapeutics Inc. Warrants
BEARISH
-50
VRPX
—
Virpax Pharmaceuticals, Inc.
BEARISH
-50
VRAX
—
Virax Biolabs Group Limited
BEARISH
-50
RNAZ
—
TransCode Therapeutics, Inc.
BEARISH
-50
SCNI
—
Scinai Immunotherapeutics Ltd.
BEARISH
-50
GHRS
$1.2B
GH Research PLC
BEARISH
-52
ABUS
$830M
Arbutus Biopharma Corp
BEARISH
-52
QTTB
$260M
Q32 Bio Inc.
BEARISH
-52
HOPHF
$20M
Hemogenyx Pharmaceuticals Plc
BEARISH
-52
ANL
$560M
Adlai Nortye Ltd.
BEARISH
-53
ARTV
$300M
Artiva Biotherapeutics, Inc.
BEARISH
-53
PLX
$210M
Protalix BioTherapeutics, Inc.
BEARISH
-53
FBIOP
$130M
Fortress Biotech, Inc.
BEARISH
-53
ALZN
$10M
Alzamend Neuro Inc
BEARISH
-53
AFFY
—
Affymax, Inc.
BEARISH
-53
XBIO
—
Xenetic Biosciences, Inc.
BEARISH
-53
PLYX
$90M
Polaryx Therapeutics, Inc. Common Stock
BEARISH
-55
SYRS
—
Syros Pharmaceuticals, Inc.
BEARISH
-56
MLYS
$1.8B
Mineralys Therapeutics, Inc.
BEARISH
-58
GENB
$1.6B
Generate Biomedicines, Inc.
BEARISH
-58
CMPS
$1.6B
COMPASS Pathways plc
BEARISH
-58
NKTR
$1.1B
Nektar Therapeutics
BEARISH
-58
AVBP
$1.0B
ArriVent BioPharma, Inc.
BEARISH
-58
ALMS
$880M
Alumis Inc.
BEARISH
-58
SANA
$700M
Sana Biotechnology, Inc.
BEARISH
-58
FULC
$280M
Fulcrum Therapeutics, Inc.
BEARISH
-58
IPSC
$260M
Century Therapeutics, Inc.
BEARISH
-58
TARA
$140M
Protara Therapeutics, Inc.
BEARISH
-58
OTLK
$130M
Outlook Therapeutics, Inc.
BEARISH
-58
VERU
$40M
Veru Inc.
BEARISH
-58
SEOVF
$30M
Sernova Corp.
BEARISH
-58
AKTX
$20M
Akari Therapeutics, Plc
BEARISH
-58
SNANF
$20M
Sona Nanotech Inc.
BEARISH
-58
ADIL
$10M
Adial Pharmaceuticals, Inc.
BEARISH
-58
LTRN
$10M
Lantern Pharma Inc.
BEARISH
-58
PLRZ
$10M
Polyrizon Ltd.
BEARISH
-58
ANEB
$10M
Anebulo Pharmaceuticals, Inc.
BEARISH
-58
HMTXF
$10M
Hemostemix Inc.
BEARISH
-58
SNTI
$10M
Senti Biosciences, Inc.
BEARISH
-58
AMBS
—
Amarantus BioScience Holdings, Inc.
BEARISH
-58
ANTH
—
Anthera Pharmaceuticals, Inc.
BEARISH
-58
ATRX
—
Adhera Therapeutics Inc
BEARISH
-58
SLXN
—
Silexion Therapeutics Ltd.
BEARISH
-58
EVGN
—
Evogene Ltd.
BEARISH
-58
AMPE
—
Ampio Pharmaceuticals, Inc.
BEARISH
-58
LIPO
—
Lipella Pharmaceuticals Inc.
BEARISH
-58
ORIC
$1.4B
ORIC Pharmaceuticals, Inc.
BEARISH
-59
IMRN
$10M
Immuron Limited
BEARISH
-59
BCTXZ
—
BriaCell Therapeutics Corp. Warrant
BEARISH
-59
ANRO
$860M
Alto Neuroscience, Inc.
BEARISH
-60
DSGN
$640M
Design Therapeutics, Inc.
BEARISH
-60
BRIBF
$90M
Brii Biosciences Limited
BEARISH
-60
ELOX
$40M
Eloxx Pharmaceuticals, Inc.
BEARISH
-60
AUTL
$410M
Autolus Therapeutics plc
BEARISH
-62
BVAXF
—
BioVaxys Technology Corp.
BEARISH
-62
AVLN
$1.1B
Avalyn Pharma Inc. Common Stock
BEARISH
-65
BCAX
$1.1B
Bicara Therapeutics Inc. Common Stock
BEARISH
-65
MNKD
$1.0B
MannKind Corporation
BEARISH
-65
GLUE
$920M
Monte Rosa Therapeutics, Inc.
BEARISH
-65
WVE
$630M
Wave Life Sciences Ltd.
BEARISH
-65
LRMR
$240M
Larimar Therapeutics, Inc.
BEARISH
-65
ALXO
$160M
ALX Oncology Holdings Inc.
BEARISH
-65
HUMA
$120M
Humacyte, Inc.
BEARISH
-65
IMUX
$100M
Immunic, Inc.
BEARISH
-65
ADAG
$90M
Adagene Inc.
BEARISH
-65
RECEF
$70M
Recce Pharmaceuticals Ltd
BEARISH
-65
TELO
$70M
Telomir Pharmaceuticals, Inc. Common Stock
BEARISH
-65
TENX
$50M
Tenax Therapeutics, Inc.
BEARISH
-65
CVM
$30M
CEL-SCI Corporation
BEARISH
-65
ARTL
$10M
Artelo Biosciences, Inc.
BEARISH
-65
FNAM
—
Evolutionary Genomics, Inc.
BEARISH
-65
WINT
—
Windtree Therapeutics, Inc.
BEARISH
-65
SYBE
—
SYBLEU Inc
BEARISH
-65
RGRX
—
RegeneRx Biopharmaceuticals, Inc.
BEARISH
-65
BICTF
—
Biocure Technology Inc.
BEARISH
-65
INVA
$1.5B
Innoviva, Inc.
BEARISH
-66
ACHV
$670M
Achieve Life Sciences, Inc.
BEARISH
-66
TECX
$390M
Tectonic Therapeutic, Inc.
BEARISH
-66
EIKN
$390M
Eikon Therapeutics, Inc. Common Stock
BEARISH
-66
CLVLF
$250M
Clinuvel Pharmaceuticals Limited
BEARISH
-66
RNAC
$190M
Cartesian Therapeutics, Inc.
BEARISH
-66
NAGE
$190M
Niagen Bioscience Inc
BEARISH
-66
VRXA
$140M
Veraxa Biotech Holding AG
BEARISH
-66
GNLX
$90M
Genelux Corporation
BEARISH
-66
TNXP
$90M
Tonix Pharmaceuticals Holding Corp.
BEARISH
-66
CNXU
$90M
Conexeu Sciences Inc.
BEARISH
-66
INO
$60M
Inovio Pharmaceuticals, Inc.
BEARISH
-66
ONCY
$50M
Oncolytics Biotech Inc.
BEARISH
-66
NDTP
$50M
NDT Pharmaceuticals Inc.
BEARISH
-66
CLCS
$40M
Cell Source, Inc.
BEARISH
-66
CNTX
$20M
Context Therapeutics Inc.
BEARISH
-66
NEUP
$20M
Neuphoria Therapeutics Inc.
BEARISH
-66
RVXCF
$20M
Resverlogix Corp.
BEARISH
-66
LPCN
$10M
Lipocine Inc.
BEARISH
-66
ICU
$10M
SeaStar Medical Holding Corporation
BEARISH
-66
PHIO
$10M
Phio Pharmaceuticals Corp.
BEARISH
-66
CDT
—
CDT Equity Inc.
BEARISH
-66
BRTX
—
BioRestorative Therapies, Inc.
BEARISH
-66
BBLG
—
Bone Biologics Corporation
BEARISH
-66
AFMDQ
—
Affimed N.V.
BEARISH
-66
SXTP
—
60 Degrees Pharmaceuticals, Inc.
BEARISH
-66
VIVS
—
VivoSim Labs, Inc.
BEARISH
-66
LNAI
—
Lunai Bioworks Inc.
BEARISH
-66
GRI
—
GRI Bio, Inc.
BEARISH
-66
DRMA
—
Dermata Therapeutics, Inc.
BEARISH
-66
MTNB
—
Matinas BioPharma Holdings, Inc.
BEARISH
-66
VCNX
—
Vaccinex, Inc.
BEARISH
-66
SPRC
—
SciSparc Ltd.
BEARISH
-66
BLEG
—
Branded Legacy, Inc.
BEARISH
-66
LITS
$40M
Lite Strategy, Inc.
BEARISH
-68
DRTS
$1.2B
Alpha Tau Medical Ltd
BEARISH
-69
SLDB
$630M
Solid Biosciences Inc.
BEARISH
-69
ORMP
$170M
Oramed Pharmaceuticals Inc.
BEARISH
-69
AMGXF
$140M
AnGes, Inc.
BEARISH
-69
ANTX
$130M
AN2 Therapeutics, Inc.
BEARISH
-69
BBIXF
$50M
Bonus BioGroup Ltd.
BEARISH
-69
INTI
$10M
Inhibitor Therapeutics, Inc.
BEARISH
-69
RMTG
—
Regenerative Medical Technology Group Inc.
BEARISH
-69
MYMX
—
Mymetics Corporation
BEARISH
-69
NWPHF
$410M
Newron Pharmaceuticals S.p.A.
BEARISH
-71
VRXAW
—
Veraxa Biotech AG
BEARISH
-71
SRNE
—
Sorrento Therapeutics, Inc.
BEARISH
-73
OLMA
$560M
Olema Pharmaceuticals, Inc.
BEARISH
-74
CBIO
$480M
Crescent Biopharma, Inc.
BEARISH
-74
BLSM
$430M
BlossomHill Therapeutics, Inc.
BEARISH
-74
GOSS
$60M
Gossamer Bio, Inc.
BEARISH
-74
IBO
$30M
Impact BioMedical Inc.
BEARISH
-74
AIM
$10M
AIM ImmunoTech Inc.
BEARISH
-74
LGVN
—
Longeveron Inc.
BEARISH
-74
BTAIQ
—
BioXcel Therapeutics, Inc.
BEARISH
-74
SILO
—
Silo Pharma, Inc.
BEARISH
-74
AAPG
$1.4B
Ascentage Pharma Group International
BEARISH
-75
OMER
$1.2B
Omeros Corporation
BEARISH
-75
ASCLF
$770M
Ascletis Pharma Inc.
BEARISH
-75
NVCT
$650M
Nuvectis Pharma, Inc.
BEARISH
-75
FDMT
$600M
4D Molecular Therapeutics, Inc.
BEARISH
-75
PHAT
$460M
Phathom Pharmaceuticals, Inc.
BEARISH
-75
EPRX
$450M
Eupraxia Pharmaceuticals Inc.
BEARISH
-75
AGEN
$290M
Agenus Inc.
BEARISH
-75
GALT
$210M
Galectin Therapeutics Inc.
BEARISH
-75
CGEN
$180M
Compugen Ltd.
BEARISH
-75
SEER
$110M
Seer, Inc.
BEARISH
-75
VANI
$100M
Vivani Medical, Inc.
BEARISH
-75
COYA
$90M
Coya Therapeutics, Inc.
BEARISH
-75
MNOV
$70M
MediciNova, Inc.
BEARISH
-75
PMVP
$70M
PMV Pharmaceuticals, Inc.
BEARISH
-75
OSTX
$60M
OS Therapies Incorporated
BEARISH
-75
SPRO
$60M
Spero Therapeutics, Inc.
BEARISH
-75
HRTX
$60M
Heron Therapeutics, Inc.
BEARISH
-75
ALPS
$50M
Alps Group Inc
BEARISH
-75
XLO
$50M
Xilio Therapeutics, Inc.
BEARISH
-75
MREO
$40M
Mereo BioPharma Group plc
BEARISH
-75
CRVO
$30M
CervoMed Inc.
BEARISH
-75
COCP
$20M
Cocrystal Pharma, Inc.
BEARISH
-75
PHYOF
$10M
IXICO plc
BEARISH
-75
OTLC
$10M
Oncotelic Therapeutics, Inc.
BEARISH
-75
GLWLF
$10M
Glow Lifetech Corp.
BEARISH
-75
KPRX
$10M
Kiora Pharmaceuticals, Inc.
BEARISH
-75
PASG
$10M
Passage Bio, Inc.
BEARISH
-75
ADTX
—
Aditxt, Inc.
BEARISH
-75
HMGN
—
Hemagen Diagnostics, Inc.
BEARISH
-75
YECO
—
EV Biologics, Inc.
BEARISH
-75
ISCO
—
International Stem Cell Corporation
BEARISH
-75
EVLO
—
Evelo Biosciences, Inc.
BEARISH
-75
ELAB
—
PMGC Holdings Inc.
BEARISH
-75
CVKD
—
Cadrenal Therapeutics, Inc. Common Stock
BEARISH
-75
CHMMF
—
Chimeric Therapeutics Limited
BEARISH
-75
MAJI
—
Nextel Medical Corp.
BEARISH
-75
RGBPP
—
Regen BioPharma, Inc.
BEARISH
-75
AGNPF
—
Grey Matters Health Inc.
BEARISH
-75
LIMNW
—
Liminatus Pharma, Inc. Warrants
BEARISH
-75
NUVB
$1.6B
Nuvation Bio Inc.
BEARISH
-78
NVAX
$1.6B
Novavax, Inc.
BEARISH
-78
MGTX
$880M
MeiraGTx Holdings plc
BEARISH
-78
LXRX
$630M
Lexicon Pharmaceuticals, Inc.
BEARISH
-78
CLYM
$590M
Climb Bio, Inc.
BEARISH
-78
MDXG
$570M
MiMedx Group, Inc.
BEARISH
-78
MNPR
$470M
Monopar Therapeutics Inc.
BEARISH
-78
AVIR
$320M
Atea Pharmaceuticals, Inc.
BEARISH
-78
PRQR
$180M
ProQR Therapeutics N.V.
BEARISH
-78
PYXS
$110M
Pyxis Oncology, Inc.
BEARISH
-78
INMB
$40M
INmune Bio, Inc.
BEARISH
-78
BMEA
$40M
Biomea Fusion, Inc.
BEARISH
-78
CELU
$30M
Celularity Inc.
BEARISH
-78
TVGN
$30M
Tevogen Bio Holdings Inc.
BEARISH
-78
AVEFF
$20M
Avecho Biotechnology Limited
BEARISH
-78
SER
$20M
Serina Therapeutics, Inc.
BEARISH
-78
SYBX
$10M
Synlogic, Inc.
BEARISH
-78
CMMB
$10M
Chemomab Therapeutics Ltd.
BEARISH
-78
XRTX
—
XORTX Therapeutics Inc.
BEARISH
-78
XTLB
—
XTL Biopharmaceuticals Ltd.
BEARISH
-78
OZYMF
—
Strategic Partners A/S
BEARISH
-78
GNLKQ
—
GeneLink, Inc.
BEARISH
-78
GLABF
—
Gemina Laboratories Ltd.
BEARISH
-78
HXBM
—
Helix BioMedix, Inc.
BEARISH
-78
KRSA
$150M
Korsana Biosciences, Inc.
BEARISH
-80
HBMHF
$1.3B
HBM Holdings Limited
BEARISH
-82
GERN
$720M
Geron Corporation
BEARISH
-82
SLBT
$640M
SL Science Holding Ltd
BEARISH
-82
GYRE
$620M
Gyre Therapeutics, Inc.
BEARISH
-82
ANNX
$610M
Annexon, Inc.
BEARISH
-82
AGMB
$450M
AgomAb Therapeutics N.V. American Depositary Shares
BEARISH
-82
ASMB
$400M
Assembly Biosciences, Inc.
BEARISH
-82
RLMD
$350M
Relmada Therapeutics, Inc.
BEARISH
-82
MPLT
$340M
MapLight Therapeutics, Inc.
BEARISH
-82
CTNM
$270M
Contineum Therapeutics, Inc.
BEARISH
-82
LXEO
$230M
Lexeo Therapeutics, Inc. Common Stock
BEARISH
-82
BOVNF
$220M
BioInvent International AB (publ)
BEARISH
-82
BBOT
$210M
BridgeBio Oncology Therapeutics Inc.
BEARISH
-82
MENS
$130M
Jyong Biotech Ltd. Ordinary Shares
BEARISH
-82
MIST
$80M
Milestone Pharmaceuticals Inc.
BEARISH
-82
NMRA
$70M
Neumora Therapeutics, Inc. Common Stock
BEARISH
-82
HBPCF
$60M
Helix BioPharma Corp.
BEARISH
-82
IMA
$50M
ImageneBio Inc
BEARISH
-82
PRRUF
$20M
Immutep Limited
BEARISH
-82
CLRB
$10M
Cellectar Biosciences, Inc.
BEARISH
-82
ARNI
—
Arno Therapeutics, Inc.
BEARISH
-82
BIOAF
—
Bioasis Technologies Inc.
BEARISH
-82
ENLV
—
Enlivex Therapeutics Ltd.
BEARISH
-82
ARUXF
—
Acrux Limited
BEARISH
-82
SEPSF
—
Asep Medical Holdings Inc
BEARISH
-82
MYNDF
—
MYND Life Sciences Inc.
BEARISH
-82
ZVRA
$580M
Zevra Therapeutics, Inc.
BEARISH
-84
IRD
$290M
Opus Genetics, Inc.
BEARISH
-84
CUE
$140M
Cue Biopharma, Inc.
BEARISH
-84
MGNX
$140M
MacroGenics, Inc.
BEARISH
-84
ACRV
$70M
Acrivon Therapeutics, Inc. Common Stock
BEARISH
-84
SKYE
$10M
Skye Bioscience, Inc.
BEARISH
-84
PTIX
—
Protagenic Therapeutics, Inc.
BEARISH
-84
EMMA
—
Emmaus Life Sciences, Inc.
BEARISH
-84
PHRRF
—
PharmaTher Holdings Ltd.
BEARISH
-84
RVLPQ
—
RVL Pharmaceuticals plc
BEARISH
-84
URGN
$1.7B
UroGen Pharma Ltd.
BEARISH
-87
MDCLF
$1.1B
MedinCell S.A.
BEARISH
-87
IMMX
$680M
Immix Biopharma, Inc.
BEARISH
-87
CADL
$610M
Candel Therapeutics, Inc.
BEARISH
-87
GNFTF
$470M
Genfit S.A.
BEARISH
-87
IKT
$220M
Inhibikase Therapeutics, Inc.
BEARISH
-87
TRGNF
$120M
Transgene S.A.
BEARISH
-87
PRNAF
$50M
Alterity Therapeutics Limited
BEARISH
-87
BOLD
$50M
Boundless Bio, Inc.
BEARISH
-87
BMNDF
$20M
Biomind Labs Inc.
BEARISH
-87
PBM
—
Psyence Biomedical Ltd.
BEARISH
-87
GENSF
$1.8B
Genus plc
BEARISH
-91
OCUL
$1.4B
Ocular Therapeutix, Inc.
BEARISH
-91
GPCR
$1.2B
Structure Therapeutics Inc.
BEARISH
-91
SNDX
$1.2B
Syndax Pharmaceuticals, Inc.
BEARISH
-91
AKTS
$850M
Aktis Oncology, Inc.
BEARISH
-91
ARDX
$770M
Ardelyx, Inc.
BEARISH
-91
CTMX
$510M
CytomX Therapeutics, Inc.
BEARISH
-91
PROK
$470M
ProKidney Corp.
BEARISH
-91
FTH
$440M
Faeth Therapeutics, Inc.
BEARISH
-91
ALLO
$430M
Allogene Therapeutics, Inc.
BEARISH
-91
AVCTF
$420M
Avacta Group Plc
BEARISH
-91
SPRY
$400M
ARS Pharmaceuticals, Inc.
BEARISH
-91
CAPR
$340M
Capricor Therapeutics, Inc.
BEARISH
-91
KYTX
$330M
Kyverna Therapeutics, Inc.
BEARISH
-91
SPHDF
$280M
Santhera Pharmaceuticals Holding AG
BEARISH
-91
ORYZF
$250M
Oryzon Genomics S.A.
BEARISH
-91
ABEO
$250M
Abeona Therapeutics Inc.
BEARISH
-91
OCGN
$250M
Ocugen, Inc.
BEARISH
-91
VNDA
$240M
Vanda Pharmaceuticals Inc.
BEARISH
-91
HLOSF
$240M
Healios K.K.
BEARISH
-91
IPHYF
$210M
Innate Pharma S.A.
BEARISH
-91
BIOA
$190M
BioAge Labs Inc.
BEARISH
-91
EVMN
$190M
Evommune, Inc.
BEARISH
-91
NBP
$160M
NovaBridge Biosciences
BEARISH
-91
SION
$160M
Sionna Therapeutics, Inc.
BEARISH
-91
AKBA
$160M
Akebia Therapeutics, Inc.
BEARISH
-91
ZNTL
$160M
Zentalis Pharmaceuticals, Inc.
BEARISH
-91
CNTN
$150M
Canton Strategic Holdings Inc
BEARISH
-91
NGEN
$150M
NervGen Pharma Corp. Common stock
BEARISH
-91
STRO
$150M
Sutro Biopharma, Inc.
BEARISH
-91
CDXS
$140M
Codexis, Inc.
BEARISH
-91
NKTX
$130M
Nkarta, Inc.
BEARISH
-91
AVXL
$120M
Anavex Life Sciences Corp.
BEARISH
-91
CBUS
$110M
Cibus, Inc.
BEARISH
-91
UNCY
$110M
Unicycive Therapeutics, Inc.
BEARISH
-91
CLLS
$100M
Cellectis S.A.
BEARISH
-91
ORPOF
$100M
OSE Immunotherapeutics S.A.
BEARISH
-91
VXRT
$100M
Vaxart, Inc.
BEARISH
-91
TNYA
$90M
Tenaya Therapeutics, Inc.
BEARISH
-91
CRBP
$80M
Corbus Pharmaceuticals Holdings, Inc.
BEARISH
-91
JWCTF
$80M
JW (Cayman) Therapeutics Co. Ltd
BEARISH
-91
CRDF
$70M
Cardiff Oncology, Inc.
BEARISH
-91
CGTX
$70M
Cognition Therapeutics, Inc.
BEARISH
-91
CRBU
$60M
Caribou Biosciences, Inc.
BEARISH
-91
IBIO
$50M
iBio, Inc.
BEARISH
-91
HYFT
$50M
MindWalk Holdings Corp.
BEARISH
-91
CNTB
$50M
Connect Biopharma Holdings Limited
BEARISH
-91
VTIAF
$50M
FamiCord AG
BEARISH
-91
EXOZ
$40M
eXoZymes, Inc.
BEARISH
-91
TIL
$40M
Instil Bio, Inc.
BEARISH
-91
DWTX
$40M
Dogwood Therapeutics, Inc.
BEARISH
-91
ANVS
$40M
Annovis Bio, Inc.
BEARISH
-91
RANI
$40M
Rani Therapeutics Holdings, Inc.
BEARISH
-91
ALDX
$40M
Aldeyra The
BEARISH
-91
IXHL
$30M
Incannex Healthcare Limited
BEARISH
-91
FLNA
$30M
Filana Therapeutics, Inc.
BEARISH
-91
BCTX
$30M
BriaCell Therapeutics Corp.
BEARISH
-91
IGC
$30M
IGC Pharma, Inc.
BEARISH
-91
GRCE
$30M
Grace Therapeutics, Inc.
BEARISH
-91
BYSI
$20M
BeyondSpring Inc.
BEARISH
-91
ATYR
$20M
aTyr Pharma, Inc.
BEARISH
-91
MVMDF
$20M
More Life Company Corp.
BEARISH
-91
TOVX
$10M
Theriva Biologics, Inc.
BEARISH
-91
QNRX
$10M
Quoin Pharmaceuticals, Ltd.
BEARISH
-91
GUTS
$10M
Fractyl Health, Inc.
BEARISH
-91
TCRX
$10M
TScan Therapeutics, Inc.
BEARISH
-91
BLRX
$10M
BioLineRx Ltd.
BEARISH
-91
VTGN
$10M
VistaGen Therapeutics, Inc.
BEARISH
-91
MSLE
$10M
Satellos Bioscience Inc.
BEARISH
-91
RDTCF
$10M
Rapid Dose Therapeutics Corp.
BEARISH
-91
CDIO
$10M
Cardio Diagnostics Holdings, Inc.
BEARISH
-91
APRE
$10M
Aprea Therapeutics, Inc.
BEARISH
-91
PTN
$10M
Palatin Technologies, Inc.
BEARISH
-91
INAB
$10M
IN8bio, Inc.
BEARISH
-91
TPST
$10M
Tempest Therapeutics, Inc.
BEARISH
-91
IMNN
$10M
Imunon, Inc.
BEARISH
-91
GTBP
$10M
GT Biopharma, Inc.
BEARISH
-91
TVRD
$10M
Tvardi Therapeutics, Inc.
BEARISH
-91
GSGTF
$10M
GenSight Biologics S.A.
BEARISH
-91
DARE
$10M
Dare Bioscience, Inc.
BEARISH
-91
QNTM
$10M
Quantum BioPharma Ltd.
BEARISH
-91
OPTBF
$10M
OptiBiotix Health Plc
BEARISH
-91
INTS
$10M
Intensity Therapeutics, Inc.
BEARISH
-91
PXXLF
$10M
Poxel S.A.
BEARISH
-91
TRAW
$10M
Traws Pharma, Inc.
BEARISH
-91
KTTA
$10M
Pasithea Therapeutics Corp.
BEARISH
-91
LIFS
—
Life Stem Genetics Inc.
BEARISH
-91
RADX
—
Radiopharm Theranostics Limited
BEARISH
-91
RASP
—
Actavia Life Sciences, Inc.
BEARISH
-91
LIMN
—
Liminatus Pharma, Inc. Class A Common Stock
BEARISH
-91
GNPX
—
Genprex, Inc.
BEARISH
-91
OGEN
—
Oragenics, Inc.
BEARISH
-91
SUVZ
—
Suvanza Pharma, LLC
BEARISH
-91
HCWB
—
HCW Biologics Inc.
BEARISH
-91
MBAI
—
MBody AI Ltd.
BEARISH
-91
KAPA
—
Kairos Pharma, Ltd.
BEARISH
-91
DCOY
—
Decoy Therapeutics Inc.
BEARISH
-91
APVO
—
Aptevo Therapeutics Inc.
BEARISH
-91
EVFM
—
Evofem Biosciences, Inc.
BEARISH
-91
CLDI
—
Calidi Biotherapeutics, Inc.
BEARISH
-91
KALA
—
KALA BIO, Inc.
BEARISH
-91
ENZC
—
Enzolytics Inc.
BEARISH
-91
MBIO
—
Mustang Bio, Inc.
BEARISH
-91
TSOI
—
Therapeutic Solutions International, Inc.
BEARISH
-91
WSNAF
—
Wesana Health Holdings Inc.
BEARISH
-91
NCEL
—
NewcelX Ltd.
BEARISH
-91
NBRVF
—
Nabriva Therapeutics plc
BEARISH
-91
BNIGF
—
Beroni Group Limited
BEARISH
-91
ZVSA
—
ZyVersa Therapeutics, Inc.
BEARISH
-91
NIKI
—
Niki BioSolutions, Inc.
BEARISH
-91
MLECW
—
Moolec Science S.A.
BEARISH
-91
XENO
—
Xeno Transplants Corporation
BEARISH
-91
TNGNQ
—
Tengion, Inc.
BEARISH
-91
VPRO
—
Viropro Inc.
BEARISH
-91
ZHCLF
—
Zenith Capital Corp.
BEARISH
-91
VBIO
—
Valion Bio, Inc.
BEARISH
-91
MDCX
—
Medicus Pharma Ltd. Common Stock
BEARISH
-91
AXIM
—
AXIM Biotechnologies, Inc.
BEARISH
-91
GOVX
—
GeoVax Labs, Inc.
BEARISH
-91
IVEVF
$750M
Inventiva S.A.
BEARISH
-100
RGNX
$440M
REGENXBIO Inc.
BEARISH
-100
ALT
$410M
Altimmune, Inc.
BEARISH
-100
AVTX
$370M
Avalo Therapeutics, Inc.
BEARISH
-100
DMTRF
$310M
3-D Matrix, Ltd.
BEARISH
-100
ACIU
$250M
AC Immune S.A.
BEARISH
-100
CABA
$250M
Cabaletta Bio, Inc.
BEARISH
-100
SCTX
$250M
Scribe Therapeutics Inc.
BEARISH
-100
PALI
$230M
Palisade Bio, Inc.
BEARISH
-100
IVVD
$180M
Invivyd, Inc.
BEARISH
-100
UPB
$150M
Upstream Bio, Inc.
BEARISH
-100
CMPX
$140M
Compass Therapeutics, Inc.
BEARISH
-100
NERV
$110M
Minerva Neurosciences, Inc.
BEARISH
-100
VYGR
$110M
Voyager Therapeutics, Inc.
BEARISH
-100
LENZ
$100M
LENZ Therapeutics, Inc.
BEARISH
-100
VTVT
$100M
vTv Therapeutics Inc.
BEARISH
-100
ENGN
$100M
enGene Holdings Inc.
BEARISH
-100
PTHS
$70M
Pelthos Therapeutics Inc.
BEARISH
-100
XBIT
$60M
XBiotech Inc.
BEARISH
-100
TLSA
$60M
Tiziana Life Sciences Ltd
BEARISH
-100
VRCA
$60M
Verrica Pharmaceuticals Inc.
BEARISH
-100
PLRX
$50M
Pliant Therapeutics, Inc.
BEARISH
-100
GANX
$50M
Gain Therapeutics, Inc.
BEARISH
-100
KLRS
$40M
Kalaris Therapeutics Inc
BEARISH
-100
ACET
$40M
Adicet Bio, Inc.
BEARISH
-100
EDSA
$30M
Edesa Biotech, Inc.
BEARISH
-100
ALGS
$30M
Aligos Therapeutics, Inc.
BEARISH
-100
EYPT
$30M
EyePoint Pharmaceuticals, Inc.
BEARISH
-100
NRXBF
$30M
NurExone Biologic Inc.
BEARISH
-100
BSEM
$30M
BioStem Technologies, Inc.
BEARISH
-100
AARD
$30M
Aardvark Therapeutics, Inc. Common Stock
BEARISH
-100
MGX
$30M
Metagenomi, Inc. Common Stock
BEARISH
-100
KYNB
$20M
Kyntra Bio, Inc.
BEARISH
-100
MCRB
$20M
Seres Therapeutics, Inc.
BEARISH
-100
TELIF
$20M
Telescope Innovations Corp.
BEARISH
-100
BXPHF
$20M
Botanix Pharmaceuticals Limited
BEARISH
-100
FBLG
$10M
FibroBiologics, Inc. Common Stock
BEARISH
-100
AIMD
$10M
Ainos, Inc.
BEARISH
-100
ACXP
$10M
Acurx Pharmaceuticals, Inc.
BEARISH
-100
RVPH
$10M
Reviva Pharmaceuticals Holdings, Inc.
BEARISH
-100
MTVA
$10M
MetaVia Inc.
BEARISH
-100
ACTU
$10M
Actuate Therapeutics Inc
BEARISH
-100
HIND
$10M
Vyome Holdings, Inc.
BEARISH
-100
BCDA
$10M
BioCardia, Inc.
BEARISH
-100
CODX
—
Co-Diagnostics, Inc.
BEARISH
-100
FAMDF
—
Futura Medical plc
BEARISH
-100
PPBT
—
Purple Biotech Ltd.
BEARISH
-100
NAVBQ
—
Navidea Biopharmaceuticals, Inc.
BEARISH
-100
LABT
—
Lakewood-Amedex Biotherapeutics, Inc.
BEARISH
-100
NSHSF
—
NanoSphere Health Sciences Inc.
BEARISH
-100
CANF
—
Can-Fite BioPharma Ltd.
BEARISH
-100
NRSN
—
NeuroSense Therapeutics Ltd.
BEARISH
-100
PMCB
—
PharmaCyte Biotech, Inc.
BEARISH
-100
CRIS
—
Curis, Inc.
BEARISH
-100
OXBOF
—
Oxford BioDynamics Plc
BEARISH
-100
XSNX
—
NovAccess Global Inc.
BEARISH
-100
CELZ
—
Creative Medical Technology Holdings, Inc.
BEARISH
-100
ZLDAF
—
Zelira Therapeutics Limited
BEARISH
-100
NMLSF
—
Restart Life Sciences Corp.
BEARISH
-100
SCPX
—
Scorpius Holdings, Inc.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| KRRO Korro Bio, Inc. | $180M | -1.3 | -97.7 | -196.6 | — | -62.1 | 2 | BULLISH | -65.1 |
| SEPN Septerna Inc | $1.9B | -81.7 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BULLISH | 103.7 |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.6B | — | — | — | — | — | — | BULLISH | — |
| VSTM Verastem, Inc. | $910M | -4.1 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | BULLISH | 27.0 |
| SOLTF Nxera Pharma Co., Ltd. | $770M | -15.8 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | BULLISH | 38.2 |
| PYPD PolyPid Ltd. | $110M | -3.9 | -1913.8 | 231.6 | — | — | 3 | BULLISH | 67.7 |
| ANIX Anixa Biosciences, Inc. | $100M | -10.8 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -20.8 |
| GRDX GridAI Technologies Corp. | $40M | -1.4 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | 44.5 |
| KLRA Kailera Therapeutics, Inc. | $1.7B | — | — | — | — | — | — | BULLISH | — |
| SPTX Seaport Therapeutics, Inc. Common Stock | $1.1B | — | — | — | — | — | — | BULLISH | — |
| SGP SpyGlass Pharma, Inc. Common Stock | $950M | — | — | — | — | — | — | BULLISH | — |
| ENTX Entera Bio Ltd. | $510M | -8.8 | -138.9 | 314.4 | — | -100.0 | 1 | BULLISH | 37.8 |
| ATNM Actinium Pharmaceuticals, Inc. | $50M | 3.9 | 45.9 | -197.8 | 79.7 | — | 3 | BULLISH | -15.0 |
| PRME Prime Medicine, Inc. | $670M | -4.0 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | -18.4 |
| XFOR X4 Pharmaceuticals, Inc. | $320M | -2.7 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BULLISH | -14.5 |
| CING Cingulate Inc. | $70M | -1.1 | -198.7 | -1452.8 | — | — | 4 | BULLISH | 43.3 |
| ESLA Estrella Immunopharma, Inc. | $40M | -3.8 | 148.1 | 102.1 | — | — | 3 | BULLISH | -60.8 |
| INDP Indaptus Therapeutics, Inc. | $360M | -0.5 | -318.0 | 6437.4 | — | — | 4 | BULLISH | -8.8 |
| VIR Vir Biotechnology, Inc. | $1.8B | -6.3 | -26.1 | -38.8 | 33.5 | 1495.9 | 5 | BULLISH | 93.5 |
| MAZE Maze Therapeutics, Inc. | $1.7B | -11.6 | -37.3 | -112.3 | — | — | 3 | BULLISH | 4.3 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -4.5 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -53.1 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.2B | -13.3 | -25.8 | -768.9 | — | — | 2 | BULLISH | 148.2 |
| OABIW OmniAb, Inc. | $1.1B | -13.8 | -16.9 | -16.8 | -43.7 | 66.9 | 6 | BULLISH | -17.6 |
| RIGL Rigel Pharmaceuticals, Inc. | $900M | 2.9 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 68.7 |
| HURA TuHURA Biosciences, Inc. | $140M | -3.9 | -161.4 | -137.6 | — | — | 2 | BULLISH | -7.9 |
| MXCT MaxCyte, Inc. | $140M | -4.6 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BULLISH | -5.5 |
| IRLA IRulya Therapeutics Inc. | $30M | — | — | — | — | — | — | BULLISH | — |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.6 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | BULLISH | -42.6 |
| AGTX Agentix Corp. | — | -5.1 | 12.0 | 8.1 | — | — | 3 | BULLISH | 6.9 |
| NAUT Nautilus Biotechnolgy, Inc. | $410M | -6.3 | -41.0 | -89.2 | -6682.1 | — | 2 | BULLISH | 136.9 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.9 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | BULLISH | -50.0 |
| XNCR Xencor, Inc. | $1.9B | -13.8 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | BULLISH | 127.0 |
| TRAX First Tracks Biotherapeutics Inc | $1.6B | — | — | — | — | — | — | BULLISH | — |
| SLN Silence Therapeutics plc | $930M | -5.2 | -90.4 | 157.8 | — | -97.6 | 1 | BULLISH | 171.0 |
| PBYI Puma Biotechnology, Inc. | $570M | 20.4 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | BULLISH | 108.8 |
| SGMT Sagimet Biosciences Inc. | $310M | -8.1 | -24.4 | -231.4 | — | — | 3 | BULLISH | 14.0 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.4 | -119.9 | 354.7 | 17.5 | — | 4 | BULLISH | -41.2 |
| NNVC NanoViricides, Inc. | $40M | -3.5 | -101.5 | -111.4 | — | — | 3 | BULLISH | -4.6 |
| MBRX Moleculin Biotech, Inc. | $10M | -0.0 | -1371.6 | -494.1 | — | — | 3 | BULLISH | -23.7 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 5 | BULLISH | 94.8 |
| NBTX Nanobiotix S.A. | $1.5B | -27.5 | 104.2 | 62.0 | -626.0 | 49.1 | 4 | BULLISH | 79.8 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.4 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | BULLISH | 6.2 |
| BDRX Biodexa Pharmaceuticals Plc | — | -0.1 | -42.3 | -117.9 | — | — | 2 | BULLISH | -89.1 |
| CBDG THC Farmaceuticals, Inc. | — | -30.9 | 2.0 | -0.9 | — | 28.1 | 5 | BULLISH | -63.1 |
| NTLA Intellia Therapeutics, Inc. | $1.6B | -3.7 | -55.4 | -92.1 | -1392.3 | 12.6 | 5 | BULLISH | -52.0 |
| PHAR Pharming Group N.V. | $710M | 81.8 | 3.6 | 3.2 | 1.8 | 7.8 | 7 | BULLISH | -12.7 |
| PCSA Processa Pharmaceuticals, Inc. | $10M | -0.3 | -464.2 | 1977.5 | — | — | 2 | BULLISH | -76.5 |
| ICCC ImmuCell Corporation | $90M | 121.3 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BULLISH | 68.8 |
| PLUR Pluri Inc. | $10M | -0.5 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | BULLISH | -69.5 |
| CASBF CanSino Biologics Inc. | $1.4B | 367.7 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BULLISH | -25.5 |
| REPL Replimune Group, Inc. | $1.1B | -4.1 | -134.3 | -1055.2 | — | — | 1 | BULLISH | 48.3 |
| PPCB Propanc Biopharma, Inc. | — | -0.1 | -161.9 | -166.7 | — | — | 4 | BULLISH | 59.9 |
| HALB Halberd Corporation | — | -25.4 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -13.9 |
| ABSI Absci Corporation | $1.6B | -13.2 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BULLISH | 147.5 |
| CRMD CorMedix Inc. | $610M | 3.3 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BULLISH | -28.4 |
| DTIL Precision BioSciences, Inc. | $180M | -2.4 | -135.1 | 203.1 | — | 3473.0 | 5 | BULLISH | 1.0 |
| NRXS NeurAxis, Inc. | $90M | -9.6 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 110.9 |
| OKYO OKYO Pharma Limited | $70M | -6.2 | -263.8 | 88.0 | — | — | 3 | BULLISH | -37.7 |
| XERS Xeris Biopharma Holdings, Inc. | $1.9B | -107.6 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 13.5 |
| ADCT ADC Therapeutics S.A. | $180M | -2.4 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BULLISH | -61.1 |
| SCNLF Scancell Holdings plc | $170M | -5.1 | 153.2 | 179.2 | — | -100.0 | 2 | BULLISH | 969.8 |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.4 | -140.0 | 105.8 | -5.6 | — | 2 | BULLISH | — |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | BULLISH | -82.9 |
| VOR Vor Biopharma Inc. | $990M | 0.1 | -73.6 | 22.2 | — | — | 3 | BULLISH | -28.1 |
| ALEC Alector, Inc. | $200M | -1.9 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | BULLISH | 40.0 |
| ACUT Accustem Sciences Inc. | — | -1.4 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BULLISH | -88.8 |
| KNBIF Kane Biotech Inc. | — | -2.4 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | BULLISH | -27.9 |
| RXRX Recursion Pharmaceuticals, Inc. | $2.0B | -3.9 | -56.6 | -99.7 | -1708.0 | -14.9 | 4 | BULLISH | -33.0 |
| KROS Keros Therapeutics, Inc. | $220M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | BULLISH | -24.0 |
| TXTM ProText Mobility, Inc. | $90M | 86.0 | -0.4 | -0.3 | — | -100.0 | 1 | BULLISH | 273.9 |
| IMCR Immunocore Holdings plc | $1.6B | -177.3 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BULLISH | -3.4 |
| DMAC DiaMedica Therapeutics Inc. | $470M | -12.1 | -114.6 | 616.3 | — | — | 2 | BULLISH | 26.3 |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BULLISH | — |
| MLTX MoonLake Immunotherapeutics | $1.0B | -3.1 | -67.4 | 2902.7 | — | — | 1 | BULLISH | 25.3 |
| PDSB PDS Biotechnology Corporation | $60M | -2.0 | -544.0 | 456.9 | — | — | 1 | BULLISH | 41.4 |
| NYMXF Nymox Pharmaceutical Corporation | $10M | -0.9 | 193.9 | 89.4 | — | — | 2 | BULLISH | -63.2 |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.1 | -115.7 | -377.9 | — | -133.3 | 3 | BULLISH | -25.0 |
| PULM Pulmatrix, Inc. | $10M | -1.4 | -98.3 | -835.1 | — | -100.0 | 3 | BULLISH | -69.2 |
| TCRT Alaunos Therapeutics, Inc. | $10M | -1.1 | -185.9 | -607.2 | — | -50.0 | 1 | BULLISH | -26.9 |
| EDIT Editas Medicine, Inc. | $370M | -3.5 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BULLISH | -30.1 |
| PEPG PepGen Inc. | $170M | -1.7 | -75.5 | -327.5 | — | — | 4 | BULLISH | -43.1 |
| NGNE Neurogene Inc. | $370M | -4.9 | -45.3 | -111469.0 | — | — | 2 | LEAN BULL | -9.7 |
| BCYC Bicycle Therapeutics plc | $250M | -1.4 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | LEAN BULL | -52.0 |
| LCTX Lineage Cell Therapeutics, Inc. | $250M | -7.3 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | LEAN BULL | -39.4 |
| ABOS Acumen Pharmaceuticals, Inc. | $140M | -1.5 | -162.7 | 466.8 | — | — | 2 | LEAN BULL | 2.3 |
| IUGNF Imugene Limited | $30M | -0.1 | -389.5 | -458.5 | — | -100.0 | 1 | LEAN BULL | -74.0 |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | LEAN BULL | 0.0 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | LEAN BULL | -92.3 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | LEAN BULL | 100.0 |
| PTCHF PureTech Health plc | $390M | 157.0 | 0.2 | 50.8 | 1890.6 | 7.7 | 4 | LEAN BULL | -5.4 |
| OBIO Orchestra BioMed Holdings, Inc. | $340M | -5.8 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | LEAN BULL | 46.0 |
| ACOG Alpha Cognition Inc | $130M | -8.2 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | LEAN BULL | 11.1 |
| CKDXF Ceryvyn Therapeutics Ltd | $10M | 0.1 | -243.9 | 2882.8 | — | -97.3 | 3 | LEAN BULL | -97.6 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | LEAN BULL | -44.7 |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -326.4 | 584.9 | — | -100.0 | 1 | LEAN BULL | -93.9 |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | LEAN BULL | 300.0 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | LEAN BULL | 200.0 |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.2 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | LEAN BULL | -79.8 |
| NTRR Neutra Corp. | — | 2.0 | -139.6 | -802.5 | -3.8 | 142.2 | 7 | LEAN BULL | -33.3 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.8 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | LEAN BULL | -19.1 |
| CCCC C4 Therapeutics, Inc. | $380M | -3.2 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | LEAN BULL | 31.0 |
| ZURA Zura Bio Limited | $320M | -3.8 | -65.4 | 806.5 | — | — | 2 | LEAN BULL | 15.7 |
| BIVI BioVie Inc. | $10M | -0.4 | -0.0 | -0.0 | — | — | 3 | LEAN BULL | -23.4 |
| VSBC VitaSpring Biomedical Co. Ltd. | $10M | -13.8 | 10.3 | 15.9 | — | -100.0 | 4 | LEAN BULL | -96.8 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | LEAN BULL | 29.6 |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | LEAN BULL | 600.0 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.6 | -125.6 | 710.2 | — | — | 3 | LEAN BULL | 92.1 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | LEAN BULL | 23.3 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 4 | LEAN BULL | 194.5 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | LEAN BULL | 100.0 |
| ACHFF Arch Biopartners Inc. | $40M | -20.5 | 73.5 | 165.4 | — | 100.0 | 2 | LEAN BULL | -12.6 |
| PRLD Prelude Therapeutics Incorporated | $210M | -4.9 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | LEAN BULL | 139.5 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | LEAN BULL | — |
| SRZN Surrozen, Inc. | $190M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | LEAN BULL | 114.8 |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | LEAN BULL | — |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| CYDY CytoDyn Inc. | $380M | -4.9 | 57.8 | 24.6 | — | 100.0 | 4 | LEAN BULL | -16.2 |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | LEAN BULL | -65.7 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | LEAN BULL | -20.0 |
| PVLA Palvella Therapeutics, Inc. | $1.8B | -27.5 | -46.6 | 137.5 | — | — | 3 | LEAN BULL | 82.1 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -9.0 | -45.3 | -2390.9 | — | — | 2 | LEAN BULL | 51.2 |
| PRTA Prothena Corporation plc | $420M | -10.6 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | LEAN BULL | -10.3 |
| ENTA Enanta Pharmaceuticals, Inc. | $340M | -5.1 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BULL | 15.9 |
| GLSI Greenwich LifeSciences, Inc. | $240M | -11.3 | -951.6 | 299.9 | — | — | 2 | LEAN BULL | 74.4 |
| CLNN Clene Inc. | $60M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | LEAN BULL | -52.4 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | LEAN BULL | 0.0 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -2.8 | 9.2 | 7.5 | — | — | 2 | LEAN BULL | -51.2 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BULL | 100.0 |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | LEAN BULL | 0.0 |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | LEAN BULL | -90.0 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -13.1 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | NEUTRAL | -17.2 |
| ABVC ABVC BioPharma, Inc. | $30M | -3.6 | -82.2 | -43.0 | — | -100.0 | 2 | NEUTRAL | -64.4 |
| ANAB AnaptysBio, Inc. | $1.5B | 7.4 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | NEUTRAL | 112.3 |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | NEUTRAL | -50.0 |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | NEUTRAL | — |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | NEUTRAL | 0.0 |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | NEUTRAL | -38.4 |
| SABS SAB Biotherapeutics, Inc. | $260M | 0.9 | -11.3 | -48.4 | — | -100.0 | 3 | NEUTRAL | 1.3 |
| NWBO Northwest Biotherapeutics, Inc. | $260M | -6.5 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | NEUTRAL | -33.7 |
| MLLCF Molecular Partners AG | $150M | -2.3 | -62.1 | 650.3 | — | -100.0 | 2 | NEUTRAL | 14.6 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | NEUTRAL | 900.0 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.2 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | NEUTRAL | -71.9 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | NEUTRAL | 9900.0 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | NEUTRAL | 0.0 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | NEUTRAL | 900.0 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | NEUTRAL | -90.0 |
| LYCA Lycia Therapeutics Inc. | $1.6B | — | — | — | — | — | — | N/A | — |
| CTY City Therapeutics Inc. | $200M | — | — | — | — | — | — | N/A | — |
| IAM Iambic Therapeutics Inc. | $130M | — | — | — | — | — | — | N/A | — |
| ATOS Atossa Therapeutics, Inc. | $30M | -0.5 | -89.2 | -4213.1 | — | — | 2 | NEUTRAL | -83.0 |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| ORGS Orgenesis Inc. | — | -0.2 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | NEUTRAL | 66.7 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.5 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | NEUTRAL | -30.7 |
| ODTX Odyssey Therapeutics, Inc. | $940M | — | — | — | — | — | — | NEUTRAL | — |
| DRUG Bright Minds Biosciences Inc. | $520M | -26.2 | -13.7 | -105758.3 | — | — | 3 | NEUTRAL | -11.7 |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.2 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | NEUTRAL | 1.7 |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | NEUTRAL | — |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | NEUTRAL | -96.7 |
| CNBX CNBX Pharmaceuticals Inc. | — | -0.5 | 17.8 | 13.3 | — | 100.0 | 3 | NEUTRAL | -57.1 |
| CALC CalciMedica, Inc. | — | -0.2 | -365.7 | 118.3 | — | — | 4 | NEUTRAL | -91.3 |
| YARW Yarrow Bioscience Inc | $180M | — | — | — | — | — | — | NEUTRAL | — |
| ELUT Elutia Inc | $40M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | NEUTRAL | -10.6 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | NEUTRAL | 9900.0 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | NEUTRAL | -69.4 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | NEUTRAL | -99.6 |
| RNXT RenovoRx, Inc. | $60M | -4.4 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | NEUTRAL | 17.8 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | NEUTRAL | 100.0 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -2.8 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | NEUTRAL | 14.2 |
| VCRE Vicore Pharma Holding AB | $260M | — | — | — | — | — | — | NEUTRAL | — |
| ENGNW enGene Holdings Inc. Warrants | $10M | -5.5 | -2.3 | 134.1 | — | -100.0 | 2 | NEUTRAL | -64.6 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | NEUTRAL | 0.0 |
| NXTC NextCure, Inc. | $20M | -0.5 | -195.2 | 949.7 | — | — | 2 | NEUTRAL | -37.8 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | NEUTRAL | -48.4 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | NEUTRAL | 0.0 |
| ATXI Avenue Therapeutics, Inc. | — | -0.5 | -120.0 | 178.4 | — | -100.0 | 2 | NEUTRAL | -43.9 |
| MBXBF Microbix Biosystems Inc. | $30M | -8.6 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | LEAN BEAR | 24.3 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | LEAN BEAR | -25.4 |
| POLBF Poolbeg Pharma PLC | $70M | -8.5 | -58.8 | -255.9 | — | — | 1 | LEAN BEAR | 125.4 |
| CLYYF Celyad Oncology S.A. | $10M | 2.5 | -11.7 | -979.7 | 64360.6 | -88.7 | 5 | LEAN BEAR | 40.0 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | LEAN BEAR | 125.6 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.7 | -46.9 | 1464.5 | — | — | 4 | LEAN BEAR | -21.7 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | LEAN BEAR | -86.5 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.2 | 9.2 | 4.5 | — | -100.0 | 3 | LEAN BEAR | -50.0 |
| APLMW Apollomics, Inc. | $170M | -2.6 | -233.7 | 845.7 | 1188.0 | -75.9 | 3 | LEAN BEAR | -56.5 |
| ARMP Armata Pharmaceuticals, Inc. | $140M | -0.7 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | LEAN BEAR | -42.4 |
| EQ Equillium, Inc. | $80M | -5.3 | -59.0 | 2703.6 | — | -100.0 | 3 | LEAN BEAR | -3.5 |
| LEXX Lexaria Bioscience Corp. | $10M | -0.6 | -150.3 | -504.2 | — | -68.5 | 4 | LEAN BEAR | -78.8 |
| KPTI Karyopharm Therapeutics Inc. | $10M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | LEAN BEAR | -92.4 |
| ADXN Addex Therapeutics Ltd | — | -0.4 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | LEAN BEAR | -68.8 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -50.5 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | LEAN BEAR | -47.5 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | LEAN BEAR | 0.0 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | LEAN BEAR | 1900.0 |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | LEAN BEAR | -97.7 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | LEAN BEAR | 900.0 |
| SLGL Sol-Gel Technologies Ltd. | $230M | -12.1 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | LEAN BEAR | 74.8 |
| MMIRF MedMira Inc. | $30M | -11.4 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | LEAN BEAR | -20.4 |
| JBIO Jade Biosciences, Inc. | $930M | -5.4 | -47.8 | 629.9 | — | — | 3 | LEAN BEAR | 47.4 |
| CGEM Cullinan Therapeutics, Inc. | $880M | -4.4 | -50.3 | 1635.6 | — | — | 1 | LEAN BEAR | 91.2 |
| ACRS Aclaris Therapeutics, Inc. | $550M | -6.5 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | LEAN BEAR | 76.3 |
| IFRX InflaRx N.V. | $230M | -3.1 | -38.5 | 251.5 | — | -106.2 | 4 | LEAN BEAR | 18.6 |
| LADX LadRx Corporation | — | -0.0 | 278.9 | 118.4 | — | -61.0 | 1 | LEAN BEAR | -99.0 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BEAR | -97.6 |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| ADRX ADARx Pharmaceuticals, Inc. | $1.9B | — | — | — | — | — | — | LEAN BEAR | — |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | LEAN BEAR | 983.3 |
| HSTC HST Global, Inc. | $210M | -538.5 | -2.5 | -1.2 | -13.7 | 564.0 | 5 | LEAN BEAR | 349900.0 |
| DBVT DBV Technologies S.A. | $230M | -2.6 | -142.6 | -2201.5 | — | -100.0 | 2 | LEAN BEAR | -34.3 |
| RNA Atrium Therapeutics, Inc. | $140M | -2.2 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | LEAN BEAR | -82.9 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | LEAN BEAR | -55.3 |
| PBIGF Paradigm Biopharmaceuticals Limited | $10M | -1.6 | -456.6 | 1081.8 | -60158.9 | 53.6 | 4 | LEAN BEAR | -96.1 |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | LEAN BEAR | — |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | LEAN BEAR | 100.0 |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | LEAN BEAR | -75.0 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 100.0 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -81.7 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | LEAN BEAR | 18.1 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -10.8 | -1773.6 | 55.8 | — | -100.0 | 4 | LEAN BEAR | 67.0 |
| KARD Kardigan, Inc. | $1.1B | — | — | — | — | — | — | LEAN BEAR | — |
| YDES YD Bio Limited Ordinary Shares | $350M | — | — | — | — | — | — | LEAN BEAR | -64.9 |
| FATE Fate Therapeutics, Inc. | $250M | -2.0 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | LEAN BEAR | 115.1 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.4 | -37.2 | -1604.9 | — | -100.0 | 1 | LEAN BEAR | -55.5 |
| NTHI Neonc Technologies Holdings, Inc. | $90M | — | — | — | — | — | — | LEAN BEAR | -66.1 |
| SGMOQ Sangamo Therapeutics, Inc. | $50M | — | — | — | — | — | — | LEAN BEAR | — |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | LEAN BEAR | -80.8 |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | LEAN BEAR | 0.0 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -20.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | LEAN BEAR | 0.0 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | LEAN BEAR | 0.0 |
| FGHQF Frontage Holdings Corporation | $360M | 36.5 | 3.1 | 3.0 | 4.6 | 9.8 | 7 | LEAN BEAR | 16.8 |
| GWIN Glorywin Entertainment Group, Inc. | $360M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 229.5 |
| KNTPF Kintor Pharmaceutical Limited | $120M | -2.9 | -116.6 | -74.4 | -145.6 | 2237.9 | 3 | LEAN BEAR | -10.2 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -5.1 | -47.4 | -24288.6 | — | -100.0 | 3 | LEAN BEAR | 51.6 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -0.8 | 119.2 | 76.7 | — | -100.0 | 1 | LEAN BEAR | 12.7 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | LEAN BEAR | 100.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | LEAN BEAR | 586.4 |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | LEAN BEAR | — |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | LEAN BEAR | -99.8 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -53.1 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 123.7 | 6.2 | 22.4 | 14.6 | -68.5 | 5 | LEAN BEAR | 20.8 |
| CUBT Curative Biotechnology, Inc. | — | -2.0 | 31.0 | 15.3 | — | — | 4 | LEAN BEAR | 8.5 |
| KZIA Kazia Therapeutics Ltd ADR | $10M | -1.1 | -104.5 | 62.7 | — | -99.2 | 4 | LEAN BEAR | 17.1 |
| LIANY LianMedical | — | 1.1 | 74.7 | -612.1 | — | — | 6 | LEAN BEAR | -28.6 |
| TSHA Taysha Gene Therapies, Inc. | $1.3B | -10.1 | -47.1 | 961.0 | — | -32.3 | 3 | BEARISH | -10.5 |
| ARVN Arvinas, Inc. | $470M | 39.2 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BEARISH | -19.1 |
| CAMP CAMP4 Therapeutics Corporation | $210M | -1.6 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | BEARISH | -1.9 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | BEARISH | -58.1 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BEARISH | -7.5 |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | BEARISH | -99.2 |
| PKTX ProtoKinetix, Incorporated | — | -1.0 | -117.2 | -115.0 | — | — | 2 | BEARISH | -95.4 |
| INNMF Amplia Therapeutics Limited | $30M | -4.9 | -24.9 | -86.9 | — | -100.0 | 2 | BEARISH | -35.3 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $10M | -4.9 | 64.4 | 131.0 | — | — | 4 | BEARISH | -42.8 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | 33.3 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| SNBIF SanBio Company Limited | $1.3B | -19.5 | -55.8 | -2935.2 | — | — | 3 | BEARISH | 0.0 |
| OVID Ovid Therapeutics Inc. | $420M | -4.7 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | BEARISH | 38.6 |
| RZLT Rezolute, Inc. | $370M | -5.4 | -59.0 | 1060.6 | — | — | 2 | BEARISH | -55.3 |
| MDWD MediWound Ltd. | $150M | -7.8 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | BEARISH | -31.9 |
| CSBR Champions Oncology, Inc. | $70M | -61.1 | -30.7 | -7.8 | -2.8 | 6.7 | 3 | BEARISH | -29.9 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.0 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | -7.6 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.8 | -237.8 | -86.8 | — | — | 4 | BEARISH | -53.1 |
| XCUR Exicure, Inc. | $10M | -0.8 | -168.4 | 779.8 | — | — | 2 | BEARISH | -78.0 |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | BEARISH | 100.0 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | BEARISH | 0.0 |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.4 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | BEARISH | 0.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | BEARISH | 0.0 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | BEARISH | 0.0 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 0.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | BEARISH | 0.0 |
| TRVI Trevi Therapeutics, Inc. | $1.8B | -39.5 | -19.7 | -1451.7 | — | — | 3 | BEARISH | 27.0 |
| QURE uniQure N.V. | $1.6B | -6.0 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | BEARISH | -60.2 |
| BPMUF Basilea Pharmaceutica AG | $960M | 16.9 | 39.5 | 75.9 | 23.5 | 4.5 | 7 | BEARISH | 27.1 |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.2 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BEARISH | -16.9 |
| INKT MiNK Therapeutics, Inc. | $50M | -4.4 | 57.9 | 42.8 | — | — | 4 | BEARISH | -29.0 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.6 | -218.7 | -392.2 | — | — | 1 | BEARISH | -64.0 |
| SYGGF Synairgen plc | — | -0.2 | -71.9 | -381.4 | — | — | 1 | BEARISH | -50.0 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.2B | -9.1 | -40.0 | 3981.5 | — | — | 4 | BEARISH | 6.2 |
| ATGGF Actinogen Medical Limited | $140M | -8.5 | -77.5 | -235.8 | — | -100.0 | 1 | BEARISH | 17.2 |
| NRXP NRx Pharmaceuticals, Inc. | $110M | -3.6 | 131.2 | 61.3 | -1500.5 | — | 5 | BEARISH | -14.6 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | 4.3 |
| MEOBF Mesoblast Limited | $2.0B | -30.6 | -9.9 | -14.4 | -23.4 | 613.8 | 5 | BEARISH | -20.0 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -75.2 |
| BCRX BioCryst Pharmaceuticals, Inc. | $1.9B | -5.6 | 87.8 | 62.3 | 35.9 | 68.7 | 5 | BEARISH | 12.5 |
| APMD Apnimed, Inc. | $790M | — | — | — | — | — | — | BEARISH | — |
| STTK Shattuck Labs, Inc. | $550M | -11.3 | -39.2 | -29.3 | — | -66.6 | 4 | BEARISH | 200.5 |
| BNTC Benitec Biopharma Inc. | $300M | -8.9 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -35.5 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.4 | -110.7 | 411.1 | — | — | 2 | BEARISH | -30.8 |
| CHRS Coherus Oncology, Inc. | $160M | -1.0 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | BEARISH | -35.1 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.1 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | BEARISH | -49.6 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.8 | -218.7 | 330.4 | — | — | 3 | BEARISH | -18.2 |
| AURX Nuo Therapeutics, Inc. | $60M | -31.1 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | BEARISH | -47.8 |
| RNTX Rein Therapeutics Inc. | $50M | -0.4 | -753.6 | 53.9 | — | — | 3 | BEARISH | -51.1 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.9 | -774.6 | 2147.3 | — | — | 4 | BEARISH | -81.1 |
| JSPR Jasper Therapeutics, Inc. | $20M | -0.3 | -255.0 | 773.9 | — | — | 2 | BEARISH | -78.1 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -74.2 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.6 | -66.1 | -87.8 | -1125.6 | -11.3 | 0 | BEARISH | -62.8 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -4.6 | -36.8 | -30.3 | -1182.3 | -95.8 | 2 | BEARISH | -95.4 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | BEARISH | -99.8 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | BEARISH | -56.8 |
| PPTDF PeptiDream Inc. | $870M | -38.0 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BEARISH | -38.7 |
| TRDA Entrada Therapeutics, Inc. | $170M | -1.1 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | BEARISH | -35.4 |
| ERNA Ernexa Therapeutics Inc. | — | -0.1 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -93.6 |
| MRES Institute of Biomedical Research Corp. | — | -2.3 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -81.2 |
| CSPHF CStone Pharmaceuticals | $1.4B | -14.4 | -51.4 | -340.2 | -123.0 | 135.6 | 5 | BEARISH | -15.4 |
| DRTSW Alpha Tau Medical Ltd. | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 807.7 |
| RLYB Rallybio Corporation | $90M | 3.5 | 34.5 | -1198.7 | — | -35.6 | 6 | BEARISH | 2511.5 |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | BEARISH | -73.5 |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.6 | -99.9 | 590.1 | — | -90.7 | 2 | BEARISH | -56.6 |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | BEARISH | -98.5 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | BEARISH | -86.8 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | BEARISH | -99.9 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -75.0 |
| RNUGF ReNeuron Group plc | — | -0.0 | -106.8 | 210.1 | -1809.6 | -68.2 | 1 | BEARISH | 0.0 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| WHWK Whitehawk Therapeutics Inc | $180M | -3.0 | -45.0 | 963.4 | — | -100.0 | 1 | BEARISH | 38.2 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -7.0 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | BEARISH | -42.7 |
| HNSBF Hansa Biopharma AB (publ) | $330M | -4.6 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | -28.2 |
| VICP Vicapsys Life Sciences, Inc. | $10M | -20.5 | 31.3 | 17.6 | — | — | 5 | BEARISH | -73.3 |
| VOGX Vogenx Inc. | $260M | — | — | — | — | — | — | BEARISH | — |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| IDRSF Idorsia Ltd | $1.4B | -3.5 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | 19.6 |
| VBIZF Viva Biotech Holdings | $400M | 13.0 | 4.5 | 4.2 | 8.0 | 2.9 | 7 | BEARISH | -35.1 |
| RCKT Rocket Pharmaceuticals, Inc. | $250M | -15.3 | -4.8 | -137.8 | — | — | 3 | BEARISH | -36.4 |
| CRVS Corvus Pharmaceuticals, Inc. | $890M | -16.5 | -35.4 | -415.6 | — | — | 4 | BEARISH | 43.4 |
| SVRA Savara Inc. | $870M | -8.4 | -105.5 | -15438.9 | — | — | 2 | BEARISH | 11.5 |
| IMRX Immuneering Corporation | $240M | -3.7 | -52.1 | -112.8 | — | — | 4 | BEARISH | -36.6 |
| PMN ProMIS Neurosciences, Inc. | $70M | -0.6 | -172.3 | 844.3 | — | — | 2 | BEARISH | -10.3 |
| IMTX Immatics N.V. | $1.1B | -4.1 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -28.7 |
| KURA Kura Oncology, Inc. | $850M | -2.9 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BEARISH | 2.1 |
| ATTO Attovia Therapeutics, Inc. | $630M | -16.1 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 272.2 |
| OCS Oculis Holding AG | $490M | -4.6 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -63.1 |
| DYAI Dyadic International, Inc. | $20M | -1.8 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -65.5 |
| DVHGF Devonian Health Group, Inc. | $20M | — | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| ALLR Allarity Therapeutics, Inc. | $10M | -1.2 | -157.1 | -96.5 | — | — | 2 | BEARISH | -33.8 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| BITRF Biotron Limited | — | -3.6 | -87.5 | -87.8 | -113.4 | -71.0 | 0 | BEARISH | -90.7 |
| BIORQ Biora Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| AURA Aura Biosciences, Inc. | $650M | -3.5 | -53.5 | -1360.0 | — | — | 4 | BEARISH | 7.5 |
| TTRX Turn Therapeutics Inc. | $310M | -35.8 | -952.4 | 115.0 | — | — | 2 | BEARISH | 105.1 |
| ARCT Arcturus Therapeutics Holdings Inc. | $280M | -3.4 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | BEARISH | 0.1 |
| SPHRY Starpharma Holdings Limited | $220M | -26.6 | -46.5 | -441.4 | -725.1 | 186.8 | 4 | BEARISH | 73.3 |
| BETRF BetterLife Pharma Inc. | $110M | -10.2 | 34.9 | 21.6 | — | — | 4 | BEARISH | 243.4 |
| NTRB Nutriband Inc. | $70M | -10.4 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | BEARISH | -16.8 |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $30M | -4.9 | 239.0 | 256.6 | -409.4 | — | 2 | BEARISH | — |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -4.3 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -33.9 |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | BEARISH | -85.1 |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | BEARISH | -96.2 |
| VRAX Virax Biolabs Group Limited | — | -0.0 | -110.9 | -481.7 | -40439.1 | 121.6 | 4 | BEARISH | 103.4 |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | BEARISH | -87.5 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -63.6 |
| GHRS GH Research PLC | $1.2B | -20.0 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 43.5 |
| ABUS Arbutus Biopharma Corp | $830M | 5.4 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -1.6 |
| QTTB Q32 Bio Inc. | $260M | 3.1 | 72.1 | 435.2 | — | — | 5 | BEARISH | 193.3 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.7 | -628.5 | -474.6 | — | — | 4 | BEARISH | 0.0 |
| ANL Adlai Nortye Ltd. | $560M | -5.5 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | BEARISH | 549.1 |
| ARTV Artiva Biotherapeutics, Inc. | $300M | -1.3 | -36.6 | -954.6 | — | — | 3 | BEARISH | -21.1 |
| PLX Protalix BioTherapeutics, Inc. | $210M | 10.5 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | BEARISH | 7.2 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 131.0 |
| ALZN Alzamend Neuro Inc | $10M | -0.5 | -163.2 | 401.5 | — | — | 1 | BEARISH | -54.6 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | -11.1 |
| XBIO Xenetic Biosciences, Inc. | — | -1.5 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | BEARISH | -54.6 |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $90M | -15.4 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | 0.0 |
| MLYS Mineralys Therapeutics, Inc. | $1.8B | -5.0 | -80.9 | 2274.6 | — | — | 2 | BEARISH | -47.0 |
| GENB Generate Biomedicines, Inc. | $1.6B | -7.8 | -28.2 | -175.0 | -1065.2 | — | 1 | BEARISH | — |
| CMPS COMPASS Pathways plc | $1.6B | -2.1 | -319.1 | 48.8 | — | — | 2 | BEARISH | 88.1 |
| NKTR Nektar Therapeutics | $1.1B | -5.7 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -36.8 |
| AVBP ArriVent BioPharma, Inc. | $1.0B | -4.2 | -53.1 | 2345.1 | — | — | 3 | BEARISH | -17.2 |
| ALMS Alumis Inc. | $880M | -1.7 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | BEARISH | 47.2 |
| SANA Sana Biotechnology, Inc. | $700M | -3.3 | -152.9 | -242.3 | — | — | 3 | BEARISH | -55.8 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.1 | -32.4 | 2389.1 | — | — | 4 | BEARISH | -59.9 |
| IPSC Century Therapeutics, Inc. | $260M | -1.4 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 151.2 |
| TARA Protara Therapeutics, Inc. | $140M | -1.8 | -45.8 | -41.3 | — | — | 2 | BEARISH | -51.6 |
| OTLK Outlook Therapeutics, Inc. | $130M | -0.5 | 256.9 | 1372.0 | -225766.7 | -169.4 | 3 | BEARISH | -61.9 |
| VERU Veru Inc. | $40M | -3.8 | -62.3 | -211.2 | — | -100.0 | 3 | BEARISH | -40.0 |
| SEOVF Sernova Corp. | $30M | -3.7 | 57.0 | 76.3 | — | — | 3 | BEARISH | -35.6 |
| AKTX Akari Therapeutics, Plc | $20M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -71.0 |
| SNANF Sona Nanotech Inc. | $20M | -12.9 | 526.4 | 252.2 | — | — | 1 | BEARISH | -58.7 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.2 | -2011.6 | 159.6 | — | — | 3 | BEARISH | -58.8 |
| LTRN Lantern Pharma Inc. | $10M | -0.4 | -400.9 | 115.9 | — | — | 2 | BEARISH | -84.3 |
| PLRZ Polyrizon Ltd. | $10M | -1.9 | -21.4 | -68.2 | — | — | 0 | BEARISH | 39.6 |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -1.7 | -69.7 | 650.7 | — | — | 1 | BEARISH | -90.5 |
| HMTXF Hemostemix Inc. | $10M | -2.0 | 69.9 | 190.1 | — | — | 1 | BEARISH | -44.5 |
| SNTI Senti Biosciences, Inc. | $10M | -0.1 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -91.0 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | BEARISH | -66.7 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 0.0 |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | 0.0 |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -95.0 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -69.6 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 5806.4 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.4B | -6.7 | -39.8 | -102.9 | — | — | 3 | BEARISH | -31.3 |
| IMRN Immuron Limited | $10M | -2.9 | -40.2 | -187.8 | -54.4 | -29.7 | 5 | BEARISH | -56.7 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BEARISH | -68.2 |
| ANRO Alto Neuroscience, Inc. | $860M | -9.4 | -49.2 | -201.4 | — | — | 3 | BEARISH | 110.7 |
| DSGN Design Therapeutics, Inc. | $640M | -9.0 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 85.5 |
| BRIBF Brii Biosciences Limited | $90M | -3.3 | -10.3 | -62.6 | — | 22.5 | 4 | BEARISH | -46.0 |
| ELOX Eloxx Pharmaceuticals, Inc. | $40M | -8.8 | -107.5 | 81.5 | — | — | 4 | BEARISH | 13339900.4 |
| AUTL Autolus Therapeutics plc | $410M | -1.5 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | 1.3 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -45.4 |
| AVLN Avalyn Pharma Inc. Common Stock | $1.1B | — | — | — | — | — | — | BEARISH | — |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.1B | -5.6 | -41.0 | 583.9 | — | — | 2 | BEARISH | 2.0 |
| MNKD MannKind Corporation | $1.0B | -23.6 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | BEARISH | -38.0 |
| GLUE Monte Rosa Therapeutics, Inc. | $920M | -4.9 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | -4.3 |
| WVE Wave Life Sciences Ltd. | $630M | -3.2 | -80.0 | -1243.7 | -470.5 | -35.1 | 4 | BEARISH | -51.6 |
| LRMR Larimar Therapeutics, Inc. | $240M | -1.2 | -139.6 | 590.9 | — | — | 2 | BEARISH | -43.2 |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.0 | -80.6 | -851.1 | — | — | 4 | BEARISH | -37.1 |
| HUMA Humacyte, Inc. | $120M | -0.9 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | BEARISH | -73.9 |
| IMUX Immunic, Inc. | $100M | -1.6 | -138.2 | 345.6 | — | — | 5 | BEARISH | -0.9 |
| ADAG Adagene Inc. | $90M | -5.5 | -28.6 | 111.8 | -1011.1 | 8927.0 | 5 | BEARISH | 45.8 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -5.8 | 151.4 | 200.5 | — | -100.0 | 2 | BEARISH | -56.0 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $70M | -0.7 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -32.0 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.2 | -59.8 | 1235.8 | — | — | 1 | BEARISH | -76.7 |
| CVM CEL-SCI Corporation | $30M | -0.6 | -252.5 | -142.9 | — | -100.0 | 4 | BEARISH | -82.9 |
| ARTL Artelo Biosciences, Inc. | $10M | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -92.8 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | BEARISH | -99.6 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| INVA Innoviva, Inc. | $1.5B | 4.3 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | BEARISH | 18.2 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.5 | -845.0 | 24.6 | — | — | 2 | BEARISH | 38.6 |
| TECX Tectonic Therapeutic, Inc. | $390M | -4.5 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 18.6 |
| EIKN Eikon Therapeutics, Inc. Common Stock | $390M | — | — | — | — | — | — | BEARISH | — |
| CLVLF Clinuvel Pharmaceuticals Limited | $250M | 10.6 | 13.2 | 126.7 | 41.1 | -1.1 | 6 | BEARISH | -32.0 |
| RNAC Cartesian Therapeutics, Inc. | $190M | -1.1 | 241.0 | 37.3 | — | 44.0 | 2 | BEARISH | -29.5 |
| NAGE Niagen Bioscience Inc | $190M | 12.9 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -67.0 |
| VRXA Veraxa Biotech Holding AG | $140M | — | — | — | — | — | — | BEARISH | — |
| GNLX Genelux Corporation | $90M | -2.3 | -168.9 | 20537.7 | — | — | 2 | BEARISH | -73.8 |
| TNXP Tonix Pharmaceuticals Holding Corp. | $90M | -0.4 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -72.3 |
| CNXU Conexeu Sciences Inc. | $90M | — | — | — | — | — | — | BEARISH | — |
| INO Inovio Pharmaceuticals, Inc. | $60M | -0.8 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -61.8 |
| ONCY Oncolytics Biotech Inc. | $50M | -1.9 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -61.5 |
| NDTP NDT Pharmaceuticals Inc. | $50M | -39.2 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -83.3 |
| CLCS Cell Source, Inc. | $40M | -4.6 | 27.7 | 34.5 | — | — | 4 | BEARISH | 24.0 |
| CNTX Context Therapeutics Inc. | $20M | -0.5 | -76.1 | 841.7 | — | — | 2 | BEARISH | -81.4 |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -45.7 |
| RVXCF Resverlogix Corp. | $20M | -1.5 | 11.5 | 25.3 | — | — | 4 | BEARISH | -30.1 |
| LPCN Lipocine Inc. | $10M | -0.8 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -49.7 |
| ICU SeaStar Medical Holding Corporation | $10M | -0.6 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BEARISH | -59.0 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.7 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -57.1 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -97.3 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -95.7 |
| BBLG Bone Biologics Corporation | — | -0.2 | -47.5 | 1744.6 | — | — | 2 | BEARISH | -83.6 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | BEARISH | — |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.1 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BEARISH | -50.5 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | -343.1 | 241.9 | -7433.3 | 202.7 | 2 | BEARISH | -93.5 |
| LNAI Lunai Bioworks Inc. | — | -0.3 | -21.6 | 30.2 | — | — | 2 | BEARISH | -97.1 |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | BEARISH | -97.2 |
| DRMA Dermata Therapeutics, Inc. | — | -0.2 | -183.9 | 734.5 | — | — | 2 | BEARISH | -80.8 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | BEARISH | -92.4 |
| VCNX Vaccinex, Inc. | — | -0.4 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BEARISH | -20.1 |
| SPRC SciSparc Ltd. | — | -0.0 | -519.9 | -161.9 | -1891.2 | -26.8 | 5 | BEARISH | -78.9 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -99.5 |
| LITS Lite Strategy, Inc. | $40M | -0.1 | -170.9 | -28.2 | — | — | 2 | BEARISH | -40.2 |
| DRTS Alpha Tau Medical Ltd | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 219.4 |
| SLDB Solid Biosciences Inc. | $630M | -3.2 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 10.1 |
| ORMP Oramed Pharmaceuticals Inc. | $170M | 1.0 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 74.1 |
| AMGXF AnGes, Inc. | $140M | -3.0 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| ANTX AN2 Therapeutics, Inc. | $130M | -3.6 | -50.1 | 1243.3 | — | — | 2 | BEARISH | 229.9 |
| BBIXF Bonus BioGroup Ltd. | $50M | -17.4 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | 13233.3 |
| INTI Inhibitor Therapeutics, Inc. | $10M | -4.2 | 358.8 | 88.0 | — | — | 1 | BEARISH | 59.8 |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.1 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| NWPHF Newron Pharmaceuticals S.p.A. | $410M | -6.7 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | BEARISH | -96.7 |
| OLMA Olema Pharmaceuticals, Inc. | $560M | -3.3 | -52.7 | 585.3 | — | — | 2 | BEARISH | -12.3 |
| CBIO Crescent Biopharma, Inc. | $480M | -1.8 | -107.7 | 1928.6 | — | — | 5 | BEARISH | 4.6 |
| BLSM BlossomHill Therapeutics, Inc. | $430M | — | — | — | — | — | — | BEARISH | — |
| GOSS Gossamer Bio, Inc. | $60M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | BEARISH | -95.1 |
| IBO Impact BioMedical Inc. | $30M | -2.9 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -50.1 |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -93.5 |
| LGVN Longeveron Inc. | — | -0.2 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -81.2 |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| SILO Silo Pharma, Inc. | — | -0.2 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 116.9 |
| AAPG Ascentage Pharma Group International | $1.4B | -6.1 | -236.8 | -144.8 | -270.2 | 170.9 | 3 | BEARISH | -58.7 |
| OMER Omeros Corporation | $1.2B | 9.2 | -89.2 | 71.8 | 46.4 | — | 5 | BEARISH | 131.7 |
| ASCLF Ascletis Pharma Inc. | $770M | -7.8 | -28.4 | -7144.0 | — | -60.6 | 2 | BEARISH | -40.0 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.1 | -214.6 | 174.4 | — | — | 1 | BEARISH | 197.4 |
| FDMT 4D Molecular Therapeutics, Inc. | $600M | -4.4 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | BEARISH | 5.5 |
| PHAT Phathom Pharmaceuticals, Inc. | $460M | -4.7 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -55.7 |
| EPRX Eupraxia Pharmaceuticals Inc. | $450M | -7.0 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 29.4 |
| AGEN Agenus Inc. | $290M | 2.4 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | BEARISH | 60.6 |
| GALT Galectin Therapeutics Inc. | $210M | -7.9 | 21.9 | 99.4 | — | — | 2 | BEARISH | -35.4 |
| CGEN Compugen Ltd. | $180M | 5.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 9.4 |
| SEER Seer, Inc. | $110M | -1.6 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BEARISH | -15.2 |
| VANI Vivani Medical, Inc. | $100M | -3.3 | -220.4 | -127.1 | — | — | 4 | BEARISH | -29.6 |
| COYA Coya Therapeutics, Inc. | $90M | -3.9 | -60.5 | -18820.6 | -2723.4 | 1793.8 | 4 | BEARISH | -34.6 |
| MNOV MediciNova, Inc. | $70M | -6.5 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | BEARISH | 14.6 |
| PMVP PMV Pharmaceuticals, Inc. | $70M | -0.9 | -70.9 | 815.8 | — | — | 2 | BEARISH | -19.9 |
| OSTX OS Therapies Incorporated | $60M | -1.1 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -34.4 |
| SPRO Spero Therapeutics, Inc. | $60M | 8.1 | 19.2 | -128.5 | — | -7.0 | 7 | BEARISH | -48.4 |
| HRTX Heron Therapeutics, Inc. | $60M | -1.6 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | BEARISH | -74.9 |
| ALPS Alps Group Inc | $50M | — | — | — | — | — | — | BEARISH | — |
| XLO Xilio Therapeutics, Inc. | $50M | -5.4 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | BEARISH | 913.9 |
| MREO Mereo BioPharma Group plc | $40M | -1.6 | -67.8 | 6194.3 | — | -100.0 | 2 | BEARISH | -85.4 |
| CRVO CervoMed Inc. | $30M | -0.7 | -107.6 | 1244.8 | — | — | 2 | BEARISH | -68.6 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.2 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -16.9 |
| PHYOF IXICO plc | $10M | -6.0 | -15.8 | -23.6 | -28.5 | 13.2 | 2 | BEARISH | 0.0 |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 181.4 | -1.4 | 155.3 | — | 5 | BEARISH | -79.2 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | BEARISH | -16.1 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -0.9 | -56.4 | -2884.1 | — | — | 2 | BEARISH | -10.2 |
| PASG Passage Bio, Inc. | $10M | -0.3 | -169.1 | 159.0 | — | — | 3 | BEARISH | -53.1 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| YECO EV Biologics, Inc. | — | -0.0 | 16.2 | 18.1 | 18.6 | 264.7 | 5 | BEARISH | -99.9 |
| ISCO International Stem Cell Corporation | — | -2.4 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | 2.4 |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -100.0 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -93.6 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 655.2 | 80.8 | — | -100.0 | 2 | BEARISH | 0.0 |
| MAJI Nextel Medical Corp. | — | 0.6 | -2.6 | 42.9 | — | — | 1 | BEARISH | — |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.9 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -55.6 |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.1 | -4165.9 | 252.1 | — | — | 2 | BEARISH | -83.3 |
| NUVB Nuvation Bio Inc. | $1.6B | -10.5 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | -6.2 |
| NVAX Novavax, Inc. | $1.6B | -6.6 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BEARISH | 17.6 |
| MGTX MeiraGTx Holdings plc | $880M | 12.4 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 7.8 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.8 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 24.4 |
| CLYM Climb Bio, Inc. | $590M | -11.5 | -27.1 | -88.6 | — | — | 2 | BEARISH | 380.9 |
| MDXG MiMedx Group, Inc. | $570M | 97.5 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | BEARISH | -42.3 |
| MNPR Monopar Therapeutics Inc. | $470M | -30.7 | -19.5 | 523.8 | — | — | 2 | BEARISH | -11.9 |
| AVIR Atea Pharmaceuticals, Inc. | $320M | -2.0 | -58.1 | 974.6 | — | — | 3 | BEARISH | 29.9 |
| PRQR ProQR Therapeutics N.V. | $180M | -3.0 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -54.0 |
| PYXS Pyxis Oncology, Inc. | $110M | -1.3 | -179.1 | 1953.9 | — | 291.4 | 2 | BEARISH | -46.8 |
| INMB INmune Bio, Inc. | $40M | -2.2 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -20.0 |
| BMEA Biomea Fusion, Inc. | $40M | -1.3 | -164.1 | 210.3 | — | — | 2 | BEARISH | -56.0 |
| CELU Celularity Inc. | $30M | -0.4 | 150.9 | 40592.8 | 13.0 | -58.1 | 4 | BEARISH | -61.4 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.1 | 235.3 | 244.1 | — | — | 5 | BEARISH | 842.5 |
| AVEFF Avecho Biotechnology Limited | $20M | -9.3 | -268.2 | 103.4 | -3227.5 | -46.6 | 3 | BEARISH | 0.0 |
| SER Serina Therapeutics, Inc. | $20M | -0.9 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -67.7 |
| SYBX Synlogic, Inc. | $10M | -19.6 | -5.3 | 306.3 | — | — | 2 | BEARISH | -39.0 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.0 | -82.7 | -314.7 | — | — | 1 | BEARISH | -68.6 |
| XRTX XORTX Therapeutics Inc. | — | -0.4 | -99.1 | -68.5 | — | — | 3 | BEARISH | 66.6 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -0.6 | -26.8 | -38.7 | -88.2 | — | 3 | BEARISH | 47.1 |
| OZYMF Strategic Partners A/S | — | 19.0 | 0.8 | -117.5 | 1019.0 | — | 6 | BEARISH | 0.0 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -78.3 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| KRSA Korsana Biosciences, Inc. | $150M | — | — | — | — | — | — | BEARISH | — |
| HBMHF HBM Holdings Limited | $1.3B | 12.5 | 24.1 | 53.0 | 53.0 | 54.6 | 4 | BEARISH | -38.1 |
| GERN Geron Corporation | $720M | -11.5 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -7.3 |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| GYRE Gyre Therapeutics, Inc. | $620M | -32.8 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BEARISH | -20.1 |
| ANNX Annexon, Inc. | $610M | -3.2 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 17.1 |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $450M | — | — | — | — | — | — | BEARISH | — |
| ASMB Assembly Biosciences, Inc. | $400M | 36.9 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -30.6 |
| RLMD Relmada Therapeutics, Inc. | $350M | -3.5 | -55.7 | 460.5 | — | — | 3 | BEARISH | 52.9 |
| MPLT MapLight Therapeutics, Inc. | $340M | -1.6 | -57.5 | -366.6 | — | — | 2 | BEARISH | — |
| CTNM Contineum Therapeutics, Inc. | $270M | -5.2 | -28.0 | -541.6 | — | — | 4 | BEARISH | -18.6 |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $230M | -2.5 | -46.8 | -249.1 | — | — | 3 | BEARISH | -68.9 |
| BOVNF BioInvent International AB (publ) | $220M | -2.8 | -88.2 | 20101.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $210M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -75.5 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $130M | — | — | — | — | — | — | BEARISH | -96.9 |
| MIST Milestone Pharmaceuticals Inc. | $80M | -1.0 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -64.0 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $70M | -0.3 | -187.1 | 231.9 | — | — | 2 | BEARISH | -79.1 |
| HBPCF Helix BioPharma Corp. | $60M | -23.6 | -50.8 | -21.5 | — | — | 3 | BEARISH | -55.5 |
| IMA ImageneBio Inc | $50M | -0.8 | -40.7 | -594.7 | — | — | 3 | BEARISH | -49.8 |
| PRRUF Immutep Limited | $20M | -0.4 | -77.3 | 1092.5 | -328.8 | 255.0 | 3 | BEARISH | -89.5 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.3 | -119.6 | 717.6 | — | — | 3 | BEARISH | -69.8 |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| ENLV Enlivex Therapeutics Ltd. | — | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -99.0 |
| ARUXF Acrux Limited | — | -7.1 | -48.5 | -74.2 | -26.5 | 289.9 | 7 | BEARISH | -99.0 |
| SEPSF Asep Medical Holdings Inc | — | -0.3 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| ZVRA Zevra Therapeutics, Inc. | $580M | 10.5 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | -5.2 |
| IRD Opus Genetics, Inc. | $290M | -2.7 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 73.9 |
| CUE Cue Biopharma, Inc. | $140M | -0.7 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | -22.2 |
| MGNX MacroGenics, Inc. | $140M | -11.1 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 32.6 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $70M | -0.9 | -64.6 | 5251.5 | — | — | 1 | BEARISH | -15.9 |
| SKYE Skye Bioscience, Inc. | $10M | -0.1 | -233.9 | 389.5 | — | — | 3 | BEARISH | -5.8 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.2 | -485.4 | -367.8 | — | 100.0 | 6 | BEARISH | -78.7 |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | BEARISH | 292.2 |
| PHRRF PharmaTher Holdings Ltd. | — | -7.6 | -76.9 | 234.4 | — | — | 2 | BEARISH | -56.0 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | BEARISH | 0.0 |
| URGN UroGen Pharma Ltd. | $1.7B | -17.1 | 86.5 | 119.0 | -19.8 | 169.5 | 2 | BEARISH | 78.8 |
| MDCLF MedinCell S.A. | $1.1B | -29.2 | 472.2 | 81.6 | -152.1 | -14.8 | 3 | BEARISH | 333.5 |
| IMMX Immix Biopharma, Inc. | $680M | -9.1 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 123.0 |
| CADL Candel Therapeutics, Inc. | $610M | -5.9 | -81.8 | 219.4 | — | — | 2 | BEARISH | 52.8 |
| GNFTF Genfit S.A. | $470M | -5.2 | -5084.0 | -322.7 | -124.0 | 27.5 | 3 | BEARISH | 153.5 |
| IKT Inhibikase Therapeutics, Inc. | $220M | -3.3 | -52.0 | 920.5 | — | — | 3 | BEARISH | 1.9 |
| TRGNF Transgene S.A. | $120M | -4.1 | -64.1 | -184.9 | -5760.7 | -185.8 | 4 | BEARISH | -53.1 |
| PRNAF Alterity Therapeutics Limited | $50M | -2.2 | -55.0 | -401.1 | — | -100.0 | 2 | BEARISH | 8233.3 |
| BOLD Boundless Bio, Inc. | $50M | -0.8 | -67.9 | 807.9 | — | — | 2 | BEARISH | 65.1 |
| BMNDF Biomind Labs Inc. | $20M | -13.3 | 85.8 | 101.7 | — | — | 2 | BEARISH | 1483.5 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BEARISH | -9.9 |
| GENSF Genus plc | $1.8B | 5.4 | 45.4 | 9.0 | 80.4 | -3.8 | 5 | BEARISH | -19.4 |
| OCUL Ocular Therapeutix, Inc. | $1.4B | -4.7 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -41.5 |
| GPCR Structure Therapeutics Inc. | $1.2B | -7.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | -18.3 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.2B | -5.4 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | 1.2 |
| AKTS Aktis Oncology, Inc. | $850M | -15.7 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 373763.6 |
| ARDX Ardelyx, Inc. | $770M | -13.3 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -40.5 |
| CTMX CytomX Therapeutics, Inc. | $510M | -5.1 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -29.1 |
| PROK ProKidney Corp. | $470M | -2.7 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | BEARISH | -52.5 |
| FTH Faeth Therapeutics, Inc. | $440M | — | — | — | — | — | — | BEARISH | — |
| ALLO Allogene Therapeutics, Inc. | $430M | -1.8 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 2.5 |
| AVCTF Avacta Group Plc | $420M | -6.7 | -2083.2 | -753.6 | -33970.3 | -99.7 | 5 | BEARISH | -18.7 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.7 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -59.1 |
| CAPR Capricor Therapeutics, Inc. | $340M | -2.5 | -73.7 | -107.5 | — | -100.0 | 3 | BEARISH | -1.6 |
| KYTX Kyverna Therapeutics, Inc. | $330M | -1.9 | -87.2 | 14267.8 | — | — | 2 | BEARISH | -24.3 |
| SPHDF Santhera Pharmaceuticals Holding AG | $280M | -6.6 | 729.6 | 111.3 | -44.5 | 106.3 | 7 | BEARISH | 49.1 |
| ORYZF Oryzon Genomics S.A. | $250M | -80.4 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -14.1 |
| ABEO Abeona Therapeutics Inc. | $250M | -3.9 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -18.8 |
| OCGN Ocugen, Inc. | $250M | -3.0 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -52.4 |
| VNDA Vanda Pharmaceuticals Inc. | $240M | -0.9 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -27.4 |
| HLOSF Healios K.K. | $240M | 56.3 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -48.6 |
| IPHYF Innate Pharma S.A. | $210M | -2.5 | 267.9 | 119.2 | -343.8 | 32.0 | 3 | BEARISH | -24.5 |
| BIOA BioAge Labs Inc. | $190M | -2.3 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | BEARISH | -28.0 |
| EVMN Evommune, Inc. | $190M | -1.5 | -29.6 | -82.4 | — | — | 2 | BEARISH | — |
| NBP NovaBridge Biosciences | $160M | -2.2 | -45.7 | -617.8 | — | — | 1 | BEARISH | -70.4 |
| SION Sionna Therapeutics, Inc. | $160M | -1.8 | -32.3 | -137.7 | — | — | 0 | BEARISH | -90.1 |
| AKBA Akebia Therapeutics, Inc. | $160M | -6.1 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -78.2 |
| ZNTL Zentalis Pharmaceuticals, Inc. | $160M | -0.8 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 15.8 |
| CNTN Canton Strategic Holdings Inc | $150M | -1.2 | -14.6 | -7.2 | -1287.2 | — | 2 | BEARISH | — |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| STRO Sutro Biopharma, Inc. | $150M | -0.5 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | -15.5 |
| CDXS Codexis, Inc. | $140M | -3.8 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -52.6 |
| NKTX Nkarta, Inc. | $130M | -1.1 | -38.8 | -75.4 | — | — | 1 | BEARISH | -15.0 |
| AVXL Anavex Life Sciences Corp. | $120M | -5.0 | -23.6 | 411.7 | — | — | 2 | BEARISH | -84.8 |
| CBUS Cibus, Inc. | $110M | -0.8 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | BEARISH | -11.0 |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.2 | -101.1 | 349.9 | — | — | 4 | BEARISH | -29.6 |
| CLLS Cellectis S.A. | $100M | -1.7 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | BEARISH | -69.8 |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| VXRT Vaxart, Inc. | $100M | 2.7 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 10.8 |
| TNYA Tenaya Therapeutics, Inc. | $90M | -0.8 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -75.8 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $80M | -0.6 | -95.6 | 738.2 | — | — | 1 | BEARISH | -75.4 |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.3 | -49.0 | -68.1 | -45.3 | 60.7 | 3 | BEARISH | -55.3 |
| CRDF Cardiff Oncology, Inc. | $70M | -1.5 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -60.8 |
| CGTX Cognition Therapeutics, Inc. | $70M | -4.0 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -56.1 |
| CRBU Caribou Biosciences, Inc. | $60M | -0.4 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -81.5 |
| IBIO iBio, Inc. | $50M | -2.4 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | -36.6 |
| HYFT MindWalk Holdings Corp. | $50M | -4.5 | -123.5 | -481.3 | -158.7 | -15.9 | 4 | BEARISH | -29.3 |
| CNTB Connect Biopharma Holdings Limited | $50M | -1.0 | -105.5 | 1034.1 | -1249.0 | 49.8 | 2 | BEARISH | -50.4 |
| VTIAF FamiCord AG | $50M | -6.4 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BEARISH | -55.7 |
| EXOZ eXoZymes, Inc. | $40M | -3.2 | -187.2 | 913.0 | — | — | 2 | BEARISH | -68.4 |
| TIL Instil Bio, Inc. | $40M | -1.3 | -25.3 | -69.1 | — | — | 4 | BEARISH | -69.9 |
| DWTX Dogwood Therapeutics, Inc. | $40M | -0.1 | -47.8 | -39.7 | — | — | 2 | BEARISH | -80.3 |
| ANVS Annovis Bio, Inc. | $40M | -0.6 | -703.7 | 170.2 | — | — | 1 | BEARISH | -49.8 |
| RANI Rani Therapeutics Holdings, Inc. | $40M | -2.3 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | -66.5 |
| ALDX Aldeyra The | $40M | -1.7 | -49.5 | 269.3 | — | — | 4 | BEARISH | -87.8 |
| IXHL Incannex Healthcare Limited | $30M | -2.3 | -31.9 | 5284.2 | — | -100.0 | 4 | BEARISH | -75.0 |
| FLNA Filana Therapeutics, Inc. | $30M | -0.7 | -13.5 | 38.9 | — | — | 2 | BEARISH | — |
| BCTX BriaCell Therapeutics Corp. | $30M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BEARISH | -74.2 |
| IGC IGC Pharma, Inc. | $30M | -3.0 | -129.2 | -127.6 | -1107.9 | -15.4 | 1 | BEARISH | -39.1 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.5 | -38.4 | -58.9 | — | — | 2 | BEARISH | -40.5 |
| BYSI BeyondSpring Inc. | $20M | -2.8 | 20.3 | 15.7 | — | 100.0 | 2 | BEARISH | -77.0 |
| ATYR aTyr Pharma, Inc. | $20M | -0.2 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -87.4 |
| MVMDF More Life Company Corp. | $20M | -5.2 | -167.0 | -602.2 | -5006.5 | 43.0 | 4 | BEARISH | 115.8 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -45.5 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -68.7 |
| GUTS Fractyl Health, Inc. | $10M | -0.1 | 1063.0 | -568.7 | — | -100.0 | 5 | BEARISH | -94.7 |
| TCRX TScan Therapeutics, Inc. | $10M | -0.2 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -91.7 |
| BLRX BioLineRx Ltd. | $10M | -1.1 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -44.6 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.1 | -166.5 | 851.1 | -882.8 | 287.3 | 4 | BEARISH | -95.7 |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 49.3 | 80.2 | -86.2 | 4.3 | 4 | BEARISH | -58.4 |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.6 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | BEARISH | -58.0 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.5 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -62.7 |
| PTN Palatin Technologies, Inc. | $10M | -0.9 | -877.5 | 1176.9 | -1449.1 | — | 5 | BEARISH | -20.5 |
| INAB IN8bio, Inc. | $10M | -0.5 | -111.1 | -576.1 | — | — | 4 | BEARISH | -55.1 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.1 | -931.1 | -564.2 | — | — | 1 | BEARISH | -95.2 |
| IMNN Imunon, Inc. | $10M | -0.2 | -429.7 | -226.7 | — | — | 2 | BEARISH | -81.9 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -67.4 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.3 | -126.2 | 296.9 | — | — | 1 | BEARISH | -82.6 |
| GSGTF GenSight Biologics S.A. | $10M | -1.0 | 46.5 | 47.3 | 1190.6 | -401.7 | 3 | BEARISH | -57.9 |
| DARE Dare Bioscience, Inc. | $10M | -0.8 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | BEARISH | -68.6 |
| QNTM Quantum BioPharma Ltd. | $10M | -0.4 | -425.3 | 175.1 | — | — | 4 | BEARISH | -83.3 |
| OPTBF OptiBiotix Health Plc | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -46.4 |
| PXXLF Poxel S.A. | $10M | -0.4 | 34.8 | 129.6 | -624.6 | 41.5 | 4 | BEARISH | -12.0 |
| TRAW Traws Pharma, Inc. | $10M | -0.7 | -711.4 | 133.9 | — | -100.0 | 1 | BEARISH | -87.4 |
| KTTA Pasithea Therapeutics Corp. | $10M | -0.2 | -65.5 | -453.2 | — | — | 4 | BEARISH | -44.7 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | -50.0 |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -83.1 |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | — | -0.1 | 294.4 | 252.1 | — | — | 4 | BEARISH | -95.3 |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -99.1 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -72.3 |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -95.2 |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| KAPA Kairos Pharma, Ltd. | — | -0.3 | -114.0 | -301.0 | — | — | 3 | BEARISH | -93.0 |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | BEARISH | — |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -95.2 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -27.3 |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -97.3 |
| KALA KALA BIO, Inc. | — | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.6 |
| ENZC Enzolytics Inc. | — | -11.2 | 105.9 | 1.4 | — | — | 7 | BEARISH | -25.0 |
| MBIO Mustang Bio, Inc. | — | -0.8 | -58.1 | 36.6 | — | — | 2 | BEARISH | -75.9 |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | -99.0 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -80.1 |
| NCEL NewcelX Ltd. | — | 8.3 | -48.0 | -39.1 | — | — | 2 | BEARISH | -79.5 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | 40.9 | 5 | BEARISH | 0.0 |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -99.3 |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | -38.8 |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| ZHCLF Zenith Capital Corp. | — | -0.2 | 35107.2 | 37766.2 | -360.0 | — | 3 | BEARISH | 3233.3 |
| VBIO Valion Bio, Inc. | — | -0.0 | -240.8 | -48.0 | — | -281.4 | 2 | BEARISH | — |
| MDCX Medicus Pharma Ltd. Common Stock | — | -0.0 | -3904.0 | -693.1 | — | — | 3 | BEARISH | -98.2 |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -62.2 |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -98.6 |
| IVEVF Inventiva S.A. | $750M | -6.2 | -988.4 | -371.6 | -347346.6 | -99.7 | 3 | BEARISH | -22.8 |
| RGNX REGENXBIO Inc. | $440M | -1.7 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -49.4 |
| ALT Altimmune, Inc. | $410M | -2.6 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -46.0 |
| AVTX Avalo Therapeutics, Inc. | $370M | -1.4 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | -61.6 |
| DMTRF 3-D Matrix, Ltd. | $310M | 12.2 | 75.0 | 31.1 | 9.4 | 57.0 | 6 | BEARISH | 61.3 |
| ACIU AC Immune S.A. | $250M | -4.3 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BEARISH | -30.8 |
| CABA Cabaletta Bio, Inc. | $250M | -0.9 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -40.9 |
| SCTX Scribe Therapeutics Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| PALI Palisade Bio, Inc. | $230M | -2.3 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | -31.0 |
| IVVD Invivyd, Inc. | $180M | -1.5 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -73.2 |
| UPB Upstream Bio, Inc. | $150M | -1.0 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -83.0 |
| CMPX Compass Therapeutics, Inc. | $140M | -1.8 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -81.2 |
| NERV Minerva Neurosciences, Inc. | $110M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | -52.5 |
| VYGR Voyager Therapeutics, Inc. | $110M | -1.0 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -62.8 |
| LENZ LENZ Therapeutics, Inc. | $100M | -0.8 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -90.2 |
| VTVT vTv Therapeutics Inc. | $100M | -233.8 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 23.1 |
| ENGN enGene Holdings Inc. | $100M | -5.5 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -81.3 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.3 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -54.0 |
| XBIT XBiotech Inc. | $60M | -1.2 | -29.9 | -201.2 | — | — | 2 | BEARISH | -28.0 |
| TLSA Tiziana Life Sciences Ltd | $60M | -4.3 | -780.6 | 375.0 | — | — | 1 | BEARISH | -55.0 |
| VRCA Verrica Pharmaceuticals Inc. | $60M | -2.0 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -9.9 |
| PLRX Pliant Therapeutics, Inc. | $50M | -0.6 | -50.3 | -438.3 | — | — | 3 | BEARISH | -53.6 |
| GANX Gain Therapeutics, Inc. | $50M | -2.3 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -40.9 |
| KLRS Kalaris Therapeutics Inc | $40M | -0.9 | -79.9 | 109.5 | — | — | 0 | BEARISH | -61.0 |
| ACET Adicet Bio, Inc. | $40M | -0.3 | -78.1 | -553.5 | — | — | 4 | BEARISH | -73.2 |
| EDSA Edesa Biotech, Inc. | $30M | -1.6 | -122.9 | 759.6 | — | — | 1 | BEARISH | -2.5 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.6 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | BEARISH | -51.1 |
| EYPT EyePoint Pharmaceuticals, Inc. | $30M | -0.1 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -97.0 |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| BSEM BioStem Technologies, Inc. | $30M | -0.9 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -69.0 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $30M | -0.4 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -87.8 |
| MGX Metagenomi, Inc. Common Stock | $30M | -0.3 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -72.3 |
| KYNB Kyntra Bio, Inc. | $20M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| MCRB Seres Therapeutics, Inc. | $20M | -0.8 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -89.9 |
| TELIF Telescope Innovations Corp. | $20M | 5.8 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | -21.7 |
| BXPHF Botanix Pharmaceuticals Limited | $20M | -0.3 | -96.3 | -131.6 | -203.1 | 495.6 | 4 | BEARISH | -91.5 |
| FBLG FibroBiologics, Inc. Common Stock | $10M | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -89.3 |
| AIMD Ainos, Inc. | $10M | -0.3 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -77.5 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.3 | -128.1 | 241.9 | — | — | 3 | BEARISH | -83.7 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | -33.4 |
| MTVA MetaVia Inc. | $10M | -0.3 | -175.7 | 209.3 | — | — | 0 | BEARISH | -89.3 |
| ACTU Actuate Therapeutics Inc | $10M | -0.4 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -94.5 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -69.0 |
| BCDA BioCardia, Inc. | $10M | -1.2 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -33.7 |
| CODX Co-Diagnostics, Inc. | — | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -95.5 |
| FAMDF Futura Medical plc | — | -0.3 | -145.8 | -370.5 | -72.8 | -70.7 | 2 | BEARISH | -86.7 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 56.6 |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| NSHSF NanoSphere Health Sciences Inc. | — | 9.5 | 4.6 | 11.1 | — | — | 0 | BEARISH | 0.0 |
| CANF Can-Fite BioPharma Ltd. | — | -0.3 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -81.7 |
| NRSN NeuroSense Therapeutics Ltd. | — | -0.3 | 779.3 | 571.3 | — | — | 3 | BEARISH | -90.0 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.1 | -44.0 | 793.8 | — | — | 2 | BEARISH | -64.9 |
| CRIS Curis, Inc. | — | -0.0 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -98.8 |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -214.9 | -155.8 | -649.8 | 33.6 | 3 | BEARISH | -81.1 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | 0.0 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.3 | -78.0 | 8335.2 | — | -50.0 | 2 | BEARISH | -85.9 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | 80.8 | 147.8 | -185107971.7 | -99.3 | 1 | BEARISH | -7.8 |
| NMLSF Restart Life Sciences Corp. | — | -1.8 | -214.3 | -153.9 | -307.0 | — | 2 | BEARISH | -63.3 |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | BEARISH | -66.7 |
| KRRO Korro Bio, Inc. | $180M | -1.3 | -97.7 | -196.6 | — | -62.1 | 2 | BULLISH | -65.1 |
| INGN Inogen, Inc. | $190M | -7.9 | -13.1 | -27.8 | -4.0 | 3.2 | 5 | BULLISH | -18.7 |
| OPRX OptimizeRx Corp. | $170M | 37.2 | 3.7 | 6.1 | -3.4 | -5.8 | 8 | BULLISH | -58.2 |
| BCCOY BICO Group AB (publ) | $190M | -2.0 | -41.5 | -8.4 | -11.1 | -19.8 | 6 | BULLISH | -9.6 |
| STIM Neuronetics, Inc. | $160M | -5.1 | -135.3 | -21.3 | -8.3 | 39.6 | 4 | LEAN BULL | -29.8 |
| DIUXF Diaceutics PLC | $200M | -626.6 | -0.8 | -2.3 | -15.9 | 20.4 | 4 | NEUTRAL | 68.6 |
| PROF Profound Medical Corp. | $200M | -5.8 | -73.1 | -148.0 | -384.2 | 35.5 | 3 | BEARISH | 2.7 |
| BDSX Biodesix, Inc. | $170M | -6.9 | -540.0 | -31.9 | -27.1 | 34.5 | 6 | BEARISH | 226.2 |
| NNNN Anbio Biotechnology Class A Ordinary Shares | $170M | — | — | — | — | — | — | BEARISH | -83.2 |
| CYBQF CYBERDYNE Inc. | $200M | 153.8 | 0.7 | -1.4 | 36.4 | -8.1 | 3 | BEARISH | 0.0 |
| XGN Exagen Inc. | $180M | -9.5 | -113.8 | -79.2 | -16.0 | 20.8 | 3 | BEARISH | -35.0 |
| TSNDF TerrAscend Corp. | $170M | -3.9 | -22.6 | -28.1 | -13.6 | — | 3 | BEARISH | — |
| PDEX Pro-Dex, Inc. | $200M | 14.8 | 32.4 | 17.5 | 14.0 | 16.4 | 8 | BEARISH | 119.3 |
| FOCL EDAP TMS S.A. American Depositary Shares | $160M | — | — | — | — | — | — | BEARISH | — |
| PFGTF Pacific Edge Limited | $170M | -6.0 | -194.5 | -709.2 | -299.7 | -49.4 | 2 | BEARISH | 36.9 |
| MFCSF Medical Facilities Corporation | $170M | 8.1 | 46.9 | 50.2 | 2.5 | 3.2 | 7 | BEARISH | -2.4 |
| CRLBF Cresco Labs Inc. | $210M | -2.0 | -25.8 | 5.5 | 9.7 | -4.5 | 2 | BEARISH | -49.8 |
| ETRA Electra Therapeutics Inc. | $180M | — | — | — | — | — | — | BEARISH | — |
| VMTHF Venus Medtech (Hangzhou) Inc. | $180M | -0.8 | -25.6 | -18.2 | -141.2 | -40.7 | 4 | BEARISH | -57.5 |
| GLAS Glass House Brands Inc | $190M | — | — | — | — | — | — | BEARISH | — |
| CATX Perspective Therapeutics, Inc. | $180M | -0.8 | -39.5 | -108.8 | -33069.1 | -35.3 | 3 | BEARISH | -60.2 |
| KRRO Korro Bio, Inc. | $180M | -1.3 | -97.7 | -196.6 | — | -62.1 | 2 | BULLISH | -65.1 |
| SEPN Septerna Inc | $1.9B | -81.7 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BULLISH | 103.7 |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.6B | — | — | — | — | — | — | BULLISH | — |
| CERT Certara, Inc. | $1.6B | -24.7 | -6.7 | 0.6 | -59.3 | 0.7 | 6 | BULLISH | -13.5 |
| MRCHF H.U. Group Holdings, Inc. | $1.3B | 22.0 | 7.2 | 3.3 | 2.5 | 1.8 | 9 | BULLISH | -7.4 |
| LTGHY Life Healthcare Group Holdings Limited | $1.1B | 2.7 | 68.5 | 10.7 | 6.2 | -3.0 | 4 | BULLISH | 14.5 |
| VSTM Verastem, Inc. | $910M | -4.1 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | BULLISH | 27.0 |
| SOLTF Nxera Pharma Co., Ltd. | $770M | -15.8 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | BULLISH | 38.2 |
| CTKB Cytek Biosciences, Inc. | $730M | -9.6 | -23.0 | -40.8 | -25.3 | 5.4 | 3 | BULLISH | 40.4 |
| RCEL Avita Medical Inc. | $390M | -11.1 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 305.0 |
| OSUR OraSure Technologies, Inc. | $280M | -6.0 | -14.1 | -23.5 | 20.4 | -18.9 | 4 | BULLISH | 40.5 |
| PYPD PolyPid Ltd. | $110M | -3.9 | -1913.8 | 231.6 | — | — | 3 | BULLISH | 67.7 |
| ANIX Anixa Biosciences, Inc. | $100M | -10.8 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -20.8 |
| GRDX GridAI Technologies Corp. | $40M | -1.4 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | 44.5 |
| AMN AMN Healthcare Services, Inc. | $1.9B | 17.3 | 15.6 | 8.9 | 3.1 | 24.0 | 8 | BULLISH | 120.8 |
| HCSG Healthcare Services Group, Inc. | $1.7B | 16.1 | 20.4 | 27.0 | 5.2 | 4.0 | 7 | BULLISH | 31.8 |
| ARDT Ardent Health Inc. | $1.7B | 21.5 | 6.0 | 13.5 | 1.0 | 3.3 | 5 | BULLISH | -22.3 |
| KLRA Kailera Therapeutics, Inc. | $1.7B | — | — | — | — | — | — | BULLISH | — |
| GDRX GoodRx Holdings, Inc. | $1.2B | 66.2 | 2.5 | 3.5 | 4.3 | -1.8 | 6 | BULLISH | -11.9 |
| SPTX Seaport Therapeutics, Inc. Common Stock | $1.1B | — | — | — | — | — | — | BULLISH | — |
| HSTM HealthStream, Inc. | $1.1B | 47.8 | 6.0 | 6.5 | 8.0 | 8.8 | 8 | BULLISH | 30.1 |
| CBLL CeriBell, Inc. | $1.0B | -15.5 | -43.9 | -263.7 | -68.6 | 69.3 | 3 | BULLISH | 111.2 |
| BVS Bioventus Inc. | $1.0B | 17.9 | 28.0 | 21.3 | 21.8 | 3.1 | 7 | BULLISH | 107.8 |
| SIBN SI-BONE, Inc. | $960M | -63.1 | -8.3 | -32.2 | -7.3 | 15.3 | 6 | BULLISH | 38.4 |
| SGP SpyGlass Pharma, Inc. Common Stock | $950M | — | — | — | — | — | — | BULLISH | — |
| PHR Phreesia, Inc. | $790M | 71.4 | 3.1 | 16.7 | 1.5 | 12.9 | 4 | BULLISH | -47.7 |
| AONC American Oncology Network, Inc. | $640M | -29.7 | 5.6 | -14.7 | 0.3 | 37.5 | 6 | BULLISH | 132.2 |
| ENTX Entera Bio Ltd. | $510M | -8.8 | -138.9 | 314.4 | — | -100.0 | 1 | BULLISH | 37.8 |
| MOBI Mobia Medical, Inc. Common Stock | $350M | — | — | — | — | — | — | BULLISH | — |
| ANIK Anika Therapeutics, Inc. | $290M | -79.2 | -2.7 | -3.3 | 10.1 | 31.4 | 7 | BULLISH | 113.3 |
| QSI Quantum-Si incorporated | $280M | -3.6 | -49.1 | -121.8 | -6841.3 | -53.0 | 3 | BULLISH | -27.9 |
| BIOYF BioSyent Inc. | $140M | 19.1 | 23.7 | 23.8 | 14.3 | 41.0 | 5 | BULLISH | 49.2 |
| ATNM Actinium Pharmaceuticals, Inc. | $50M | 3.9 | 45.9 | -197.8 | 79.7 | — | 3 | BULLISH | -15.0 |
| MCUJF Medicure Inc. | $30M | -6.3 | -49.9 | -54.9 | -19.2 | 38.3 | 4 | BULLISH | 291.0 |
| LWSCF Sienna Senior Living Inc. | $1.6B | 38.9 | 6.7 | 3.9 | 4.4 | 16.2 | 7 | BULLISH | 7.9 |
| AHG Akso Health Group | $1.1B | -21.0 | -50.1 | -44.9 | -546.5 | 22.7 | 4 | BULLISH | -17.1 |
| PRME Prime Medicine, Inc. | $670M | -4.0 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | -18.4 |
| MYGN Myriad Genetics, Inc. | $560M | -5.3 | -32.5 | -19.5 | -22.7 | -3.2 | 4 | BULLISH | -22.8 |
| XFOR X4 Pharmaceuticals, Inc. | $320M | -2.7 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BULLISH | -14.5 |
| INGN Inogen, Inc. | $190M | -7.9 | -13.1 | -27.8 | -4.0 | 3.2 | 5 | BULLISH | -18.7 |
| CING Cingulate Inc. | $70M | -1.1 | -198.7 | -1452.8 | — | — | 4 | BULLISH | 43.3 |
| ESLA Estrella Immunopharma, Inc. | $40M | -3.8 | 148.1 | 102.1 | — | — | 3 | BULLISH | -60.8 |
| TNDM Tandem Diabetes Care, Inc. | $1.2B | -20.7 | -48.0 | -8.2 | -8.3 | -7.1 | 4 | BULLISH | 28.6 |
| TDOC Teladoc Health, Inc. | $1.1B | -6.5 | -13.0 | -8.7 | -6.4 | -2.1 | 5 | BULLISH | -31.8 |
| STAA STAAR Surgical Company | $1.1B | 302.0 | 1.1 | 3.5 | 8.6 | 51.3 | 5 | BULLISH | -8.0 |
| LMRI Lumexa Imaging Holdings, Inc. Common Stock | $1.1B | -31.1 | -3.9 | 0.1 | 1.0 | — | 3 | BULLISH | — |
| INDP Indaptus Therapeutics, Inc. | $360M | -0.5 | -318.0 | 6437.4 | — | — | 4 | BULLISH | -8.8 |
| TMCI Treace Medical Concepts, Inc. | $280M | -4.9 | -72.0 | -44.8 | -35.0 | -4.0 | 2 | BULLISH | -33.8 |
| VIR Vir Biotechnology, Inc. | $1.8B | -6.3 | -26.1 | -38.8 | 33.5 | 1495.9 | 5 | BULLISH | 93.5 |
| KIDS OrthoPediatrics Corp. | $640M | -16.7 | -11.4 | -4.6 | -10.2 | 14.5 | 6 | BULLISH | 39.9 |
| MASS 908 Devices Inc. | $470M | -13.3 | -25.1 | -103.8 | -74.0 | 4.6 | 5 | BULLISH | 45.2 |
| AVHHL AVITA Medical, Inc. | $360M | -11.1 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 149.1 |
| AMWL American Well Corporation | $230M | -2.8 | -31.0 | -215.3 | -19.1 | -19.0 | 4 | BULLISH | 144.5 |
| BIOE Bio Essence Corporation | $20M | 11.3 | -392.9 | 38.8 | 34.0 | 416.6 | 5 | BULLISH | 508.7 |
| MAZE Maze Therapeutics, Inc. | $1.7B | -11.6 | -37.3 | -112.3 | — | — | 3 | BULLISH | 4.3 |
| AZTA Azenta, Inc. | $1.6B | -14.2 | -7.7 | -1.4 | 1.5 | 1.5 | 4 | BULLISH | 21.1 |
| GRRMF Gerresheimer AG | $1.2B | -2.8 | 1.6 | 2.2 | -2.3 | 11.8 | 4 | BULLISH | -27.1 |
| ENOV Enovis Corporation | $1.2B | -1.1 | -54.3 | -13.5 | -0.2 | 4.9 | 4 | BULLISH | -34.4 |
| TDVXF Dynavox Group AB (publ) | $900M | 27.8 | 39.7 | 17.2 | 12.8 | 8.8 | 8 | BULLISH | -22.7 |
| OM Outset Medical, Inc. | $80M | -1.1 | -59.2 | -97.3 | -56.8 | -1.3 | 4 | BULLISH | -70.6 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -4.5 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -53.1 |
| SAEYY Redcare Pharmacy N.V. | $1.7B | -37.3 | -8.7 | -1.2 | 0.6 | 20.5 | 2 | BULLISH | -5.2 |
| KMTS Kestra Medical Technologies, Ltd. | $1.7B | -11.2 | -73.7 | -113.5 | -142.3 | 191.6 | 3 | BULLISH | 15.3 |
| AGL Agilon Health, Inc. | $1.5B | -5.9 | -78.9 | -273.7 | 1.2 | 0.3 | 6 | BULLISH | 273.6 |
| NWKHY Netcare Limited | $1.4B | 12.5 | 16.9 | 8.1 | 6.7 | 5.0 | 7 | BULLISH | 59.5 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.2B | -13.3 | -25.8 | -768.9 | — | — | 2 | BULLISH | 148.2 |
| OABIW OmniAb, Inc. | $1.1B | -13.8 | -16.9 | -16.8 | -43.7 | 66.9 | 6 | BULLISH | -17.6 |
| ARRJF Arjo AB (publ) | $920M | 25.3 | 4.6 | 4.4 | 2.0 | -2.0 | 6 | BULLISH | 3.1 |
| RIGL Rigel Pharmaceuticals, Inc. | $900M | 2.9 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 68.7 |
| VMD Viemed Healthcare, Inc. | $370M | 25.7 | 10.2 | 11.8 | 3.5 | 25.2 | 4 | BULLISH | 39.9 |
| HURA TuHURA Biosciences, Inc. | $140M | -3.9 | -161.4 | -137.6 | — | — | 2 | BULLISH | -7.9 |
| MXCT MaxCyte, Inc. | $140M | -4.6 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BULLISH | -5.5 |
| CCEL Cryo-Cell International, Inc. | $40M | -22.1 | 18.1 | -0.7 | 16.2 | -2.0 | 6 | BULLISH | 14.0 |
| INM InMed Pharmaceuticals Inc. | $10M | 14.6 | -129.6 | 732.1 | -0.2 | 37942.8 | 3 | BULLISH | -24.1 |
| EVH Evolent Health, Inc. | $540M | -1.0 | -79.0 | -1.8 | -4.3 | -4.5 | 5 | BULLISH | -43.4 |
| INFU InfuSystem Holdings, Inc. | $280M | 33.6 | 15.0 | 11.4 | 8.7 | 2.5 | 9 | BULLISH | 39.5 |
| IRLA IRulya Therapeutics Inc. | $30M | — | — | — | — | — | — | BULLISH | — |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.6 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | BULLISH | -42.6 |
| AGTX Agentix Corp. | — | -5.1 | 12.0 | 8.1 | — | — | 3 | BULLISH | 6.9 |
| QDEL QuidelOrtho Corporation | $940M | -0.9 | -45.9 | -13.7 | -14.7 | 0.1 | 4 | BULLISH | -55.5 |
| PACB Pacific Biosciences of California, Inc. | $660M | -5.7 | -929.3 | -29.4 | -114.7 | 2.0 | 2 | BULLISH | 21.3 |
| NAUT Nautilus Biotechnolgy, Inc. | $410M | -6.3 | -41.0 | -89.2 | -6682.1 | — | 2 | BULLISH | 136.9 |
| NUWE Nuwellis, Inc. | — | -0.0 | 202.0 | 173.3 | -245.2 | 8.4 | 5 | BULLISH | 65.2 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.9 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | BULLISH | -50.0 |
| CBWTF Auxly Cannabis Group Inc. | $250M | 10.4 | 16.6 | 2.2 | 16.8 | 10.8 | 7 | BULLISH | 71.5 |
| KRMD KORU Medical Systems, Inc. | $150M | -80.9 | -10.5 | -8.8 | 2.1 | 22.4 | 6 | BULLISH | -25.2 |
| BMGL Basel Medical Group Ltd Ordinary Shares | $10M | — | — | — | — | — | — | BULLISH | -76.8 |
| XNCR Xencor, Inc. | $1.9B | -13.8 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | BULLISH | 127.0 |
| TGLVY Top Glove Corporation Bhd. | $1.7B | 25.1 | 6.3 | 8.5 | 12.6 | 21.4 | 8 | BULLISH | 51.4 |
| TRAX First Tracks Biotherapeutics Inc | $1.6B | — | — | — | — | — | — | BULLISH | — |
| SLN Silence Therapeutics plc | $930M | -5.2 | -90.4 | 157.8 | — | -97.6 | 1 | BULLISH | 171.0 |
| BBNX Beta Bionics, Inc. | $860M | -11.4 | -26.2 | -79.6 | -73.1 | 191.1 | 3 | BULLISH | 2.1 |
| PBYI Puma Biotechnology, Inc. | $570M | 20.4 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | BULLISH | 108.8 |
| CV CapsoVision, Inc. | $370M | -10.7 | -226.6 | -73.0 | -205.4 | — | 2 | BULLISH | 37.8 |
| SGMT Sagimet Biosciences Inc. | $310M | -8.1 | -24.4 | -231.4 | — | — | 3 | BULLISH | 14.0 |
| OPRX OptimizeRx Corp. | $170M | 37.2 | 3.7 | 6.1 | -3.4 | -5.8 | 8 | BULLISH | -58.2 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.4 | -119.9 | 354.7 | 17.5 | — | 4 | BULLISH | -41.2 |
| NNVC NanoViricides, Inc. | $40M | -3.5 | -101.5 | -111.4 | — | — | 3 | BULLISH | -4.6 |
| RAPH Raphael Pharmaceutical Inc. | $30M | -30.7 | 59.9 | 47.0 | — | — | 2 | BULLISH | 277.5 |
| MBRX Moleculin Biotech, Inc. | $10M | -0.0 | -1371.6 | -494.1 | — | — | 3 | BULLISH | -23.7 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 5 | BULLISH | 94.8 |
| XRAY DENTSPLY SIRONA Inc. | $1.9B | -3.4 | -33.0 | 9.9 | 4.1 | -0.8 | 5 | BULLISH | -27.6 |
| IDGXF Integrated Diagnostics Holdings plc | $340M | 10.4 | 41.4 | 38.4 | 13.8 | 46.8 | 8 | BULLISH | 10.8 |
| HBIO Harvard Bioscience, Inc. | $40M | -3.6 | -89.9 | 1.8 | -12.8 | -1.1 | 7 | BULLISH | 104.7 |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | $20M | -0.2 | -90.1 | -46.0 | — | — | 4 | BULLISH | 67.0 |
| TBIO Telesis Bio, Inc. | — | -0.0 | -180.9 | -154.3 | -424.1 | -54.9 | 3 | BULLISH | 250.9 |
| NBTX Nanobiotix S.A. | $1.5B | -27.5 | 104.2 | 62.0 | -626.0 | 49.1 | 4 | BULLISH | 79.8 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.4 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | BULLISH | 6.2 |
| BDRX Biodexa Pharmaceuticals Plc | — | -0.1 | -42.3 | -117.9 | — | — | 2 | BULLISH | -89.1 |
| CBDG THC Farmaceuticals, Inc. | — | -30.9 | 2.0 | -0.9 | — | 28.1 | 5 | BULLISH | -63.1 |
| NTLA Intellia Therapeutics, Inc. | $1.6B | -3.7 | -55.4 | -92.1 | -1392.3 | 12.6 | 5 | BULLISH | -52.0 |
| CSTL Castle Biosciences, Inc. | $1.0B | -52.3 | -4.2 | -10.6 | -2.0 | 3.2 | 4 | BULLISH | 40.8 |
| PHAR Pharming Group N.V. | $710M | 81.8 | 3.6 | 3.2 | 1.8 | 7.8 | 7 | BULLISH | -12.7 |
| CARL Carlsmed, Inc. | $400M | -11.3 | -43.8 | -122.7 | -55.5 | — | 2 | BULLISH | 14.4 |
| HLTRF HLS Therapeutics Inc. | $90M | -12.0 | -14.1 | -4.2 | -7.0 | -0.2 | 5 | BULLISH | -20.4 |
| HYEX Healthy Extracts Inc. | $10M | -8.1 | -7.7 | -2.8 | -6.3 | 84.1 | 5 | BULLISH | -42.1 |
| BGMS Bio Green Med Solution, Inc. | $10M | -0.3 | -30.7 | -64.2 | -120.5 | — | 2 | BULLISH | -48.7 |
| PCSA Processa Pharmaceuticals, Inc. | $10M | -0.3 | -464.2 | 1977.5 | — | — | 2 | BULLISH | -76.5 |
| PCRX Pacira BioSciences, Inc. | $1.4B | 103.4 | 2.0 | 1.8 | 2.4 | 5.7 | 8 | BULLISH | 67.4 |
| KHTRF Knight Therapeutics Inc. | $810M | 76.7 | 1.9 | 2.6 | -2.3 | 42.4 | 8 | BULLISH | 98.5 |
| SUSRF Surgical Science Sweden AB (publ) | $280M | 32.0 | 2.1 | 2.7 | 8.2 | 8.1 | 6 | BULLISH | -37.8 |
| ICCC ImmuCell Corporation | $90M | 121.3 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BULLISH | 68.8 |
| OMCL Omnicell, Inc. | $1.7B | 43.0 | 3.1 | 3.2 | 7.8 | 8.5 | 9 | BULLISH | 18.2 |
| VTRLY Vitrolife AB (publ) | $1.4B | -3.1 | -46.2 | -41.3 | 14.3 | -2.0 | 5 | BULLISH | -34.0 |
| OPK OPKO Health, Inc. | $1.2B | -16.9 | -5.9 | -3.0 | -5.1 | -11.5 | 2 | BULLISH | 7.3 |
| EMBC Embecta Corp. | $380M | 4.4 | -13.6 | 26.3 | 7.8 | -7.6 | 5 | BULLISH | -53.7 |
| DH Definitive Healthcare Corp. | $120M | -0.7 | -75.0 | 96.7 | -9.8 | -5.0 | 6 | BULLISH | -62.6 |
| CVALF Covalon Technologies Ltd. | $80M | 27.9 | 14.3 | 28.5 | 28.0 | 4.2 | 8 | BULLISH | 117.2 |
| PLUR Pluri Inc. | $10M | -0.5 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | BULLISH | -69.5 |
| IDTA IDenta Corp. | — | 9.8 | 13.8 | 25.0 | -9.1 | 57.3 | 8 | BULLISH | 95.5 |
| EBYH Strainsforpains, Inc. | — | -23.4 | -3.4 | 16.3 | -603.3 | 1679.9 | 5 | BULLISH | 54.5 |
| VIBEF Vibe Growth Corporation | — | -0.2 | 40.9 | -1.4 | -8.6 | 24.4 | 6 | BULLISH | 626.0 |
| CASBF CanSino Biologics Inc. | $1.4B | 367.7 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BULLISH | -25.5 |
| REPL Replimune Group, Inc. | $1.1B | -4.1 | -134.3 | -1055.2 | — | — | 1 | BULLISH | 48.3 |
| CTSO Cytosorbents Corporation | $20M | -0.8 | -336.2 | -46.3 | -45.9 | 3.1 | 4 | BULLISH | -72.2 |
| SNNC Sibannac, Inc. | — | -2.4 | 44.4 | 105.9 | — | -14.2 | 3 | BULLISH | -64.3 |
| PPCB Propanc Biopharma, Inc. | — | -0.1 | -161.9 | -166.7 | — | — | 4 | BULLISH | 59.9 |
| ACUR Acura Pharmaceuticals, Inc. | — | -0.0 | 30.8 | -306.4 | 80.6 | -56.2 | 4 | BULLISH | 0.0 |
| UMCN UMC, Inc. | $50M | -93.7 | -840.4 | -95.6 | -590.7 | 2325.0 | 4 | BULLISH | 483.3 |
| PFHO Pacific Health Care Organization, Inc. | $10M | 13.1 | 7.5 | 60.8 | 18.4 | -2.6 | 4 | BULLISH | -13.0 |
| RDGT Ridgetech, Inc. | — | -0.0 | -3.6 | -5.9 | -1.7 | 170.8 | 4 | BULLISH | -52.8 |
| HADV Health Advance Inc. | — | -4.4 | 77.3 | -29.9 | — | — | 1 | BULLISH | 0.0 |
| FZMD Fuse Medical, Inc. | — | 15.0 | -177.1 | -13.7 | 6.2 | -5.8 | 5 | BULLISH | -50.0 |
| KOAN Resonate Blends, Inc. | — | -0.0 | 46.5 | -991.9 | -399.0 | -32.1 | 4 | BULLISH | -96.8 |
| HALB Halberd Corporation | — | -25.4 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -13.9 |
| LMAT LeMaitre Vascular, Inc. | $1.9B | 28.9 | 16.8 | 25.6 | 24.2 | 11.8 | 8 | BULLISH | -5.8 |
| ABSI Absci Corporation | $1.6B | -13.2 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BULLISH | 147.5 |
| CRON Cronos Group Inc. | $1.2B | 18.1 | 6.5 | 5.4 | 60.5 | 72.9 | 7 | BULLISH | 34.1 |
| PRCT PROCEPT BioRobotics Corporation | $1.1B | -10.2 | -30.2 | -47.6 | -28.4 | 22.7 | 2 | BULLISH | -43.4 |
| CRMD CorMedix Inc. | $610M | 3.3 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BULLISH | -28.4 |
| IOBCF Ion Beam Applications S.A. | $550M | 19.7 | 20.6 | 14.0 | 2.9 | 7.0 | 5 | BULLISH | 39.5 |
| TCMD Tactile Systems Technology, Inc. | $540M | 21.5 | 11.9 | 13.8 | 9.1 | 17.2 | 8 | BULLISH | 55.4 |
| NRC NRC Health | $490M | 71.9 | 42.0 | 9.9 | -9.3 | -0.2 | 6 | BULLISH | 48.3 |
| SI Shoulder Innovations, Inc. | $410M | -11.3 | -28.2 | -69.1 | -59.1 | — | 1 | BULLISH | 57.7 |
| DTIL Precision BioSciences, Inc. | $180M | -2.4 | -135.1 | 203.1 | — | 3473.0 | 5 | BULLISH | 1.0 |
| NRXS NeurAxis, Inc. | $90M | -9.6 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 110.9 |
| OKYO OKYO Pharma Limited | $70M | -6.2 | -263.8 | 88.0 | — | — | 3 | BULLISH | -37.7 |
| PROCF Sofgen Pharma S.A. | $60M | — | — | — | — | — | — | BULLISH | — |
| XERS Xeris Biopharma Holdings, Inc. | $1.9B | -107.6 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 13.5 |
| ADCT ADC Therapeutics S.A. | $180M | -2.4 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BULLISH | -61.1 |
| SCNLF Scancell Holdings plc | $170M | -5.1 | 153.2 | 179.2 | — | -100.0 | 2 | BULLISH | 969.8 |
| ZYBT Zhengye Biotechnology Holding Limited | $70M | — | — | — | — | — | — | BULLISH | -39.3 |
| ESTA Establishment Labs Holdings Inc. | $1.9B | -51.2 | -175.3 | -6.9 | -17.4 | 38.6 | 5 | BULLISH | 36.4 |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.4 | -140.0 | 105.8 | -5.6 | — | 2 | BULLISH | — |
| VRSEF Verisante Technology Inc. | — | 5.4 | 124.9 | 102.2 | — | — | 3 | BULLISH | 354.6 |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | BULLISH | -82.9 |
| VOR Vor Biopharma Inc. | $990M | 0.1 | -73.6 | 22.2 | — | — | 3 | BULLISH | -28.1 |
| KMDA Kamada Ltd. | $450M | 21.0 | 8.4 | 11.0 | 16.9 | 13.2 | 7 | BULLISH | 17.2 |
| ALEC Alector, Inc. | $200M | -1.9 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | BULLISH | 40.0 |
| SYRA Syra Health Corp. Class A Common Stock | $10M | 98.3 | 5.2 | 11.3 | 10.5 | 0.3 | 4 | BULLISH | 1006.2 |
| HDVY Health Discovery Corporation | — | -0.1 | -3852.6 | 357.6 | — | -100.0 | 1 | BULLISH | 100.0 |
| ACUT Accustem Sciences Inc. | — | -1.4 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BULLISH | -88.8 |
| KNBIF Kane Biotech Inc. | — | -2.4 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | BULLISH | -27.9 |
| RXRX Recursion Pharmaceuticals, Inc. | $2.0B | -3.9 | -56.6 | -99.7 | -1708.0 | -14.9 | 4 | BULLISH | -33.0 |
| PAHC Phibro Animal Health Corporation | $1.6B | 15.6 | 29.7 | 13.2 | 5.5 | 17.1 | 7 | BULLISH | -9.1 |
| KROS Keros Therapeutics, Inc. | $220M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | BULLISH | -24.0 |
| TXTM ProText Mobility, Inc. | $90M | 86.0 | -0.4 | -0.3 | — | -100.0 | 1 | BULLISH | 273.9 |
| NEGXF NexgenRx Inc. | $30M | — | 30.1 | -9.7 | 19.7 | 12.0 | 4 | BULLISH | 120.0 |
| CNNC Cannonau Corp. | — | 0.0 | -96.5 | -93.3 | — | -100.0 | 2 | BULLISH | -33.3 |
| IMCR Immunocore Holdings plc | $1.6B | -177.3 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BULLISH | -3.4 |
| CNMD CONMED Corporation | $1.5B | 25.5 | 5.5 | 5.2 | 6.7 | 3.4 | 7 | BULLISH | -1.3 |
| PNTG The Pennant Group, Inc. | $1.5B | 44.3 | 9.6 | 5.5 | 3.0 | 37.9 | 6 | BULLISH | 72.8 |
| DMAC DiaMedica Therapeutics Inc. | $470M | -12.1 | -114.6 | 616.3 | — | — | 2 | BULLISH | 26.3 |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BULLISH | — |
| MLTX MoonLake Immunotherapeutics | $1.0B | -3.1 | -67.4 | 2902.7 | — | — | 1 | BULLISH | 25.3 |
| TNPH Tian'an Pharmaceutical Co., Ltd. | $20M | -1961.1 | 0.3 | 33.0 | — | -100.0 | 3 | BULLISH | 1150.0 |
| PDSB PDS Biotechnology Corporation | $60M | -2.0 | -544.0 | 456.9 | — | — | 1 | BULLISH | 41.4 |
| NYMXF Nymox Pharmaceutical Corporation | $10M | -0.9 | 193.9 | 89.4 | — | — | 2 | BULLISH | -63.2 |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.1 | -115.7 | -377.9 | — | -133.3 | 3 | BULLISH | -25.0 |
| AIBT Aibotics Inc. | — | — | — | — | — | — | — | BULLISH | — |
| NUMIF Numinus Wellness Inc. | $10M | -0.8 | 57.6 | 40.6 | -18.7 | 429.3 | 5 | BULLISH | -46.4 |
| IGPK Integrated Cannabis Solutions, Inc. | $10M | 8.0 | -3.2 | -5.2 | 0.6 | 2762.5 | 5 | BULLISH | -75.0 |
| PULM Pulmatrix, Inc. | $10M | -1.4 | -98.3 | -835.1 | — | -100.0 | 3 | BULLISH | -69.2 |
| SHWGF Shandong Weigao Group Medical Polymer Company Limited | $1.9B | 9.3 | 5.6 | 7.4 | 11.3 | 2.2 | 6 | BULLISH | -39.1 |
| JCRRF JCR Pharmaceuticals Co., Ltd. | $460M | 75.9 | 1.9 | -0.5 | -19.7 | 66.6 | 4 | BULLISH | -17.1 |
| TCRT Alaunos Therapeutics, Inc. | $10M | -1.1 | -185.9 | -607.2 | — | -50.0 | 1 | BULLISH | -26.9 |
| CNHC China Health Management Corp. | — | 13.7 | 3.2 | 3.3 | 29.8 | -1.0 | 6 | BULLISH | 53.6 |
| YBGJ Yubo International Biotech Limited | — | -1.7 | 28.2 | 30.1 | — | 9417.8 | 5 | BULLISH | -20.6 |
| APLIF Appili Therapeutics Inc. | — | — | 27.8 | 79.4 | -1441.5 | 277.2 | 2 | BULLISH | -63.2 |
| CDXQ China De Xiao Quan Care Group Co., Ltd | — | 0.1 | -136.1 | -277.5 | — | — | 4 | BULLISH | 2000.0 |
| UPHL UpHealth, Inc. | — | -0.0 | -84.2 | -4.7 | — | -46.7 | 3 | BULLISH | 50.0 |
| EDIT Editas Medicine, Inc. | $370M | -3.5 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BULLISH | -30.1 |
| AIMV AI Maverick Intel, Inc. | $10M | — | — | — | — | — | — | BULLISH | — |
| CSWYF China Shineway Pharmaceutical Group Limited | $760M | 6.0 | 19.9 | 46.7 | 21.6 | 1081.8 | 8 | BULLISH | 0.0 |
| PEPG PepGen Inc. | $170M | -1.7 | -75.5 | -327.5 | — | — | 4 | BULLISH | -43.1 |
| BCCOY BICO Group AB (publ) | $190M | -2.0 | -41.5 | -8.4 | -11.1 | -19.8 | 6 | BULLISH | -9.6 |
| LGNDZ Ligand Pharmaceuticals, Inc. | — | 0.0 | 20.4 | 11.3 | 76.2 | — | 3 | BULLISH | — |
| SOPH SOPHiA GENETICS S.A. | $630M | -6.6 | -101.2 | -155.2 | -95.9 | 23.6 | 3 | LEAN BULL | 77.4 |
| NGNE Neurogene Inc. | $370M | -4.9 | -45.3 | -111469.0 | — | — | 2 | LEAN BULL | -9.7 |
| BCYC Bicycle Therapeutics plc | $250M | -1.4 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | LEAN BULL | -52.0 |
| LCTX Lineage Cell Therapeutics, Inc. | $250M | -7.3 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | LEAN BULL | -39.4 |
| ABOS Acumen Pharmaceuticals, Inc. | $140M | -1.5 | -162.7 | 466.8 | — | — | 2 | LEAN BULL | 2.3 |
| LUNG Pulmonx Corporation | $80M | -2.0 | -88.9 | -92.5 | -44.3 | -3.4 | 4 | LEAN BULL | 20.7 |
| IUGNF Imugene Limited | $30M | -0.1 | -389.5 | -458.5 | — | -100.0 | 1 | LEAN BULL | -74.0 |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | LEAN BULL | 0.0 |
| MHTX Manhattan Scientifics, Inc. | — | -0.0 | 45.1 | 23.3 | — | 104.9 | 3 | LEAN BULL | 0.0 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | LEAN BULL | -92.3 |
| AGFAF Digicann Ventures Inc. | — | -0.0 | 30.8 | 63.6 | — | — | 2 | LEAN BULL | 47.7 |
| RLBD Real Brands, Inc. | — | -0.2 | 62.2 | 111.8 | — | 204.2 | 5 | LEAN BULL | 900.0 |
| GRCU Global Roundtable Corporation | — | -2.9 | 28.1 | 25.5 | -673.8 | 35.7 | 7 | LEAN BULL | 9900.0 |
| MICR Micron Solutions, Inc. | — | -0.1 | -32.9 | -10.2 | -16.0 | 19.3 | 3 | LEAN BULL | 25450.0 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | LEAN BULL | 100.0 |
| SGHT Sight Sciences, Inc. | $500M | -16.2 | -48.4 | -145.7 | -19.0 | 9.3 | 4 | LEAN BULL | 71.0 |
| PTCHF PureTech Health plc | $390M | 157.0 | 0.2 | 50.8 | 1890.6 | 7.7 | 4 | LEAN BULL | -5.4 |
| OBIO Orchestra BioMed Holdings, Inc. | $340M | -5.8 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | LEAN BULL | 46.0 |
| ACOG Alpha Cognition Inc | $130M | -8.2 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | LEAN BULL | 11.1 |
| EVGRF China Evergrande New Energy Vehicle Group Limited | $20M | -12.9 | 104.0 | 16.8 | -766929.9 | 284.5 | 4 | LEAN BULL | 185.7 |
| CKDXF Ceryvyn Therapeutics Ltd | $10M | 0.1 | -243.9 | 2882.8 | — | -97.3 | 3 | LEAN BULL | -97.6 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | LEAN BULL | -44.7 |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -326.4 | 584.9 | — | -100.0 | 1 | LEAN BULL | -93.9 |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | LEAN BULL | 300.0 |
| MSGP MedSmart Group Inc. | — | -0.6 | 33.6 | 85.8 | — | -100.0 | 1 | LEAN BULL | 2000.0 |
| BIEI Premier Graphene, Inc. | — | -28.3 | 9.8 | 7.4 | — | -100.0 | 5 | LEAN BULL | 28.6 |
| NEWUF Newtopia Inc. | — | -0.1 | 75.4 | 107.5 | -166.7 | -36.4 | 2 | LEAN BULL | 0.0 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | LEAN BULL | 200.0 |
| THCT THC Therapeutics, Inc. | — | -0.0 | 16.8 | 16.9 | — | — | 2 | LEAN BULL | 300.0 |
| MSTH Mystic Holdings, Inc. | — | -0.2 | -35.2 | -19.8 | -27.1 | 24.7 | 5 | LEAN BULL | -79.2 |
| MNZO Manzo Pharmaceuticals, Inc. | — | -9.8 | 4.6 | 4.1 | — | — | 2 | LEAN BULL | 0.0 |
| USPH U.S. Physical Therapy, Inc. | $1.3B | 513.8 | -1.3 | 7.7 | 0.7 | 17.1 | 5 | LEAN BULL | -3.7 |
| DBCCF Decibel Cannabis Company Inc. | $50M | -115.6 | -1.0 | -3.0 | 11.7 | 26.5 | 3 | LEAN BULL | -2.2 |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.2 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | LEAN BULL | -79.8 |
| IRIX IRIDEX Corporation | $10M | -3.6 | -73.1 | -73.9 | -10.1 | 3.7 | 5 | LEAN BULL | -32.7 |
| TSMRF Tsumura & Co. | $1.7B | 9.2 | 9.9 | 6.6 | 13.0 | 10.7 | 4 | LEAN BULL | 0.0 |
| SWGHF Sawai Group Holdings Co., Ltd. | $1.3B | 22.7 | 4.3 | 4.6 | 4.7 | 11.4 | 4 | LEAN BULL | 0.0 |
| TWAPF Towa Pharmaceutical Co., Ltd. | $1.3B | 21.1 | 4.7 | 3.2 | 7.7 | 7.1 | 7 | LEAN BULL | 54.4 |
| KKPCF Kaken Pharmaceutical Co., Ltd. | $980M | 14.0 | 6.9 | 7.9 | 28.0 | -6.6 | 4 | LEAN BULL | 8.3 |
| CPIVF Captiva Verde Wellness Corp. | $30M | -40.6 | -49.0 | -123.3 | — | — | 2 | LEAN BULL | 500.0 |
| NTRR Neutra Corp. | — | 2.0 | -139.6 | -802.5 | -3.8 | 142.2 | 7 | LEAN BULL | -33.3 |
| VREX Varex Imaging Corporation | $780M | 35.2 | 4.6 | 7.6 | 7.5 | 5.3 | 6 | LEAN BULL | 54.0 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.8 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | LEAN BULL | -19.1 |
| CERS Cerus Corporation | $470M | -66.3 | -10.8 | -7.4 | -5.1 | 15.1 | 5 | LEAN BULL | 56.9 |
| CCCC C4 Therapeutics, Inc. | $380M | -3.2 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | LEAN BULL | 31.0 |
| ZURA Zura Bio Limited | $320M | -3.8 | -65.4 | 806.5 | — | — | 2 | LEAN BULL | 15.7 |
| STIM Neuronetics, Inc. | $160M | -5.1 | -135.3 | -21.3 | -8.3 | 39.6 | 4 | LEAN BULL | -29.8 |
| EKDHF EKF Diagnostics Holdings plc | $140M | 42.1 | 3.5 | 5.2 | 9.3 | 2.5 | 7 | LEAN BULL | -17.8 |
| BIVI BioVie Inc. | $10M | -0.4 | -0.0 | -0.0 | — | — | 3 | LEAN BULL | -23.4 |
| VSBC VitaSpring Biomedical Co. Ltd. | $10M | -13.8 | 10.3 | 15.9 | — | -100.0 | 4 | LEAN BULL | -96.8 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | LEAN BULL | 29.6 |
| ERGO Entia Biosciences, Inc. | — | -0.0 | 106.8 | 92.5 | -1021.5 | -23.5 | 5 | LEAN BULL | 900.0 |
| BGXXQ Bright Green Corporation | — | — | — | — | — | — | — | LEAN BULL | — |
| MDCN Medican Enterprises, Inc. | — | -3.4 | 40.4 | -2.1 | — | -38.5 | 3 | LEAN BULL | -0.0 |
| SMAS Somatic Systems, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | LEAN BULL | 600.0 |
| HPMM Hemp Naturals, Inc. | — | -0.0 | -141.5 | -78.5 | — | — | 3 | LEAN BULL | -80.0 |
| ESMC Escalon Medical Corp. | — | 0.7 | 102.3 | -0.0 | 46.1 | 5.7 | 7 | LEAN BULL | 10.1 |
| SONX Sonendo, Inc. | — | -0.4 | -166.8 | -185.6 | -76.7 | -27.7 | 5 | LEAN BULL | 212.2 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.6 | -125.6 | 710.2 | — | — | 3 | LEAN BULL | 92.1 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | LEAN BULL | 23.3 |
| PBIO Pressure BioSciences, Inc. | — | -0.0 | 100.6 | 84.5 | -1687.2 | -25.3 | 3 | LEAN BULL | -98.7 |
| BGMD BG Medicine, Inc. | — | -0.0 | 747.3 | 104.5 | -311.0 | -43.8 | 5 | LEAN BULL | 0.0 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 4 | LEAN BULL | 194.5 |
| CNFHF CanaFarma Hemp Products Corp. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| TGIFF 1933 Industries Inc. | — | 6.2 | -14.6 | -33.1 | 8.9 | -11.8 | 5 | LEAN BULL | -48.0 |
| AFIB Acutus Medical, Inc. | — | -0.0 | 153.1 | -0.4 | -19.7 | 375.7 | 2 | LEAN BULL | -87.5 |
| CENBF CEN Biotech, Inc. | — | -0.0 | 32.0 | -64.0 | 569.4 | -54.9 | 5 | LEAN BULL | 100.0 |
| OMHE OMNI Health, Inc. | — | 0.0 | 30.4 | -8.8 | -6.1 | 2046.4 | 4 | LEAN BULL | 233.3 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | LEAN BULL | 100.0 |
| INNV Innovage Holding Corp. | $1.3B | -440.6 | -1.1 | -89.6 | 3.2 | 16.4 | 6 | LEAN BULL | 73.1 |
| COLL Collegium Pharmaceutical, Inc. | $750M | 15.0 | 17.6 | 9.4 | -7.5 | 14.3 | 6 | LEAN BULL | -34.8 |
| HITI High Tide Inc. | $230M | -9.9 | -27.0 | 0.8 | 5.7 | 26.8 | 3 | LEAN BULL | -19.6 |
| VASO Vaso Corporation | $50M | 17.9 | 10.0 | -3055.8 | 7.5 | -8.0 | 8 | LEAN BULL | 150.0 |
| ACHFF Arch Biopartners Inc. | $40M | -20.5 | 73.5 | 165.4 | — | 100.0 | 2 | LEAN BULL | -12.6 |
| CBIH Cannabis Bioscience International Holdings, Inc. | — | -0.0 | 48.2 | 34.0 | -341.5 | -58.2 | 1 | LEAN BULL | -50.0 |
| PRLD Prelude Therapeutics Incorporated | $210M | -4.9 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | LEAN BULL | 139.5 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | LEAN BULL | — |
| SRZN Surrozen, Inc. | $190M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | LEAN BULL | 114.8 |
| TRIB Trinity Biotech plc | $150M | -0.2 | 69.8 | -14.6 | -157.8 | -28.8 | 2 | LEAN BULL | 615.0 |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | LEAN BULL | — |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| GMRS GMR Solutions Inc. | $580M | — | — | — | — | — | — | LEAN BULL | — |
| CYDY CytoDyn Inc. | $380M | -4.9 | 57.8 | 24.6 | — | 100.0 | 4 | LEAN BULL | -16.2 |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | LEAN BULL | -65.7 |
| PIIIW P3 Health Partners Inc. | $20M | -0.1 | -168.8 | -64.8 | 1.9 | 2.8 | 4 | LEAN BULL | -18.1 |
| VYYRF Voyageur Pharmaceuticals Ltd. | $20M | -6.5 | -527.9 | -47345.4 | -6124.5 | — | 3 | LEAN BULL | -8.4 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | LEAN BULL | -20.0 |
| PVLA Palvella Therapeutics, Inc. | $1.8B | -27.5 | -46.6 | 137.5 | — | — | 3 | LEAN BULL | 82.1 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -9.0 | -45.3 | -2390.9 | — | — | 2 | LEAN BULL | 51.2 |
| STLN Starling Oncology, Inc. | $670M | — | — | — | — | — | — | LEAN BULL | — |
| PRTA Prothena Corporation plc | $420M | -10.6 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | LEAN BULL | -10.3 |
| ENTA Enanta Pharmaceuticals, Inc. | $340M | -5.1 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BULL | 15.9 |
| GLSI Greenwich LifeSciences, Inc. | $240M | -11.3 | -951.6 | 299.9 | — | — | 2 | LEAN BULL | 74.4 |
| POSC Positron Corporation | $60M | -5.5 | 1961.0 | -1406.8 | -734.6 | -22.9 | 2 | LEAN BULL | 11.0 |
| CLNN Clene Inc. | $60M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | LEAN BULL | -52.4 |
| FWDG FutureWorld Corp. | — | -0.1 | -1.2 | -0.5 | -507.1 | 153.6 | 5 | LEAN BULL | 0.0 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | LEAN BULL | 0.0 |
| BBBT Black Bird Biotech, Inc. | — | -0.0 | 129.1 | 137.7 | -3333.2 | -61.0 | 2 | LEAN BULL | 0.0 |
| CRYM Cryomass Technologies Inc. | — | -0.0 | 137.2 | 57.9 | -22040.0 | -96.0 | 2 | LEAN BULL | -60.0 |
| ATEC Alphatec Holdings, Inc. | $1.7B | -15.1 | -623.1 | -7.6 | -12.1 | 19.5 | 5 | LEAN BULL | -32.5 |
| IUSDF AS ONE Corporation | $1.0B | 19.2 | 12.2 | 13.4 | 8.1 | 5.7 | 6 | LEAN BULL | -39.5 |
| KJFI Comjoyful International Company | $210M | -98.4 | 171.5 | -1549.9 | 44.3 | 38.8 | 6 | LEAN BULL | 459.8 |
| HCTI Healthcare Triangle, Inc. | $10M | -0.0 | -57.4 | -19.3 | -48.0 | 116.4 | 3 | LEAN BULL | -95.8 |
| ETBI Eastgate Biotech Corp. | $10M | -2.6 | 93.4 | 134.9 | -7057.2 | -53.0 | 3 | LEAN BULL | 66.7 |
| LPTI Longport, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| PMHS Polomar Health Services, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| DVLP Golden Developing Solutions, Inc. | — | -0.0 | 450.9 | 46.1 | -166.7 | — | 6 | LEAN BULL | -90.0 |
| ALGWF Alliance Growers Corp. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -2.8 | 9.2 | 7.5 | — | — | 2 | LEAN BULL | -51.2 |
| CNGGF Cann Group Limited | — | 0.3 | 157.4 | -25.1 | -150.3 | -35.4 | 5 | LEAN BULL | -40.8 |
| ELIXF Elixxer Ltd. | — | -0.2 | 27.1 | 280.4 | — | — | 2 | LEAN BULL | -58.1 |
| RSCF Reflect Scientific, Inc. | — | 15.8 | 12.1 | 17.0 | 15.2 | 76.0 | 6 | LEAN BULL | 20.6 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BULL | 100.0 |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | LEAN BULL | 0.0 |
| XBRAF Xebra Brands Ltd. | — | -0.1 | -542.1 | -2373.1 | — | -100.0 | 1 | LEAN BULL | -98.5 |
| RBII Rising Biosciences, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| PXYN Praxsyn Corporation | — | -0.0 | 159.9 | 101.7 | 14.5 | 14.7 | 4 | LEAN BULL | 0.0 |
| WHSI Wearable Health Solutions, Inc. | — | -0.1 | 37.4 | 155.3 | 98.4 | -29.7 | 2 | LEAN BULL | 0.0 |
| REFG Medical Cannabis Payment Solutions | — | -3.0 | 1.2 | 1.5 | — | — | 2 | LEAN BULL | 200.0 |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | LEAN BULL | -90.0 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -13.1 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | NEUTRAL | -17.2 |
| MLAB Mesa Laboratories, Inc. | $720M | 150.3 | 2.7 | 4.4 | 4.7 | 3.0 | 8 | NEUTRAL | 63.6 |
| OFIX Orthofix Medical Inc. | $400M | -6.3 | -13.9 | -3.6 | -7.5 | 3.0 | 6 | NEUTRAL | -39.2 |
| SERA Sera Prognostics, Inc. | $80M | -3.1 | -45.0 | -184.9 | -30463.3 | -35.2 | 3 | NEUTRAL | -43.8 |
| ABVC ABVC BioPharma, Inc. | $30M | -3.6 | -82.2 | -43.0 | — | -100.0 | 2 | NEUTRAL | -64.4 |
| PJET Priority Aviation, Inc. | — | -0.1 | 19.5 | 31.9 | — | -83.3 | 2 | NEUTRAL | 0.0 |
| BTTX Better Therapeutics, Inc. | — | -0.0 | 2351.8 | 1050.0 | — | -100.0 | 1 | NEUTRAL | 0.0 |
| VSEED VSee Health, Inc. | — | — | — | — | — | — | — | NEUTRAL | — |
| SLDX Stella Diagnostics Inc. | — | -0.7 | 18.1 | 21.7 | -195.2 | — | 4 | NEUTRAL | -60.2 |
| REZNF Street Capital Inc. | — | -3.3 | 20.7 | 15.0 | — | -44.3 | 5 | NEUTRAL | 566.7 |
| NPNKF Nippon Shinyaku Co., Ltd. | $1.6B | 7.2 | 11.6 | 12.5 | 20.6 | 12.8 | 4 | NEUTRAL | -1.1 |
| ANAB AnaptysBio, Inc. | $1.5B | 7.4 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | NEUTRAL | 112.3 |
| CSCIF COSCIENS Biopharma Inc. | $10M | -0.5 | -19.9 | -18.7 | -6.4 | — | 1 | NEUTRAL | -16.7 |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | NEUTRAL | -50.0 |
| POM Pomdoctor Limited | $10M | -0.1 | 48.5 | 554.8 | -124.2 | — | 3 | NEUTRAL | -70.0 |
| THMO ThermoGenesis Holdings, Inc. | — | -0.0 | -417.9 | -71.5 | -67.8 | -7.5 | 3 | NEUTRAL | 0.0 |
| LFCR Lifecore Biomedical, Inc. | $240M | -5.9 | 202.6 | 0.1 | -18.0 | -4.1 | 5 | NEUTRAL | -5.0 |
| TLTFF Theralase Technologies Inc. | $50M | -14.1 | -93.5 | -173.9 | -646.5 | -24.8 | 4 | NEUTRAL | -2.7 |
| SNWV SANUWAVE Health Inc. | $40M | 3.1 | -238.8 | 4.8 | -7.0 | 12.0 | 7 | NEUTRAL | -83.4 |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | NEUTRAL | — |
| EDXC Endexx Corporation | — | -0.0 | 51.8 | 0.5 | — | -125.6 | 2 | NEUTRAL | -95.5 |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | NEUTRAL | 0.0 |
| SETO SETO Holdings, Inc. | — | -13.8 | -22.5 | -8.5 | -32.2 | 9760.2 | 6 | NEUTRAL | 103.7 |
| PMI Picard Medical, Inc. | $730M | -0.3 | -1631.2 | -469.0 | -191.6 | — | 2 | NEUTRAL | 28.2 |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | NEUTRAL | -38.4 |
| NXGL NEXGEL, Inc. | — | -0.0 | -128.6 | -35.8 | -98.6 | 3.4 | 2 | NEUTRAL | -91.8 |
| OSSFF Embla Medical hf. | $1.9B | 18.0 | 10.4 | 7.7 | 10.5 | 9.9 | 7 | NEUTRAL | -5.6 |
| CSSPF NIOX Group Plc | $380M | 41.3 | 10.8 | 13.0 | 24.6 | 3.5 | 7 | NEUTRAL | -2.3 |
| CAIHF CPBIO Holding Company Limited | $270M | 10.2 | 10.0 | 8.1 | 3.4 | 73.4 | 8 | NEUTRAL | 282.1 |
| SABS SAB Biotherapeutics, Inc. | $260M | 0.9 | -11.3 | -48.4 | — | -100.0 | 3 | NEUTRAL | 1.3 |
| NWBO Northwest Biotherapeutics, Inc. | $260M | -6.5 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | NEUTRAL | -33.7 |
| DIUXF Diaceutics PLC | $200M | -626.6 | -0.8 | -2.3 | -15.9 | 20.4 | 4 | NEUTRAL | 68.6 |
| MLLCF Molecular Partners AG | $150M | -2.3 | -62.1 | 650.3 | — | -100.0 | 2 | NEUTRAL | 14.6 |
| CRVW CareView Communications, Inc. | $20M | -7.8 | 6.4 | -1.4 | -10.0 | 8.5 | 7 | NEUTRAL | 12.7 |
| EXHI Exlites Holdings International, Inc. | $20M | -750.0 | -66.7 | -65.8 | -35.4 | 283.9 | 4 | NEUTRAL | 97.4 |
| ADVT Advantis Corp. | — | -0.4 | -8.4 | -3.2 | -1775.1 | — | 1 | NEUTRAL | 0.0 |
| BTCY Biotricity, Inc. | — | -0.4 | 8.3 | -17.1 | -22.4 | 13.4 | 6 | NEUTRAL | -90.6 |
| NEPTF Neptune Wellness Solutions Inc. | — | -2.8 | 606.5 | 1351.5 | -233.6 | -24.7 | 2 | NEUTRAL | -96.0 |
| FCGD First Colombia Gold Corp. | — | -95.6 | 23.1 | 122.7 | — | -93.9 | 2 | NEUTRAL | 9900.0 |
| STEK Stemtech Corporation | — | -0.0 | 58.2 | 37.1 | -46.5 | -38.6 | 2 | NEUTRAL | -98.5 |
| MDCE Medical Care Technologies Inc. | — | 1.0 | 28.0 | 28.7 | 23.9 | 0.6 | 7 | NEUTRAL | -66.7 |
| STHZF StateHouse Holdings Inc. | — | -0.1 | 36.1 | 3.8 | 0.8 | -2.6 | 4 | NEUTRAL | -99.3 |
| SFWJ Software Effective Solutions Corp. | — | -1.3 | -21.8 | -12.6 | -51.5 | 26679.3 | 6 | NEUTRAL | 20.8 |
| PAOG PAO Group, Inc. | — | -5.8 | -20.2 | 11.2 | — | — | 4 | NEUTRAL | 200.0 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | NEUTRAL | 900.0 |
| TRCNF Transnational Cannabis Ltd. | — | -0.0 | -178.2 | -75.5 | — | — | 1 | NEUTRAL | -96.0 |
| CBDD CBD of Denver, Inc. | — | -7.7 | -0.1 | -28.9 | -2.7 | 19.0 | 3 | NEUTRAL | 14900.0 |
| VRAYQ ViewRay, Inc. | — | -0.0 | -108.9 | -146.1 | -128.1 | 44.1 | 1 | NEUTRAL | 9900.0 |
| PSNL Personalis, Inc. | $1.7B | -14.7 | -50.3 | -149.3 | -141.7 | -13.3 | 2 | NEUTRAL | 65.1 |
| HUMDF Hua Medicine (Shanghai) Ltd. | $300M | -17.8 | -10.3 | -30.2 | -8.0 | 73.9 | 3 | NEUTRAL | -26.1 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.2 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | NEUTRAL | -71.9 |
| LFWD Lifeward Ltd. | $10M | -0.4 | -225.6 | -129.9 | -173.9 | -10.7 | 4 | NEUTRAL | -22.4 |
| JWCAF James E. Wagner Cultivation Corporation | — | -0.0 | -50.3 | -16.2 | -493.1 | 315.1 | 2 | NEUTRAL | 0.0 |
| RVVQF RavenQuest BioMed Inc. | — | -0.0 | -112.5 | -40.6 | -440.2 | 93.6 | 2 | NEUTRAL | 0.0 |
| CLVR Clever Leaves Holdings Inc. | — | -0.0 | -55.4 | -63.3 | -109.6 | 3.6 | 4 | NEUTRAL | 11100.0 |
| BMGP Biomagnetics Diagnostics Corp. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| HEWA HealthWarehouse.com, Inc. | — | -4.8 | 24.7 | 44.2 | -6.8 | -42.5 | 3 | NEUTRAL | -34.0 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | NEUTRAL | 9900.0 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | NEUTRAL | 0.0 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | NEUTRAL | 900.0 |
| SPBBF Speakeasy Cannabis Club Ltd. | — | -0.0 | -55.1 | -4.0 | -803.2 | 16129.5 | 3 | NEUTRAL | 0.0 |
| WMGR Wellness Matrix Group, Inc. | — | -0.0 | 24.4 | 19.3 | — | — | 2 | NEUTRAL | 0.0 |
| MSPR MSP Recovery, Inc. | — | -0.0 | 127.6 | -506.2 | -84750.5 | — | 2 | NEUTRAL | -100.0 |
| FRLI Frélii, Inc. | — | -0.0 | -671.6 | -265.5 | -10546.4 | 378.8 | 4 | NEUTRAL | 0.0 |
| VRSYF VMS Rehab Systems, Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| RDDTF Radient Technologies Inc. | — | — | 98.9 | 263.2 | -131.7 | -20.4 | 3 | NEUTRAL | 0.0 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | NEUTRAL | -90.0 |
| ISOLF Isodiol International Inc. | — | -0.0 | -220.6 | -602.3 | -73.2 | -17.7 | 4 | NEUTRAL | 0.0 |
| INLB Item 9 Labs Corp. | — | -0.0 | -47.3 | -18.4 | -117.7 | -17.4 | 2 | NEUTRAL | 0.0 |
| AUSAF Australis Capital Inc. | — | -0.0 | -52.8 | -42.1 | -1022.3 | 1388076.3 | 3 | NEUTRAL | -90.0 |
| CSTF CuraScientific Corp | — | -0.0 | -72.1 | 17.4 | -2482.5 | 954.6 | 5 | NEUTRAL | 0.0 |
| VPHIF Valeo Pharma Inc. | — | -0.0 | 65.5 | 19863.3 | -65.0 | -0.2 | 2 | NEUTRAL | -66.7 |
| LYCA Lycia Therapeutics Inc. | $1.6B | — | — | — | — | — | — | N/A | — |
| NUTX Nutex Health, Inc. | $1.4B | 7.9 | 49.2 | 53.9 | 31.2 | 6.9 | 7 | NEUTRAL | 65.8 |
| CTY City Therapeutics Inc. | $200M | — | — | — | — | — | — | N/A | — |
| DAVI Davion Healthcare Plc | $150M | — | — | — | — | — | — | N/A | — |
| IAM Iambic Therapeutics Inc. | $130M | — | — | — | — | — | — | N/A | — |
| TRXB TRex Bio Inc. | $120M | — | — | — | — | — | — | N/A | — |
| RTSN Retension Pharmaceuticals Inc. | $60M | — | — | — | — | — | — | N/A | — |
| ATOS Atossa Therapeutics, Inc. | $30M | -0.5 | -89.2 | -4213.1 | — | — | 2 | NEUTRAL | -83.0 |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| ORGS Orgenesis Inc. | — | -0.2 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | NEUTRAL | 66.7 |
| NRTSF Nobilis Health Corp. | — | 0.0 | 1.1 | 2.8 | 1.3 | -11.1 | 3 | N/A | -100.0 |
| INDR Indie Ranch Media, Inc. | — | — | — | — | — | — | — | N/A | -90.0 |
| MDVLQ MedAvail Holdings, Inc. | — | -0.0 | -164.8 | -243.8 | -1429.9 | -28.6 | 4 | NEUTRAL | 0.0 |
| ODYY Odyssey Health, Inc. | — | -0.2 | 43.4 | 10.0 | — | -100.0 | 4 | NEUTRAL | -90.2 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.5 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | NEUTRAL | -30.7 |
| VHIBF Vitalhub Corp. | $340M | 62.1 | 3.3 | 10.7 | 6.1 | 53.9 | 7 | NEUTRAL | -31.4 |
| BIEL Bioelectronics Corporation | $10M | -13.9 | 6.3 | 24.0 | -132.4 | -63.1 | 1 | NEUTRAL | -40.0 |
| ODTX Odyssey Therapeutics, Inc. | $940M | — | — | — | — | — | — | NEUTRAL | — |
| DRUG Bright Minds Biosciences Inc. | $520M | -26.2 | -13.7 | -105758.3 | — | — | 3 | NEUTRAL | -11.7 |
| EDVA Endovia Health Sciences, Inc. | — | — | — | — | — | — | — | NEUTRAL | — |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.2 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | NEUTRAL | 1.7 |
| RKAGY RHÃN-KLINIKUM Aktiengesellschaft | $1.1B | 22.3 | 2.8 | 3.1 | 2.1 | 2.5 | 6 | NEUTRAL | 10.7 |
| NVYTF Novacyt S.A. | $40M | -0.8 | -59.6 | -45.1 | -50.1 | -44.9 | 3 | NEUTRAL | 14.0 |
| AJYG AJ1G, Inc. | — | — | — | — | — | — | — | NEUTRAL | 380.1 |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | NEUTRAL | — |
| NIVF NewGenIvf Group Limited | — | -0.0 | 50.6 | -147.7 | -8.5 | — | 2 | NEUTRAL | -100.0 |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | NEUTRAL | -96.7 |
| CNBX CNBX Pharmaceuticals Inc. | — | -0.5 | 17.8 | 13.3 | — | 100.0 | 3 | NEUTRAL | -57.1 |
| CALC CalciMedica, Inc. | — | -0.2 | -365.7 | 118.3 | — | — | 4 | NEUTRAL | -91.3 |
| CNNA Cann American Corp. | — | 0.4 | -312.1 | -287.6 | -7986.6 | -64.9 | 3 | NEUTRAL | 120.0 |
| DHBUF Delivra Health Brands Inc. | — | -2.5 | -19.4 | -34.1 | -82.4 | -10.7 | 2 | NEUTRAL | -70.2 |
| EMED Electromedical Technologies, Inc. | — | -0.2 | 44.6 | 29.8 | -8153.1 | -66.6 | 2 | NEUTRAL | 0.0 |
| YARW Yarrow Bioscience Inc | $180M | — | — | — | — | — | — | NEUTRAL | — |
| ELUT Elutia Inc | $40M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | NEUTRAL | -10.6 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | NEUTRAL | 9900.0 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | NEUTRAL | -69.4 |
| ISCNF Isracann Biosciences Inc. | — | -0.5 | -252.3 | 2640.8 | — | — | 2 | NEUTRAL | 0.0 |
| GRST Ethema Health Corporation | — | -1.0 | 18.3 | 0.0 | 1.2 | 171.7 | 6 | NEUTRAL | -50.0 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | NEUTRAL | -99.6 |
| AEGY Alternative Energy Partners, Inc. | — | -0.0 | 190.5 | 67.0 | — | -165.0 | 4 | NEUTRAL | -80.0 |
| GCTK GlucoTrack, Inc. | — | -0.0 | -620.6 | 427.4 | — | — | 2 | NEUTRAL | -98.3 |
| MPXOF MPX International Corp. | — | -0.0 | -179.4 | -42.1 | -411.8 | 14.3 | 4 | NEUTRAL | -0.0 |
| NSTM NovelStem International Corp. | — | -1.5 | 15.3 | 31.5 | — | -100.0 | 3 | NEUTRAL | -50.0 |
| DOGP Dogecoin Cash, Inc. | — | -1.9 | 30.1 | 16.3 | -76.3 | 0.2 | 3 | NEUTRAL | -74.5 |
| BFRGW Bullfrog AI Holdings, Inc. Warrants | — | -1.0 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | NEUTRAL | -92.9 |
| LOWLF Lowell Farms Inc. | — | -0.0 | -146.8 | -63.3 | -111.9 | -35.7 | 5 | NEUTRAL | -99.3 |
| RNXT RenovoRx, Inc. | $60M | -4.4 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | NEUTRAL | 17.8 |
| TUTH Standard Dental Labs Inc. | — | -3.0 | 22.6 | 1394.1 | -117.5 | -7.5 | 6 | NEUTRAL | 26.4 |
| ARYC Arrayit Corporation | — | -0.0 | 116.8 | 89.8 | -513.1 | -30.5 | 2 | NEUTRAL | -90.0 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | NEUTRAL | 100.0 |
| IDCN Indocan Resources Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| PPJE PPJ Healthcare Enterprises, Inc. | — | 56.8 | -0.0 | -0.0 | 0.0 | -1.2 | 4 | NEUTRAL | -50.0 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -2.8 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | NEUTRAL | 14.2 |
| FLGT Fulgent Genetics, Inc. | $550M | -7.3 | -8.0 | -12.6 | -34.6 | 6.8 | 4 | NEUTRAL | -12.8 |
| VCRE Vicore Pharma Holding AB | $260M | — | — | — | — | — | — | NEUTRAL | — |
| SIGA SIGA Technologies, Inc. | $220M | -73.4 | -1.5 | -18.3 | 30.4 | -70.1 | 1 | NEUTRAL | -62.1 |
| EGRX Eagle Pharmaceuticals, Inc. | $10M | 0.3 | 6.4 | 3.6 | 8.0 | -5.4 | 3 | NEUTRAL | -5.0 |
| ENGNW enGene Holdings Inc. Warrants | $10M | -5.5 | -2.3 | 134.1 | — | -100.0 | 2 | NEUTRAL | -64.6 |
| BIOCQ Biocept, Inc. | — | -0.0 | -13593.8 | -631.8 | -616.5 | — | 2 | NEUTRAL | 200.0 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | NEUTRAL | 0.0 |
| SESI SES Solar Inc. | — | -0.5 | 16.7 | 1.7 | 28.0 | 324.6 | 7 | NEUTRAL | 0.0 |
| LITH BioELife Corp. | — | -0.0 | -598.1 | 467.7 | — | — | 2 | NEUTRAL | 0.0 |
| AMPH Amphastar Pharmaceuticals, Inc. | $1.1B | 14.7 | 10.3 | 7.5 | 16.5 | 1.4 | 6 | NEUTRAL | 4.3 |
| NXTC NextCure, Inc. | $20M | -0.5 | -195.2 | 949.7 | — | — | 2 | NEUTRAL | -37.8 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | NEUTRAL | -48.4 |
| VDRM ViaDerma, Inc. | — | 28.7 | 133.1 | -25.3 | -214.1 | 5.3 | 3 | NEUTRAL | -50.0 |
| PTLF Petlife Pharmaceuticals, Inc. | — | -0.0 | 257.0 | 178.4 | — | — | 2 | NEUTRAL | 1.0 |
| CANN Trees Corporation | — | -2.5 | 284.2 | -3.9 | -15.1 | -24.7 | 4 | NEUTRAL | -61.1 |
| CBDY Target Group Inc. | — | -0.3 | 23.2 | -10.4 | -17.4 | -30.4 | 2 | NEUTRAL | -44.4 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | NEUTRAL | 0.0 |
| ERBB American Green, Inc. | — | 0.1 | 33.3 | -15.0 | -629.5 | 17.7 | 3 | NEUTRAL | 0.0 |
| ATXI Avenue Therapeutics, Inc. | — | -0.5 | -120.0 | 178.4 | — | -100.0 | 2 | NEUTRAL | -43.9 |
| AHCO AdaptHealth Corp. | $820M | -3.5 | -15.5 | -0.2 | -18.1 | 22.9 | 6 | LEAN BEAR | -37.6 |
| MCTA Charming Medical Limited Class A Ordinary Shares | $450M | — | — | — | — | — | — | LEAN BEAR | — |
| MBXBF Microbix Biosystems Inc. | $30M | -8.6 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | LEAN BEAR | 24.3 |
| STSEY Stratec SE | $1.7B | -575.0 | -0.2 | -0.2 | 7.0 | -4.8 | 4 | LEAN BEAR | -17.8 |
| SAFLY Safilo Group S.p.A. | $1.4B | 15.4 | 12.0 | 10.0 | 8.7 | -3.4 | 7 | LEAN BEAR | 40.1 |
| AGYTF Allergy Therapeutics plc | $760M | -4.3 | 3372.3 | -97.9 | -54.9 | 19.9 | 3 | LEAN BEAR | 36.4 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | LEAN BEAR | -25.4 |
| OPORF hVIVO plc | $80M | -3.1 | -32.7 | -34.7 | -39.7 | -23.6 | 2 | LEAN BEAR | -54.3 |
| POLBF Poolbeg Pharma PLC | $70M | -8.5 | -58.8 | -255.9 | — | — | 1 | LEAN BEAR | 125.4 |
| CLYYF Celyad Oncology S.A. | $10M | 2.5 | -11.7 | -979.7 | 64360.6 | -88.7 | 5 | LEAN BEAR | 40.0 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | LEAN BEAR | 125.6 |
| SWNM Southwestern Medical Solutions, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -70.0 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.7 | -46.9 | 1464.5 | — | — | 4 | LEAN BEAR | -21.7 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | LEAN BEAR | -86.5 |
| DECN Decision Diagnostics Corp. | — | -0.0 | -8643.1 | -51.3 | -107.0 | -2.7 | 4 | LEAN BEAR | 0.0 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.2 | 9.2 | 4.5 | — | -100.0 | 3 | LEAN BEAR | -50.0 |
| INND InnerScope Hearing Technologies, Inc. | — | -0.0 | -1.4 | -0.4 | — | -56.8 | 4 | LEAN BEAR | -95.2 |
| NPCE NeuroPace, Inc. | $440M | -22.8 | -122.1 | -39.6 | -27.2 | 11.6 | 4 | LEAN BEAR | 24.2 |
| APLMW Apollomics, Inc. | $170M | -2.6 | -233.7 | 845.7 | 1188.0 | -75.9 | 3 | LEAN BEAR | -56.5 |
| ARMP Armata Pharmaceuticals, Inc. | $140M | -0.7 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | LEAN BEAR | -42.4 |
| EQ Equillium, Inc. | $80M | -5.3 | -59.0 | 2703.6 | — | -100.0 | 3 | LEAN BEAR | -3.5 |
| ONMD OneMedNet Corporation | $30M | -2.6 | 231.2 | 252.1 | -743.8 | 216.5 | 3 | LEAN BEAR | -81.3 |
| LEXX Lexaria Bioscience Corp. | $10M | -0.6 | -150.3 | -504.2 | — | -68.5 | 4 | LEAN BEAR | -78.8 |
| KPTI Karyopharm Therapeutics Inc. | $10M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | LEAN BEAR | -92.4 |
| MBCI MabCure Inc. | — | -0.0 | -127.0 | -14.0 | -2239.0 | — | 3 | LEAN BEAR | 0.0 |
| VIVE Viveve Medical, Inc. | — | -0.0 | -222.0 | -1442.3 | -314.1 | 2.4 | 3 | LEAN BEAR | 100.0 |
| FFNTF 4Front Ventures Corp. | — | -0.0 | 73.3 | -15.3 | -37.4 | -34.7 | 3 | LEAN BEAR | 900.0 |
| FLWPF The Flowr Corporation | — | — | -335.3 | 207.1 | -1827.8 | 38.5 | 3 | LEAN BEAR | 0.0 |
| ADXN Addex Therapeutics Ltd | — | -0.4 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | LEAN BEAR | -68.8 |
| VPTDF VentriPoint Diagnostics Ltd. | $10M | -6.1 | 58.8 | 122.3 | -3487.7 | 8.8 | 4 | LEAN BEAR | -19.0 |
| DROR Dror Ortho-Design, Inc. | $10M | -0.0 | 15.8 | 36.4 | — | — | 1 | LEAN BEAR | — |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -50.5 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | LEAN BEAR | -47.5 |
| LFCOF Lift & Co. Corp. | — | -0.0 | 149.0 | -666.2 | -170.0 | — | 2 | LEAN BEAR | 0.0 |
| CGNSF Cognetivity Neurosciences Ltd. | — | -0.1 | 78.7 | 25.2 | -6985.2 | — | 2 | LEAN BEAR | 0.0 |
| VLXC Veltex Corporation | — | -2.6 | 49.0 | -433.9 | -89.4 | 3.2 | 3 | LEAN BEAR | -28.7 |
| EVRRF Molecule Holdings Inc. | — | -0.1 | 97.7 | -3110.1 | -110.2 | 11.6 | 4 | LEAN BEAR | 0.0 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | LEAN BEAR | 0.0 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | LEAN BEAR | 1900.0 |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | LEAN BEAR | -97.7 |
| MDIN MedGen, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | LEAN BEAR | 900.0 |
| LCDX Caliber Imaging & Diagnostics, Inc. | — | -0.0 | 54.6 | 46.8 | -212.5 | 20.6 | 3 | LEAN BEAR | 100.0 |
| THCBF THC Biomed Intl Ltd. | — | -1.1 | -56.5 | -34.0 | -196.4 | -17.5 | 2 | LEAN BEAR | 0.0 |
| NSVGF Nass Valley Gateway Ltd. | — | -3.7 | 12.1 | 2.9 | — | -95.8 | 1 | LEAN BEAR | 0.0 |
| DRWN Quantum Medical Transport, Inc. | — | 0.3 | 25.7 | 20.8 | 2.2 | -96.3 | 4 | LEAN BEAR | 0.0 |
| AORT Artivion, Inc. | $1.1B | -384.9 | -0.7 | -3.4 | -10.7 | 16.4 | 4 | LEAN BEAR | -47.1 |
| RSLBF RaySearch Laboratories AB (publ) | $510M | 31.8 | 26.1 | 21.8 | 7.2 | 1.2 | 6 | LEAN BEAR | -35.8 |
| COGZF Cogstate Limited | $410M | 35.2 | 22.4 | 37.3 | 22.4 | -14.8 | 3 | LEAN BEAR | 44.9 |
| SLGL Sol-Gel Technologies Ltd. | $230M | -12.1 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | LEAN BEAR | 74.8 |
| MMIRF MedMira Inc. | $30M | -11.4 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | LEAN BEAR | -20.4 |
| YUKA Yuka Group, Inc. | — | -2.6 | 24.0 | 81.8 | -50.7 | -8.2 | 5 | LEAN BEAR | 145.7 |
| GMVDF G Medical Innovations Holdings Ltd | — | -0.0 | 5665.0 | 622.9 | -585.5 | 49.0 | 1 | LEAN BEAR | 0.0 |
| RMSL REMSleep Holdings, Inc. | — | -0.0 | 4286484750.6 | 1769.6 | -702.2 | -27.1 | 2 | LEAN BEAR | -57.5 |
| JBIO Jade Biosciences, Inc. | $930M | -5.4 | -47.8 | 629.9 | — | — | 3 | LEAN BEAR | 47.4 |
| CGEM Cullinan Therapeutics, Inc. | $880M | -4.4 | -50.3 | 1635.6 | — | — | 1 | LEAN BEAR | 91.2 |
| ACRS Aclaris Therapeutics, Inc. | $550M | -6.5 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | LEAN BEAR | 76.3 |
| ANGO AngioDynamics, Inc. | $520M | -15.5 | -19.2 | -20.5 | -8.8 | 8.2 | 5 | LEAN BEAR | -0.7 |
| SRTA Strata Critical Medical, Inc. | $410M | 9.5 | 16.0 | -6.2 | -14.5 | 0.6 | 3 | LEAN BEAR | -6.2 |
| IFRX InflaRx N.V. | $230M | -3.1 | -38.5 | 251.5 | — | -106.2 | 4 | LEAN BEAR | 18.6 |
| GBCS Selectis Health, Inc. | $20M | 1.2 | 1850.1 | -22.2 | 171.7 | -21.3 | 4 | LEAN BEAR | 172.9 |
| ZJYL Jin Medical International Ltd. | $20M | 13.6 | 4.0 | 1.9 | -1.2 | -13.6 | 3 | LEAN BEAR | 460.8 |
| LADX LadRx Corporation | — | -0.0 | 278.9 | 118.4 | — | -61.0 | 1 | LEAN BEAR | -99.0 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BEAR | -97.6 |
| PAIYY Aesthetic Medical International Holdings Group Limited | — | — | — | — | — | — | — | LEAN BEAR | -94.1 |
| BACK IMAC Holdings, Inc. | — | -0.0 | 109.1 | 67.3 | -14505.6 | 100.5 | 2 | LEAN BEAR | -99.2 |
| CSDX CS Diagnostics Corp. | — | — | — | — | — | — | — | LEAN BEAR | — |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| JNDOF JINS HOLDINGS Inc. | $810M | 17.8 | 22.7 | 27.1 | 5.1 | 15.0 | 6 | LEAN BEAR | 51.6 |
| CWBHF Charlotte's Web Holdings, Inc. | $70M | -1.1 | -97.1 | -27.9 | -38.0 | -6.9 | 5 | LEAN BEAR | 44.1 |
| COCH Envoy Medical, Inc. | $50M | -1.0 | 176.2 | 119.9 | -11729.4 | -6.8 | 5 | LEAN BEAR | -23.4 |
| ITNS Itonis, Inc. | — | -51.2 | 2.9 | 16.1 | -299.0 | -55.8 | 3 | LEAN BEAR | 0.0 |
| ADRX ADARx Pharmaceuticals, Inc. | $1.9B | — | — | — | — | — | — | LEAN BEAR | — |
| MDRSF Medartis Holding AG | $1.4B | 78.9 | 5.5 | 0.7 | 3.2 | 29.6 | 6 | LEAN BEAR | 72.5 |
| JMDMF Japan Medical Dynamic Marketing, Inc. | $130M | — | — | — | — | — | — | LEAN BEAR | 49.7 |
| BGM BGM Group Ltd. | $100M | -1.9 | -0.5 | -0.2 | -8.7 | — | 3 | LEAN BEAR | -96.9 |
| TCLIF Theraclion S.A. | $40M | -6.3 | -342.1 | 1171.9 | -543.9 | 61.2 | 2 | LEAN BEAR | 312841.2 |
| LANZ Lancer Orthodontics, Inc. | — | 4.0 | 3.3 | 2.5 | -4.3 | 4.5 | 4 | LEAN BEAR | 2566.7 |
| CCM Concord Medical Services Holdings Limited | — | -0.0 | 7.5 | -26.9 | -13.5 | -22.5 | 2 | LEAN BEAR | -31.8 |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | LEAN BEAR | 983.3 |
| NDATF nDatalyze Corp. | — | -16.7 | -61.8 | 1180.9 | — | -100.0 | 3 | LEAN BEAR | 633.9 |
| HDRPF Epsilon Healthcare Limited | — | 70.0 | -33.3 | -22.6 | -9.6 | 161.1 | 5 | LEAN BEAR | 614.3 |
| HSTC HST Global, Inc. | $210M | -538.5 | -2.5 | -1.2 | -13.7 | 564.0 | 5 | LEAN BEAR | 349900.0 |
| PLSH Panacea Life Sciences Holdings, Inc. | — | -0.8 | 128.5 | -48.4 | -1581.6 | -90.2 | 5 | LEAN BEAR | 14.0 |
| AMRN Amarin Corporation plc | $240M | -8.4 | -6.0 | -19.6 | -18.1 | -15.1 | 6 | LEAN BEAR | -39.4 |
| DBVT DBV Technologies S.A. | $230M | -2.6 | -142.6 | -2201.5 | — | -100.0 | 2 | LEAN BEAR | -34.3 |
| RNA Atrium Therapeutics, Inc. | $140M | -2.2 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | LEAN BEAR | -82.9 |
| MRAI Marpai, Inc. | $80M | -3.9 | 47.4 | 28.0 | -110.0 | -29.7 | 3 | LEAN BEAR | 114.1 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | LEAN BEAR | -55.3 |
| PBIGF Paradigm Biopharmaceuticals Limited | $10M | -1.6 | -456.6 | 1081.8 | -60158.9 | 53.6 | 4 | LEAN BEAR | -96.1 |
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | — | -0.0 | -43.7 | -41.6 | -21.7 | -42.3 | 4 | LEAN BEAR | -99.2 |
| FOXO FOXO Technologies Inc. | — | 0.0 | -62.5 | -3.2 | 172.6 | 44.0 | 3 | LEAN BEAR | 7042.9 |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | LEAN BEAR | — |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | LEAN BEAR | 100.0 |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | LEAN BEAR | -75.0 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 100.0 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -81.7 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | LEAN BEAR | 18.1 |
| MEDXF Medexus Pharmaceuticals Inc. | $110M | -46.4 | -4.7 | 8.1 | 1.9 | -2.9 | 5 | LEAN BEAR | 70.7 |
| INBS Intelligent Bio Solutions Inc. | $10M | -0.2 | -292.3 | -304.3 | -341.0 | 38.1 | 4 | LEAN BEAR | -83.0 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $10M | -1.0 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | LEAN BEAR | -66.5 |
| FITX Creative Edge Nutrition, Inc. | — | -0.0 | 242.9 | 120.2 | -98.6 | — | 3 | LEAN BEAR | 0.0 |
| NLVVF New Leaf Ventures Inc | — | -0.2 | -2466.1 | -179.6 | -152.9 | -39.2 | 1 | LEAN BEAR | 9900.0 |
| ECGS Eco-Growth Strategies Inc. | — | -1.8 | 15.4 | 46.1 | — | — | 3 | LEAN BEAR | -89.2 |
| MRRCF Wayland Group Corp. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -10.8 | -1773.6 | 55.8 | — | -100.0 | 4 | LEAN BEAR | 67.0 |
| LJUIF SSY Group Limited | $1.2B | 15.2 | 6.7 | 4.6 | 13.6 | -4.4 | 5 | LEAN BEAR | 0.0 |
| KARD Kardigan, Inc. | $1.1B | — | — | — | — | — | — | LEAN BEAR | — |
| SHEZF Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | $690M | 64.9 | 2.8 | 2.7 | 7.0 | -0.3 | 6 | LEAN BEAR | 0.0 |
| YDES YD Bio Limited Ordinary Shares | $350M | — | — | — | — | — | — | LEAN BEAR | -64.9 |
| FATE Fate Therapeutics, Inc. | $250M | -2.0 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | LEAN BEAR | 115.1 |
| RXST RxSight, Inc. | $210M | -4.3 | -17.3 | -66.9 | -35.9 | -18.8 | 3 | LEAN BEAR | -43.1 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.4 | -37.2 | -1604.9 | — | -100.0 | 1 | LEAN BEAR | -55.5 |
| NTHI Neonc Technologies Holdings, Inc. | $90M | — | — | — | — | — | — | LEAN BEAR | -66.1 |
| TLPH Talphera, Inc. | $60M | -3.4 | -143.4 | 436.3 | — | -96.3 | 2 | LEAN BEAR | -5.2 |
| SGMOQ Sangamo Therapeutics, Inc. | $50M | — | — | — | — | — | — | LEAN BEAR | — |
| TDSGF Telo Genomics Corp. | $10M | -2.1 | -2858.5 | 258.3 | — | — | 2 | LEAN BEAR | -10.2 |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | LEAN BEAR | -80.8 |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | LEAN BEAR | 0.0 |
| GEATF Radiko Holdings Corp | — | -0.0 | 178.7 | -374.3 | -40.1 | -30.5 | 3 | LEAN BEAR | 0.0 |
| NOBDF North Bud Farms Inc. | — | -0.0 | -30.5 | -29.8 | — | — | 2 | LEAN BEAR | 0.0 |
| ULGX Urologix, Inc. | — | -0.0 | 80.8 | 96.5 | -12.5 | -19.4 | 3 | LEAN BEAR | -0.0 |
| BNYN Banyan Corp. | — | -0.0 | 719.9 | -36.9 | -121.9 | -37.7 | 3 | LEAN BEAR | 0.0 |
| HENC Hero Technologies Inc. | — | -0.1 | -10112.1 | 3310.9 | — | 100.0 | 4 | LEAN BEAR | 0.0 |
| ASFX American Scientific Resources, Incorporated | — | — | — | — | — | — | — | LEAN BEAR | -25.0 |
| LRSV Link Reservations Inc. | — | -7.6 | 103.3 | 152.0 | -20.7 | 73995.4 | 5 | LEAN BEAR | -50.0 |
| HCANF Halo Collective Inc. | — | -0.0 | -132.7 | -43.7 | -192.0 | -43.0 | 2 | LEAN BEAR | 0.0 |
| GEGP Gold Entertainment Group, Inc. | — | -2.5 | 39.4 | 1402.0 | -16.8 | 39.5 | 6 | LEAN BEAR | -90.0 |
| SKYI Sky Century Investment, Inc. | — | -2.5 | 26.2 | 61.1 | -11.3 | 180.9 | 3 | LEAN BEAR | 5086.8 |
| SKTO SK3 Group, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| EWPI Emerging World Pharma, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| TCNAF TransCanna Holdings Inc. | — | -0.0 | -246.6 | -38.8 | -338.7 | 90.3 | 3 | LEAN BEAR | 0.0 |
| FSPM FusionPharm, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| HTGMQ HTG Molecular Diagnostics, Inc. | — | -0.0 | -343.2 | 734.2 | -489.6 | -28.2 | 2 | LEAN BEAR | 0.0 |
| NMRD Nemaura Medical Inc. | — | -0.0 | 45.5 | -457.0 | — | -491.0 | 1 | LEAN BEAR | -50.0 |
| WIBFF West Island Brands Inc. | — | -0.3 | -99.5 | -95.1 | -40.3 | 165.1 | 4 | LEAN BEAR | 0.0 |
| CRFTF BC Craft Supply Co. Ltd. | — | -0.0 | 152.6 | 13.1 | — | -82.0 | 2 | LEAN BEAR | 0.0 |
| IMRSQ IMRIS Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| BHNGF Bhang Inc. | — | -0.0 | 782.7 | 270.1 | -248.2 | 78.7 | 3 | LEAN BEAR | 0.0 |
| SPPH Spencer Pharmaceutical Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| CNNXF CannAmerica Brands Corp. | — | -0.0 | 53.3 | 23.6 | -127.3 | 39.6 | 4 | LEAN BEAR | 0.0 |
| VRTHF Indigenous Bloom Hemp Corp. | — | -0.3 | 77.3 | 21.2 | — | — | 3 | LEAN BEAR | 0.0 |
| EVARF Lombard Medical, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| PEMTF Thoughtful Brands Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| AHGIF Alternate Health Corp. | — | -0.0 | -611.4 | -2862.3 | -21.3 | 171.0 | 4 | LEAN BEAR | 0.0 |
| RLLVF Relevium Technologies Inc. | — | -0.3 | 969.5 | 2839.9 | -218.6 | — | 1 | LEAN BEAR | 0.0 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -20.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | LEAN BEAR | 0.0 |
| ELLXF Elixinol Wellness Limited | — | -0.7 | -52.3 | -22.6 | -14.9 | -4.8 | 1 | LEAN BEAR | -56.2 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | LEAN BEAR | 0.0 |
| GRPS Trans American Aquaculture, Inc. | — | -0.5 | 114.2 | 17.8 | — | -96.0 | 3 | LEAN BEAR | -60.8 |
| JXFGF Jinxin Fertility Group Limited | $730M | 26.4 | 1.9 | 1.8 | 7.8 | 1.4 | 7 | LEAN BEAR | 3.6 |
| FGHQF Frontage Holdings Corporation | $360M | 36.5 | 3.1 | 3.0 | 4.6 | 9.8 | 7 | LEAN BEAR | 16.8 |
| GWIN Glorywin Entertainment Group, Inc. | $360M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 229.5 |
| CLVSF CellaVision AB (publ) | $330M | 31.6 | 15.1 | 17.1 | 16.3 | -1.9 | 6 | LEAN BEAR | -27.4 |
| KNTPF Kintor Pharmaceutical Limited | $120M | -2.9 | -116.6 | -74.4 | -145.6 | 2237.9 | 3 | LEAN BEAR | -10.2 |
| HSTI High Sierra Technologies, Inc. | $30M | -22.8 | 225.7 | 189.7 | — | — | 4 | LEAN BEAR | 0.0 |
| MILFF 1CM Inc. | $30M | 4.5 | 15.1 | 7.4 | 2.5 | 7.3 | 7 | LEAN BEAR | 42.7 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -5.1 | -47.4 | -24288.6 | — | -100.0 | 3 | LEAN BEAR | 51.6 |
| PLLWF Polarean Imaging plc | $10M | -0.1 | -83.4 | -772.7 | -852.0 | 39.1 | 2 | LEAN BEAR | -40.0 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -0.8 | 119.2 | 76.7 | — | -100.0 | 1 | LEAN BEAR | 12.7 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | LEAN BEAR | 100.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | LEAN BEAR | 586.4 |
| ELXMF Nova Eye Medical Limited | — | -10.3 | -26.1 | -22.0 | -5.3 | 19.0 | 5 | LEAN BEAR | -85.7 |
| OMWS Omnia Wellness Inc. | — | -0.0 | 91.7 | -520.4 | -2231.0 | -14.0 | 1 | LEAN BEAR | 100.0 |
| HYHY Hydrogen Hybrid Technologies, Inc. | — | -0.0 | -138.6 | -342.9 | — | 16.1 | 4 | LEAN BEAR | 0.0 |
| REMI Remedent, Inc. | — | -0.1 | -11.3 | -4.3 | -86.4 | 14.2 | 6 | LEAN BEAR | 300.0 |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | LEAN BEAR | — |
| NMSCA Nutrition Management Services Company | — | 0.0 | 4.0 | 6.5 | -0.5 | -7.8 | 5 | LEAN BEAR | 200.0 |
| GRHY Green Hygienics, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -93.0 |
| HRAL Hear AtLast Holdings, Inc. | — | -0.3 | 16.3 | 89.4 | — | — | 3 | LEAN BEAR | -20.0 |
| NVOS Novo Integrated Sciences, Inc. | — | -0.0 | -81.4 | -35.0 | 162.4 | 5.7 | 3 | LEAN BEAR | -90.0 |
| BRSF Brain Scientific Inc. | — | -0.0 | -633.9 | -94.8 | -77714.6 | -19.3 | 3 | LEAN BEAR | 500.0 |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | LEAN BEAR | -99.8 |
| XSVT Xsovt Brands, Inc. | — | -0.0 | 241.0 | 189.8 | -134.3 | 300584.1 | 4 | LEAN BEAR | 233.3 |
| RTSL Rapid Therapeutic Science Laboratories, Inc. | — | -0.0 | -3.4 | 35.5 | — | -100.0 | 2 | LEAN BEAR | -86.7 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -53.1 |
| AIDA Aida Pharmaceuticals, Inc. | — | 0.0 | -20.7 | 25.4 | 19.3 | 40.9 | 6 | LEAN BEAR | 50.0 |
| BLMS Bloomios, Inc. | — | -0.0 | 221.4 | 58.3 | -3817.0 | 46.5 | 2 | LEAN BEAR | 200.0 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 123.7 | 6.2 | 22.4 | 14.6 | -68.5 | 5 | LEAN BEAR | 20.8 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $540M | 10.3 | 20.8 | 23.4 | 32.9 | 697.9 | 9 | LEAN BEAR | 0.0 |
| ACB Aurora Cannabis Inc. | $250M | -3.0 | -20.5 | -17.0 | -6.0 | -16.6 | 3 | LEAN BEAR | -20.9 |
| CPHI China Pharma Holdings, Inc. | $30M | -0.6 | -21.0 | -8.7 | -153.8 | -11.0 | 4 | LEAN BEAR | -66.5 |
| DYNTQ Dynatronics Corporation | — | — | — | — | — | — | — | LEAN BEAR | — |
| CUBT Curative Biotechnology, Inc. | — | -2.0 | 31.0 | 15.3 | — | — | 4 | LEAN BEAR | 8.5 |
| EMYSF Easy Technologies Inc. | — | -0.3 | 192.7 | 227.8 | — | -100.0 | 1 | LEAN BEAR | 0.0 |
| AEMD Aethlon Medical, Inc. | — | -0.4 | -160.9 | -883.2 | — | — | 3 | LEAN BEAR | -81.2 |
| ASTH Astrana Health, Inc. | $1.9B | 44.6 | 5.1 | 4.7 | 2.0 | 58.9 | 5 | LEAN BEAR | 10.9 |
| CLHLF COLTENE Holding AG | $330M | 19.7 | 16.1 | 12.5 | 3.6 | -2.5 | 5 | LEAN BEAR | -8.4 |
| PARK Park Dental Partners, Inc. Common Stock | $90M | -23.3 | -16.0 | 0.0 | 2.0 | — | 3 | LEAN BEAR | — |
| KZIA Kazia Therapeutics Ltd ADR | $10M | -1.1 | -104.5 | 62.7 | — | -99.2 | 4 | LEAN BEAR | 17.1 |
| WUHN Wuhan General Group (China), Inc. | — | -0.0 | 106.5 | 1.0 | -155074.0 | — | 2 | LEAN BEAR | 100.0 |
| GSAC GelStat Corporation | — | -2.8 | 25.1 | 80.4 | -124.9 | 62.9 | 6 | LEAN BEAR | -25.0 |
| LIANY LianMedical | — | 1.1 | 74.7 | -612.1 | — | — | 6 | LEAN BEAR | -28.6 |
| STME Stimcell Energetics, Inc. | — | -6.8 | 24.8 | 29.2 | — | — | 2 | LEAN BEAR | — |
| SXTC China SXT Pharmaceuticals, Inc. | — | -0.0 | -32.7 | -254.3 | 13.7 | 42.5 | 6 | LEAN BEAR | -100.0 |
| EOCN Eocene Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| TSHA Taysha Gene Therapies, Inc. | $1.3B | -10.1 | -47.1 | 961.0 | — | -32.3 | 3 | BEARISH | -10.5 |
| MDRX Veradigm Inc. | $830M | -7.1 | 4.3 | 7.0 | 6.2 | -39.7 | 5 | BEARISH | 0.0 |
| ARVN Arvinas, Inc. | $470M | 39.2 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BEARISH | -19.1 |
| CAMP CAMP4 Therapeutics Corporation | $210M | -1.6 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | BEARISH | -1.9 |
| BEAT HeartBeam, Inc. | $20M | -0.8 | -328.4 | 2958.2 | — | — | 3 | BEARISH | -75.2 |
| XCRT Xcelerate Inc. | $10M | -10.9 | 71.8 | 24.0 | — | -142.3 | 2 | BEARISH | 101.5 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | BEARISH | -58.1 |
| HKPD Cellyan Biotechnology Co., Ltd | — | -4.9 | -15.6 | -7.4 | -20.5 | 45.7 | 6 | BEARISH | -92.4 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BEARISH | -7.5 |
| OWCP OWC Pharmaceutical Research Corp. | — | -0.0 | -34.4 | 1662.7 | — | — | 2 | BEARISH | -90.0 |
| GELS Gelteq Limited Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -63.0 |
| NPHC Nutra Pharma Corp. | — | -0.1 | 23.1 | 4.7 | -11458.0 | 55.8 | 3 | BEARISH | 0.0 |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | BEARISH | -99.2 |
| PKTX ProtoKinetix, Incorporated | — | -1.0 | -117.2 | -115.0 | — | — | 2 | BEARISH | -95.4 |
| CELG-RI Bristol-Myers Squibb Company Ce | $250M | 0.0 | 46.7 | 22.0 | 25.6 | 3.1 | 8 | BEARISH | 247.9 |
| PROF Profound Medical Corp. | $200M | -5.8 | -73.1 | -148.0 | -384.2 | 35.5 | 3 | BEARISH | 2.7 |
| EBRCZ EBR Systems, Inc. | $80M | -0.9 | -102.2 | 22812.5 | -661.9 | 305113.7 | 3 | BEARISH | -87.9 |
| PETV PetVivo Holdings, Inc. | $30M | -2.1 | -384.4 | -353.6 | -478.1 | -9.5 | 4 | BEARISH | -53.5 |
| INNMF Amplia Therapeutics Limited | $30M | -4.9 | -24.9 | -86.9 | — | -100.0 | 2 | BEARISH | -35.3 |
| ROMJF Rubicon Organics Inc. | $20M | -16.3 | -4.1 | -24.0 | 2.2 | 16.7 | 1 | BEARISH | -27.5 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $10M | -4.9 | 64.4 | 131.0 | — | — | 4 | BEARISH | -42.8 |
| RQHTF Reliq Health Technologies Inc. | — | -5.4 | -4.5 | -8.2 | 15.4 | 119.4 | 5 | BEARISH | -33.3 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | 33.3 |
| PHRX Pharmagen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| VVOS Vivos Therapeutics, Inc. | — | -0.1 | -6663.0 | -267.4 | -106.4 | 45.2 | 3 | BEARISH | -95.7 |
| FUNI Hypha Labs, Inc. | — | -0.3 | 26.8 | 31.4 | — | — | 2 | BEARISH | — |
| RDHL RedHill Biopharma Ltd. | — | -3.3 | 428.1 | 117.9 | -101.3 | 157.6 | 6 | BEARISH | -72.7 |
| NXGT Nexteligent Holdings, Inc. | — | -14.0 | 2.7 | -1.5 | 5.3 | -0.2 | 3 | BEARISH | -30.9 |
| PRPH ProPhase Labs, Inc. | — | -0.0 | -544.0 | -207.6 | -301.8 | -5.5 | 3 | BEARISH | -99.8 |
| SNBIF SanBio Company Limited | $1.3B | -19.5 | -55.8 | -2935.2 | — | — | 3 | BEARISH | 0.0 |
| CVSGF CVS Group plc | $1.1B | 52.6 | 5.9 | 7.3 | 2.7 | -22.7 | 6 | BEARISH | 0.7 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| OVID Ovid Therapeutics Inc. | $420M | -4.7 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | BEARISH | 38.6 |
| CYH Community Health Systems, Inc. | $410M | -1.3 | 19.9 | -79.1 | 1.7 | 77.2 | 5 | BEARISH | -30.7 |
| RZLT Rezolute, Inc. | $370M | -5.4 | -59.0 | 1060.6 | — | — | 2 | BEARISH | -55.3 |
| TSNLF Tristel PLC | $280M | 24.4 | 23.4 | 31.6 | 15.8 | 10.3 | 8 | BEARISH | 8.5 |
| MDWD MediWound Ltd. | $150M | -7.8 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | BEARISH | -31.9 |
| LPCUF Lee's Pharmaceutical Holdings Limited | $110M | 3.8 | 9.9 | 0.2 | 11.9 | 81.2 | 8 | BEARISH | 1.1 |
| CSBR Champions Oncology, Inc. | $70M | -61.1 | -30.7 | -7.8 | -2.8 | 6.7 | 3 | BEARISH | -29.9 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.0 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | -7.6 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.8 | -237.8 | -86.8 | — | — | 4 | BEARISH | -53.1 |
| HSCS HeartSciences Inc. | $20M | -1.0 | -1851.9 | 26.8 | -151064.0 | -27.7 | 1 | BEARISH | -0.3 |
| XCUR Exicure, Inc. | $10M | -0.8 | -168.4 | 779.8 | — | — | 2 | BEARISH | -78.0 |
| PTKFY PT Kalbe Farma Tbk | $10M | 8.9 | 15.5 | 17.8 | 9.1 | 13.6 | 6 | BEARISH | -45.4 |
| AMS American Shared Hospital Services | $10M | -5.0 | -7.5 | -5.5 | -6.1 | 4.0 | 5 | BEARISH | -42.5 |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | BEARISH | 100.0 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | BEARISH | 0.0 |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| WLDFF Wildflower Brands Inc. | — | -0.0 | -27.7 | -4.7 | 1.9 | 319.8 | 7 | BEARISH | 0.0 |
| SHOM Southern Home Medical, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.4 |
| OMDD Ormand Industries Inc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PSIQ Profile Solutions, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | BEARISH | 0.0 |
| DGEN Deltagen Inc. | — | 0.0 | 19.8 | 182.7 | -27.2 | -65.8 | 4 | BEARISH | 0.0 |
| ROTH PharmaRoth Labs, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| FORZ Forza Innovations Inc. | — | -0.0 | 91.9 | 0.0 | 11330.0 | 8.7 | 3 | BEARISH | 0.0 |
| PRCNF Pure Global Cannabis Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | BEARISH | 0.0 |
| CWWBF Plant-Based Investment Corp. | — | -0.0 | -95.9 | -3827.0 | 167.3 | -218.9 | 3 | BEARISH | 0.0 |
| BNVIF Binovi Technologies Corp. | — | -0.0 | -433.7 | 182.0 | 17056.9 | -74.4 | 1 | BEARISH | 400.0 |
| DMSI Dermisonics, Inc. | — | -0.0 | -392.2 | 1105.0 | — | — | 1 | BEARISH | 0.0 |
| WCUI Wellness Center USA, Inc. | — | -0.0 | 44.8 | 1728.1 | -86.5 | 140.9 | 5 | BEARISH | -0.0 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | BEARISH | 0.0 |
| INSD Instadose Pharma Corp. | — | -0.0 | -9.7 | -3.7 | — | — | 4 | BEARISH | -90.9 |
| CBIA Canopus Biopharma, Inc. | — | -0.0 | 1457.1 | 15327.7 | — | — | 1 | BEARISH | 0.0 |
| DSOL Drug Free Solution, Inc. | — | -16.9 | 255.8 | 197.9 | — | — | 2 | BEARISH | -63.6 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 0.0 |
| IBXG iBX Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| IGRW Interactive Health Network | — | 0.2 | 1090.1 | 947.6 | -29882.2 | — | 2 | BEARISH | 0.0 |
| ROSGQ Rosetta Genomics Ltd. | — | -0.0 | -44.3 | -306.4 | 136.0 | — | 1 | BEARISH | 0.0 |
| ALID Allied Corp. | — | -0.0 | 266.4 | 484.7 | -207842.5 | -53.9 | 2 | BEARISH | -95.5 |
| AVTI Avitar, Inc. | — | -0.0 | 26.0 | -62.7 | -263.1 | -47.4 | 2 | BEARISH | 0.0 |
| UPPR Upper Street Marketing Inc. | — | -0.0 | 228.5 | -53.9 | -715.0 | — | 1 | BEARISH | 42.9 |
| CRRVF CVR Medical Corp. | — | -0.0 | 49.0 | 11.5 | — | — | 1 | BEARISH | 0.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | BEARISH | 0.0 |
| CAAOF INDVR Brands Inc. | — | -0.0 | -111.6 | -22.0 | -159.3 | 22.0 | 4 | BEARISH | 0.0 |
| RGDXQ Response Genetics, Inc | — | -0.0 | 1186.4 | -243.6 | -110.9 | -8.1 | 3 | BEARISH | 0.0 |
| IMEXF Imagin Medical Inc. | — | -0.0 | 31.8 | 185.9 | — | — | 3 | BEARISH | 0.0 |
| IONM Assure Holdings Corp. | — | -0.0 | 237.0 | 462.9 | -25500.0 | -64.6 | 1 | BEARISH | -99.0 |
| CYPS Cyclo3pss Corporation | — | — | — | — | — | — | — | BEARISH | 0.0 |
| TRVI Trevi Therapeutics, Inc. | $1.8B | -39.5 | -19.7 | -1451.7 | — | — | 3 | BEARISH | 27.0 |
| QURE uniQure N.V. | $1.6B | -6.0 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | BEARISH | -60.2 |
| BPMUF Basilea Pharmaceutica AG | $960M | 16.9 | 39.5 | 75.9 | 23.5 | 4.5 | 7 | BEARISH | 27.1 |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.2 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BEARISH | -16.9 |
| BOIRF Boiron S.A. | $550M | 12.7 | 7.2 | 7.8 | 2.0 | 97.0 | 5 | BEARISH | 10.5 |
| CTEV Claritev Corporation | $400M | -1.3 | 169.3 | 0.9 | -23.0 | 110.3 | 4 | BEARISH | -67.5 |
| IMPZY Implanet S.A. | $230M | -5.1 | 275.6 | -110.9 | -30.0 | 24.3 | 5 | BEARISH | 0.2 |
| INKT MiNK Therapeutics, Inc. | $50M | -4.4 | 57.9 | 42.8 | — | — | 4 | BEARISH | -29.0 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.6 | -218.7 | -392.2 | — | — | 1 | BEARISH | -64.0 |
| MEDS DataMEDS AI, Inc. | $10M | -0.0 | -142327.8 | -322403.1 | -1031.7 | 339160.3 | 4 | BEARISH | -22.9 |
| ANTCF Aion Therapeutic Inc. | — | -0.2 | 365.1 | 64.7 | -53.7 | 563.3 | 3 | BEARISH | 17.6 |
| SYGGF Synairgen plc | — | -0.2 | -71.9 | -381.4 | — | — | 1 | BEARISH | -50.0 |
| PFSA Profusa, Inc. Common Stock | — | -0.0 | 158.4 | 181.7 | — | — | 2 | BEARISH | 168.8 |
| MSIU Medical Supply International USA, Inc. | — | — | — | — | — | — | — | BEARISH | 300.0 |
| BSPM Biostar Pharmaceuticals, Inc. | — | -0.0 | 2.7 | 1.9 | — | -91.9 | 5 | BEARISH | 0.0 |
| CHYPF Health Logic Interactive Inc. | — | -3.5 | 20.0 | 14.2 | — | — | 1 | BEARISH | -45.2 |
| TNON Tenon Medical, Inc. | — | -0.0 | -549.9 | -452.2 | -316.7 | 80.9 | 4 | BEARISH | 72.6 |
| IDYLF Imaging Dynamics Company Ltd. | — | -0.3 | 18.7 | 39.1 | -2277.3 | -65.6 | 4 | BEARISH | 152.7 |
| ASBP Aspire Biopharma Holdings, Inc. | — | -1.1 | -1032.1 | 1368.4 | -2009.6 | — | 6 | BEARISH | -98.0 |
| OLMM OneLife Technologies Corp. | — | -0.0 | 454.4 | -594.1 | — | — | 3 | BEARISH | 900.0 |
| SYDRF Delota Corp. | — | -3.8 | -139.4 | -20.5 | -1.7 | -13.0 | 4 | BEARISH | 0.0 |
| ABMT Advanced BioMedical Technologies Inc. | — | -0.1 | 6.0 | 9.6 | 3842.6 | 264.3 | 3 | BEARISH | 400.0 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.2B | -9.1 | -40.0 | 3981.5 | — | — | 4 | BEARISH | 6.2 |
| RYHTY Ryman Healthcare Limited | $1.0B | -10.9 | -4.2 | -0.3 | -30.8 | 10.6 | 7 | BEARISH | -23.4 |
| ATGGF Actinogen Medical Limited | $140M | -8.5 | -77.5 | -235.8 | — | -100.0 | 1 | BEARISH | 17.2 |
| NRXP NRx Pharmaceuticals, Inc. | $110M | -3.6 | 131.2 | 61.3 | -1500.5 | — | 5 | BEARISH | -14.6 |
| GWLL Goldenwell Biotech, Inc. | $60M | -240.7 | 31.8 | 137.0 | — | 319257.9 | 5 | BEARISH | 225.0 |
| MJNA Medical Marijuana, Inc. | — | -1.3 | -1.3 | -2.2 | -0.9 | -22.1 | 2 | BEARISH | -66.7 |
| CGNH CardioGenics Holdings Inc | — | -0.0 | 58.8 | 40.3 | — | — | 3 | BEARISH | 0.0 |
| ADMT ADM Tronics Unlimited, Inc. | — | -7.9 | -49.5 | -22.1 | 3.7 | -2.2 | 3 | BEARISH | -48.8 |
| IGNT Ingen Technologies, Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| CANQF CanaQuest Medical Corp. | — | -0.0 | 177.1 | 159.9 | -1515.1 | 102.7 | 4 | BEARISH | 0.0 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | 4.3 |
| MEOBF Mesoblast Limited | $2.0B | -30.6 | -9.9 | -14.4 | -23.4 | 613.8 | 5 | BEARISH | -20.0 |
| BIOGY BioGaia AB (publ) | $1.3B | 32.0 | 31.8 | 52.6 | 27.5 | 13.1 | 5 | BEARISH | 19.9 |
| CBGL Cannabis Global Inc. | — | -0.5 | 5.4 | 17.3 | — | 520.3 | 3 | BEARISH | -80.0 |
| PCLOF PharmaCielo Ltd. | $10M | -2.7 | 39.6 | -31.4 | -103.5 | 11.2 | 4 | BEARISH | 71.2 |
| HMPQ HempAmericana, Inc | — | -0.5 | 25.6 | 14.8 | — | 184.6 | 2 | BEARISH | 0.0 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -75.2 |
| BCRX BioCryst Pharmaceuticals, Inc. | $1.9B | -5.6 | 87.8 | 62.3 | 35.9 | 68.7 | 5 | BEARISH | 12.5 |
| TRLV Trulieve Cannabis Corp. | $1.8B | — | — | — | — | — | — | BEARISH | — |
| LYPHF Luye Pharma Group Ltd. | $1.1B | 7.8 | 4.5 | 6.7 | 13.0 | -2.1 | 6 | BEARISH | 0.8 |
| HROW Harrow Health, Inc. | $1.1B | -29.3 | -114.8 | 1.9 | -24.4 | 21.1 | 5 | BEARISH | -24.5 |
| APMD Apnimed, Inc. | $790M | — | — | — | — | — | — | BEARISH | — |
| STTK Shattuck Labs, Inc. | $550M | -11.3 | -39.2 | -29.3 | — | -66.6 | 4 | BEARISH | 200.5 |
| BNTC Benitec Biopharma Inc. | $300M | -8.9 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -35.5 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.4 | -110.7 | 411.1 | — | — | 2 | BEARISH | -30.8 |
| CHRS Coherus Oncology, Inc. | $160M | -1.0 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | BEARISH | -35.1 |
| MAYNF Mayne Pharma Group Limited | $150M | 8.3 | 6.4 | -13.8 | 23.0 | -6.1 | 3 | BEARISH | -52.7 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.1 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | BEARISH | -49.6 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.8 | -218.7 | 330.4 | — | — | 3 | BEARISH | -18.2 |
| AURX Nuo Therapeutics, Inc. | $60M | -31.1 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | BEARISH | -47.8 |
| RNTX Rein Therapeutics Inc. | $50M | -0.4 | -753.6 | 53.9 | — | — | 3 | BEARISH | -51.1 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.9 | -774.6 | 2147.3 | — | — | 4 | BEARISH | -81.1 |
| QTI QT Imaging Holdings, Inc. | $30M | -1.5 | -1915.2 | 88.4 | -148.9 | -99.4 | 5 | BEARISH | 356.1 |
| JSPR Jasper Therapeutics, Inc. | $20M | -0.3 | -255.0 | 773.9 | — | — | 2 | BEARISH | -78.1 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -74.2 |
| RVVTF Revive Therapeutics Ltd. | $10M | -0.8 | -1114.6 | 25.7 | — | — | 2 | BEARISH | 95.0 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.6 | -66.1 | -87.8 | -1125.6 | -11.3 | 0 | BEARISH | -62.8 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -4.6 | -36.8 | -30.3 | -1182.3 | -95.8 | 2 | BEARISH | -95.4 |
| CBDHF Hempfusion Wellness Inc. | — | 0.0 | -82.5 | -84.6 | -190.5 | — | 1 | BEARISH | 0.0 |
| PZOO Pazoo, Inc. | — | -0.0 | 49.0 | 21.1 | -972321.6 | -100.0 | 4 | BEARISH | 0.0 |
| KGET CaliPharms, Inc. | — | -0.4 | 72.6 | 7.6 | -6979.1 | — | 2 | BEARISH | 3900.0 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | BEARISH | -99.8 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| WLSI Wellstar International, Inc. | — | -0.0 | 24.2 | 35.0 | — | — | 3 | BEARISH | 0.0 |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| FIORF Fiore Cannabis Ltd. | — | -0.0 | -417.3 | -33.3 | -383.4 | -6.2 | 2 | BEARISH | 0.0 |
| OTRKQ Ontrak, Inc. | — | -0.0 | -215.7 | -149.5 | -341.6 | -21.0 | 1 | BEARISH | -99.9 |
| ICBU iMD Companies, Inc. | — | -11.8 | 27.7 | 30.0 | — | -100.0 | 3 | BEARISH | -63.5 |
| SRUTF Sproutly Canada Inc. | — | -0.0 | 7045.7 | -519.2 | -1194.7 | 28.2 | 4 | BEARISH | 0.0 |
| FLOOF Flower One Holdings Inc. | — | -0.0 | 111.5 | -21.8 | -15.4 | -19.8 | 2 | BEARISH | 0.0 |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | BEARISH | -56.8 |
| PPTDF PeptiDream Inc. | $870M | -38.0 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BEARISH | -38.7 |
| TRDA Entrada Therapeutics, Inc. | $170M | -1.1 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | BEARISH | -35.4 |
| LFMDP LifeMD, Inc. | $150M | -4.2 | -687.6 | 135.4 | -15.0 | -16.7 | 4 | BEARISH | -10.6 |
| ADGM Adagio Medical Holdings, Inc. | — | -0.1 | -657.8 | -87.8 | — | -100.0 | 2 | BEARISH | -91.9 |
| BJDX Bluejay Diagnostics, Inc. | — | -0.0 | -98.9 | 5625.8 | — | — | 4 | BEARISH | -93.8 |
| ERNA Ernexa Therapeutics Inc. | — | -0.1 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -93.6 |
| MRES Institute of Biomedical Research Corp. | — | -2.3 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -81.2 |
| ALUR Allurion Technologies Inc. | — | -0.0 | 45.2 | 39.3 | -206.8 | -55.5 | 3 | BEARISH | -99.5 |
| WGS GeneDx Holdings Corp. | $1.7B | -17.2 | -40.8 | -17.2 | -15.5 | 25.4 | 4 | BEARISH | -51.3 |
| CSPHF CStone Pharmaceuticals | $1.4B | -14.4 | -51.4 | -340.2 | -123.0 | 135.6 | 5 | BEARISH | -15.4 |
| DRTSW Alpha Tau Medical Ltd. | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 807.7 |
| OMDA Omada Health | $1.2B | 280.0 | 1.8 | -1.5 | 6.0 | 404.7 | 7 | BEARISH | -26.5 |
| SMSZF SMS Co., Ltd. | $700M | -14.9 | -40.8 | 31.1 | 18.4 | 6.9 | 6 | BEARISH | 0.0 |
| ZRSEF DocMorris AG | $520M | -10.1 | -30.1 | -29.3 | -8.9 | 11.0 | 2 | BEARISH | 0.0 |
| DCTH Delcath Systems, Inc. | $500M | 1340.9 | 0.5 | -2.7 | 9.2 | 35.8 | 6 | BEARISH | 44.2 |
| EOLS Evolus, Inc. | $460M | -14.2 | 138.6 | -20.7 | -9.6 | 13.9 | 5 | BEARISH | 8.5 |
| EBS Emergent BioSolutions Inc. | $320M | -1.9 | -40.3 | -5.5 | -76.9 | -9.6 | 5 | BEARISH | -31.5 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| UNHLF EC Healthcare | $100M | -1.6 | -25.3 | 1.7 | -21.3 | -9.0 | 3 | BEARISH | 0.0 |
| RLYB Rallybio Corporation | $90M | 3.5 | 34.5 | -1198.7 | — | -35.6 | 6 | BEARISH | 2511.5 |
| POCI Precision Optics Corporation, Inc. | $50M | -9.5 | -22.3 | -19.0 | -1.2 | 65.2 | 5 | BEARISH | 2.6 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $40M | 118.8 | 228.3 | 11.8 | -21.1 | 6.2 | 3 | BEARISH | 0.0 |
| NEPH Nephros, Inc. | $40M | 21.8 | 16.1 | 20.0 | 19.9 | 24.2 | 5 | BEARISH | -35.6 |
| NSYS Nortech Systems Incorporated | $30M | 28.7 | 3.0 | 3.2 | 0.9 | 6.0 | 7 | BEARISH | 9.7 |
| CABR Caring Brands, Inc. | $10M | — | — | — | — | — | — | BEARISH | -69.2 |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | BEARISH | -73.5 |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.6 | -99.9 | 590.1 | — | -90.7 | 2 | BEARISH | -56.6 |
| BIOIF Biome Grow Inc. | — | -0.0 | 56.7 | 86.9 | — | — | 3 | BEARISH | 0.0 |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| SECI Sector 10, Inc. | — | 0.0 | 0.5 | 0.3 | — | — | 3 | BEARISH | 0.0 |
| SLNX Solanbridge Group, Inc. | — | -7.0 | 149.0 | 74.1 | — | — | 2 | BEARISH | 400.0 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | BEARISH | -98.5 |
| ADLI American Medical Technologies Inc. | — | -0.0 | -34.0 | 1108.3 | -19.7 | -21.7 | 3 | BEARISH | 0.0 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | BEARISH | -86.8 |
| VIAP VIA Pharmaceuticals, Inc. | — | -0.0 | 64.7 | 103.9 | — | — | 2 | BEARISH | 0.0 |
| UAHC United American Healthcare Corporation | — | 179.0 | 4.6 | -10.0 | — | -100.0 | 6 | BEARISH | -18.6 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | BEARISH | -99.9 |
| SPDE Speedus Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LBLTF Lattice Biologics Ltd. | — | -0.0 | 27.4 | -482.6 | — | -28.9 | 4 | BEARISH | 0.0 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -75.0 |
| BNKL Bionik Laboratories Corp. | — | -0.0 | -787.6 | -1107.0 | -282.5 | 41.7 | 3 | BEARISH | 0.0 |
| XCRP Xcorporeal, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RNUGF ReNeuron Group plc | — | -0.0 | -106.8 | 210.1 | -1809.6 | -68.2 | 1 | BEARISH | 0.0 |
| GSRX GSRX Industries Inc. | — | -0.0 | -119.6 | -84.3 | -81.5 | -5.5 | 5 | BEARISH | 0.0 |
| DHAI DIH Holding US, Inc. | — | -0.0 | 24.9 | 14.2 | -34.8 | 262.3 | 3 | BEARISH | -100.0 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| ARPC Arem Pacific Corporation | — | -9.0 | -104.2 | 50.1 | -12.7 | -7.6 | 5 | BEARISH | 0.0 |
| SCRCQ ScripsAmerica, Inc. | — | -0.0 | 168.2 | 144.2 | -17.6 | 3510.5 | 5 | BEARISH | 0.0 |
| CVHIF Ventura Cannabis & Wellness Corporation | — | -0.0 | -24592.2 | -12731.6 | -112.6 | -64.0 | 4 | BEARISH | 0.0 |
| MOTS Motus GI Holdings, Inc. | — | -0.0 | -1069.0 | -1348.2 | -3301.6 | -47.9 | 4 | BEARISH | -0.0 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| IYXI Inyx, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ENCW Enchanted World Inc. | — | — | — | — | — | — | — | BEARISH | -87.5 |
| SOFE SOAFEE, Inc. | — | 0.1 | 12.0 | -337.1 | 21.4 | 1539.1 | 4 | BEARISH | 45.5 |
| ZMSPF Zecotek Photonics Inc. | — | -0.0 | 21.5 | 53.8 | 1884.0 | 2081.2 | 3 | BEARISH | 0.0 |
| CTVEF Certive Solutions Inc. | — | -0.2 | 13.8 | 16.9 | -129.9 | 8.5 | 4 | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| VIVXF Avivagen Inc. | — | -0.1 | 63.9 | 92.2 | -2302.1 | -7.9 | 3 | BEARISH | 0.0 |
| KONEF Wellbeing Digital Sciences Inc. | — | — | 10994.4 | -1249.0 | -349.5 | — | 2 | BEARISH | 0.0 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| MCDA KMA Holding, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| EXETF Extendicare Inc. | $1.9B | 20.4 | 43.8 | 14.1 | 5.0 | 31.2 | 3 | BEARISH | 74.0 |
| UTMD Utah Medical Products, Inc. | $240M | 21.9 | 8.8 | 24.1 | 31.5 | -7.0 | 7 | BEARISH | 21.6 |
| WHWK Whitehawk Therapeutics Inc | $180M | -3.0 | -45.0 | 963.4 | — | -100.0 | 1 | BEARISH | 38.2 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -7.0 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | BEARISH | -42.7 |
| OCLG Oncologix Tech Inc. | — | -0.0 | 255.0 | — | — | -20.4 | 2 | BEARISH | 0.0 |
| SDCCQ SmileDirectClub Inc Class A | — | -0.0 | -72.6 | -19.0 | -17.5 | -23.4 | 3 | BEARISH | 0.0 |
| ALHC Alignment Healthcare, Inc. | $1.7B | 40.4 | 20.0 | -54.4 | 2.7 | 37.2 | 8 | BEARISH | -54.0 |
| TKNO Alpha Teknova, Inc. | $340M | -22.6 | -24.2 | -17.2 | -26.0 | 12.3 | 4 | BEARISH | 25.2 |
| HNSBF Hansa Biopharma AB (publ) | $330M | -4.6 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | -28.2 |
| CTOR Citius Oncology, Inc. | $50M | -1.3 | -126.6 | -109.8 | -597.4 | — | 3 | BEARISH | -64.5 |
| VICP Vicapsys Life Sciences, Inc. | $10M | -20.5 | 31.3 | 17.6 | — | — | 5 | BEARISH | -73.3 |
| RMRK Rimrock Gold Corp. | — | 204.0 | 8.6 | 6.4 | — | -100.0 | 2 | BEARISH | 0.0 |
| SDNI Scandia, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LMLLF Pharmadrug Inc. | — | -0.9 | 37.6 | 446.5 | — | — | 2 | BEARISH | -36.3 |
| VOGX Vogenx Inc. | $260M | — | — | — | — | — | — | BEARISH | — |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| IDRSF Idorsia Ltd | $1.4B | -3.5 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | 19.6 |
| VBIZF Viva Biotech Holdings | $400M | 13.0 | 4.5 | 4.2 | 8.0 | 2.9 | 7 | BEARISH | -35.1 |
| RCKT Rocket Pharmaceuticals, Inc. | $250M | -15.3 | -4.8 | -137.8 | — | — | 3 | BEARISH | -36.4 |
| CGHC Capital Group Holdings, Inc. | — | -0.0 | -44.6 | -14.9 | -24.2 | — | 5 | BEARISH | 0.0 |
| VICA Rafina Innovations Inc. | — | -0.1 | -51.0 | -15.7 | — | 873.6 | 3 | BEARISH | 233.3 |
| BBLNF Babylon Holdings Limited | — | -0.0 | 348.4 | -1412.2 | -20.3 | 198.9 | 3 | BEARISH | 0.0 |
| NMXS Net Medical Xpress Solutions, Inc. | — | -0.0 | -362.8 | -352.4 | -6733.3 | -89.2 | 2 | BEARISH | 600.0 |
| ACBM Acro Biomedical Co., Ltd. | — | -10.8 | 36.8 | 262.2 | — | 100.0 | 3 | BEARISH | 3614.3 |
| CRVS Corvus Pharmaceuticals, Inc. | $890M | -16.5 | -35.4 | -415.6 | — | — | 4 | BEARISH | 43.4 |
| SVRA Savara Inc. | $870M | -8.4 | -105.5 | -15438.9 | — | — | 2 | BEARISH | 11.5 |
| IMRX Immuneering Corporation | $240M | -3.7 | -52.1 | -112.8 | — | — | 4 | BEARISH | -36.6 |
| PMN ProMIS Neurosciences, Inc. | $70M | -0.6 | -172.3 | 844.3 | — | — | 2 | BEARISH | -10.3 |
| GGBXF Green Growth Brands Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| ANIP ANI Pharmaceuticals, Inc. | $1.7B | 14.7 | 20.0 | 20.7 | 9.3 | 30.9 | 7 | BEARISH | -24.5 |
| IMTX Immatics N.V. | $1.1B | -4.1 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -28.7 |
| KURA Kura Oncology, Inc. | $850M | -2.9 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BEARISH | 2.1 |
| ATTO Attovia Therapeutics, Inc. | $630M | -16.1 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 272.2 |
| OCS Oculis Holding AG | $490M | -4.6 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -63.1 |
| LUCD Lucid Diagnostics Inc. | $80M | -0.9 | -556.3 | -1646.4 | -792.9 | 24.9 | 6 | BEARISH | -65.8 |
| DYAI Dyadic International, Inc. | $20M | -1.8 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -65.5 |
| DVHGF Devonian Health Group, Inc. | $20M | — | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| AVTBF Avant Brands Inc. | $10M | -0.7 | -39.8 | -15.3 | 2.7 | 5.1 | 5 | BEARISH | -18.2 |
| ALLR Allarity Therapeutics, Inc. | $10M | -1.2 | -157.1 | -96.5 | — | — | 2 | BEARISH | -33.8 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| VNRX VolitionRX Ltd | — | -0.0 | 80.1 | 66.5 | -1837.7 | 86.3 | 3 | BEARISH | -58.3 |
| RSCI Redwood Scientific Technologies, Inc. | — | -0.0 | 2488.8 | 821.0 | — | — | 2 | BEARISH | -99.9 |
| BITRF Biotron Limited | — | -3.6 | -87.5 | -87.8 | -113.4 | -71.0 | 0 | BEARISH | -90.7 |
| BIORQ Biora Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BIIO Bionovate Technologies Corp | — | -0.0 | 47.5 | 16.6 | — | — | 3 | BEARISH | 0.0 |
| BSPK Bespoke Extracts, Inc. | — | -0.0 | 37.1 | 45.4 | -16.7 | 284.5 | 4 | BEARISH | -99.8 |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| PNPL Pineapple, Inc. | — | -10.4 | 63.1 | -28.2 | -276.2 | 943.8 | 7 | BEARISH | -99.6 |
| GBHPF Global Hemp Group Inc. | — | -0.1 | 61.0 | 8.0 | — | — | 2 | BEARISH | -99.2 |
| WHTCF WELL Health Technologies Corp. | $770M | 162.1 | 0.5 | 5.4 | -2.7 | 38.6 | 6 | BEARISH | -17.4 |
| GNMLF Genomma Lab Internacional, S.A.B. de C.V. | $710M | 9.0 | 14.3 | 13.4 | 11.4 | 22.0 | 4 | BEARISH | -22.7 |
| AURA Aura Biosciences, Inc. | $650M | -3.5 | -53.5 | -1360.0 | — | — | 4 | BEARISH | 7.5 |
| SENS Senseonics Holdings, Inc. | $400M | -3.7 | -118.2 | -901.4 | -253.4 | 79.0 | 3 | BEARISH | 18.8 |
| TTRX Turn Therapeutics Inc. | $310M | -35.8 | -952.4 | 115.0 | — | — | 2 | BEARISH | 105.1 |
| ARCT Arcturus Therapeutics Holdings Inc. | $280M | -3.4 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | BEARISH | 0.1 |
| SPHRY Starpharma Holdings Limited | $220M | -26.6 | -46.5 | -441.4 | -725.1 | 186.8 | 4 | BEARISH | 73.3 |
| BDSX Biodesix, Inc. | $170M | -6.9 | -540.0 | -31.9 | -27.1 | 34.5 | 6 | BEARISH | 226.2 |
| BETRF BetterLife Pharma Inc. | $110M | -10.2 | 34.9 | 21.6 | — | — | 4 | BEARISH | 243.4 |
| NTRB Nutriband Inc. | $70M | -10.4 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | BEARISH | -16.8 |
| WORX SCWorx Corp. | $40M | -0.4 | -38.1 | -8.2 | -17.1 | 3.1 | 6 | BEARISH | 343.7 |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $30M | -4.9 | 239.0 | 256.6 | -409.4 | — | 2 | BEARISH | — |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -4.3 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -33.9 |
| NDRA ENDRA Life Sciences Inc. | $10M | -0.8 | -152.0 | -105.1 | — | — | 4 | BEARISH | -6.1 |
| ADIA Adia Med Inc. | $10M | -0.1 | 32.2 | -16.3 | 8.3 | — | 1 | BEARISH | 247.2 |
| CNVIF Conavi Medical Corp. | $10M | 13.4 | 57.4 | 363.8 | -4867.7 | — | 2 | BEARISH | — |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | BEARISH | -85.1 |
| PDMI Paradigm Medical Industries, Inc. | — | -0.0 | 47.4 | -40.4 | -184.3 | -30.7 | 4 | BEARISH | -90.0 |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| CHME China Medicine Corp. | — | -145.9 | 9.7 | 9.7 | 12.7 | -4.3 | 6 | BEARISH | -16.4 |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | BEARISH | -96.2 |
| VRAX Virax Biolabs Group Limited | — | -0.0 | -110.9 | -481.7 | -40439.1 | 121.6 | 4 | BEARISH | 103.4 |
| OWPC One World Products, Inc. | — | 0.0 | -124.8 | -16.4 | 10538.7 | 1987.1 | 5 | BEARISH | -99.7 |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | BEARISH | -87.5 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -63.6 |
| CVGRF City View Green Holdings Inc. | — | -1.7 | 75.6 | 105.0 | — | — | 4 | BEARISH | -32.4 |
| EXMT Anything Technologies Media, Inc. | — | -8.4 | 27.0 | -24.5 | — | -100.0 | 2 | BEARISH | -31.8 |
| SBFM Sunshine Biopharma, Inc. | — | -0.0 | -21.9 | -31.4 | -16.9 | -2.7 | 5 | BEARISH | -99.2 |
| UTRS Minerva Surgical, Inc. | — | -0.0 | -170.1 | -43.9 | -60.0 | 3.1 | 1 | BEARISH | 0.0 |
| NUGS Cannabis Strategic Ventures | — | -0.2 | 115.4 | -142.7 | -3106.7 | -29.3 | 2 | BEARISH | 4500.0 |
| GHRS GH Research PLC | $1.2B | -20.0 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 43.5 |
| ABUS Arbutus Biopharma Corp | $830M | 5.4 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -1.6 |
| QTTB Q32 Bio Inc. | $260M | 3.1 | 72.1 | 435.2 | — | — | 5 | BEARISH | 193.3 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.7 | -628.5 | -474.6 | — | — | 4 | BEARISH | 0.0 |
| LFPI LifePoint, Inc. | — | -0.0 | -288.4 | -229.2 | -52133.6 | 161.6 | 3 | BEARISH | 1400.0 |
| AOLS Aeolus Pharmaceuticals, Inc. | — | -0.0 | -186.4 | 1650.1 | -7300.0 | -68.7 | 1 | BEARISH | -0.0 |
| NWCI NewCardio, Inc. | — | -0.0 | 258.3 | 352.6 | -23059.8 | 40.9 | 2 | BEARISH | 0.0 |
| SAGD South American Gold Corp. | — | -0.5 | 106.5 | 49.7 | — | — | 1 | BEARISH | 900.0 |
| ANL Adlai Nortye Ltd. | $560M | -5.5 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | BEARISH | 549.1 |
| AUNA Auna S.A. | $380M | -17.3 | 0.8 | 4.5 | 2.4 | 9.2 | 7 | BEARISH | -21.1 |
| SMTI Sanara MedTech Inc. | $300M | -8.8 | -147.7 | 19.8 | -1.6 | 12.9 | 5 | BEARISH | 5.7 |
| ARTV Artiva Biotherapeutics, Inc. | $300M | -1.3 | -36.6 | -954.6 | — | — | 3 | BEARISH | -21.1 |
| ELTP Elite Pharmaceuticals, Inc. | $270M | 4.9 | 74.3 | 43.6 | 18.3 | 33.7 | 5 | BEARISH | -60.6 |
| PLX Protalix BioTherapeutics, Inc. | $210M | 10.5 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | BEARISH | 7.2 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 131.0 |
| ADVB Advanced Biomed Inc. Common Stock | $10M | 6.5 | 0.4 | -42.2 | 544.5 | — | 4 | BEARISH | -65.9 |
| ALZN Alzamend Neuro Inc | $10M | -0.5 | -163.2 | 401.5 | — | — | 1 | BEARISH | -54.6 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | -11.1 |
| XBIO Xenetic Biosciences, Inc. | — | -1.5 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | BEARISH | -54.6 |
| CPMD CannaPharmaRX, Inc. | — | -0.1 | 42.4 | 22.4 | -691.1 | 24.8 | 3 | BEARISH | -58.3 |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $90M | -15.4 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| CMOPF Cosmo N.V. | $1.1B | -158.1 | -1.2 | -2.9 | -9.5 | -43.8 | 1 | BEARISH | -22.4 |
| BTMD biote Corp. | $50M | 7.0 | -7.8 | 19.7 | -14.8 | -7.8 | 5 | BEARISH | -59.2 |
| NVLPF Nova Leap Health Corp. | $30M | 20.4 | 7.0 | 5.6 | 6.9 | 20.3 | 5 | BEARISH | 72.9 |
| PUMD ProUroCare Medical Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | 0.0 |
| LTHO Legacy Technology Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MLYS Mineralys Therapeutics, Inc. | $1.8B | -5.0 | -80.9 | 2274.6 | — | — | 2 | BEARISH | -47.0 |
| GENB Generate Biomedicines, Inc. | $1.6B | -7.8 | -28.2 | -175.0 | -1065.2 | — | 1 | BEARISH | — |
| CMPS COMPASS Pathways plc | $1.6B | -2.1 | -319.1 | 48.8 | — | — | 2 | BEARISH | 88.1 |
| NKTR Nektar Therapeutics | $1.1B | -5.7 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -36.8 |
| AVBP ArriVent BioPharma, Inc. | $1.0B | -4.2 | -53.1 | 2345.1 | — | — | 3 | BEARISH | -17.2 |
| ALMS Alumis Inc. | $880M | -1.7 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | BEARISH | 47.2 |
| SANA Sana Biotechnology, Inc. | $700M | -3.3 | -152.9 | -242.3 | — | — | 3 | BEARISH | -55.8 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.1 | -32.4 | 2389.1 | — | — | 4 | BEARISH | -59.9 |
| IPSC Century Therapeutics, Inc. | $260M | -1.4 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 151.2 |
| CPHRF Cipher Pharmaceuticals Inc. | $240M | 8.2 | 23.5 | 24.9 | 33.3 | 3.7 | 6 | BEARISH | -9.6 |
| CYBQF CYBERDYNE Inc. | $200M | 153.8 | 0.7 | -1.4 | 36.4 | -8.1 | 3 | BEARISH | 0.0 |
| NNNN Anbio Biotechnology Class A Ordinary Shares | $170M | — | — | — | — | — | — | BEARISH | -83.2 |
| TARA Protara Therapeutics, Inc. | $140M | -1.8 | -45.8 | -41.3 | — | — | 2 | BEARISH | -51.6 |
| OTLK Outlook Therapeutics, Inc. | $130M | -0.5 | 256.9 | 1372.0 | -225766.7 | -169.4 | 3 | BEARISH | -61.9 |
| VERU Veru Inc. | $40M | -3.8 | -62.3 | -211.2 | — | -100.0 | 3 | BEARISH | -40.0 |
| SEOVF Sernova Corp. | $30M | -3.7 | 57.0 | 76.3 | — | — | 3 | BEARISH | -35.6 |
| NSRX Nasus Pharma Ltd. | $30M | — | — | — | — | — | — | BEARISH | -57.9 |
| AKTX Akari Therapeutics, Plc | $20M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -71.0 |
| SNANF Sona Nanotech Inc. | $20M | -12.9 | 526.4 | 252.2 | — | — | 1 | BEARISH | -58.7 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.2 | -2011.6 | 159.6 | — | — | 3 | BEARISH | -58.8 |
| LTRN Lantern Pharma Inc. | $10M | -0.4 | -400.9 | 115.9 | — | — | 2 | BEARISH | -84.3 |
| PLRZ Polyrizon Ltd. | $10M | -1.9 | -21.4 | -68.2 | — | — | 0 | BEARISH | 39.6 |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -1.7 | -69.7 | 650.7 | — | — | 1 | BEARISH | -90.5 |
| HMTXF Hemostemix Inc. | $10M | -2.0 | 69.9 | 190.1 | — | — | 1 | BEARISH | -44.5 |
| SNTI Senti Biosciences, Inc. | $10M | -0.1 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -91.0 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | BEARISH | -66.7 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -72.0 |
| IVRO InVitro International | — | 17.1 | 3.7 | 4.6 | 4.8 | -14.0 | 5 | BEARISH | -25.0 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 0.0 |
| MDIT Medite Cancer Diagnostics, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | 0.0 |
| LVRLF CordovaCann Corp. | — | -1.0 | 47.4 | -18.4 | -6.5 | -2.8 | 4 | BEARISH | 3.5 |
| EMGE Emergent Health Corp | — | -0.0 | 23.7 | 51.7 | — | -80.0 | 1 | BEARISH | 9900.0 |
| PLWY Peoplesway.com Inc. | — | -0.0 | -6.5 | -4001.9 | -1.4 | -22.7 | 5 | BEARISH | 0.0 |
| NXEN Nexien BioPharma, Inc. | — | -0.0 | 48.5 | 112.0 | — | — | 2 | BEARISH | -99.2 |
| OILFF Nextleaf Solutions Ltd. | — | -1.8 | -41.0 | -53.4 | -19.9 | -18.2 | 3 | BEARISH | -63.8 |
| AOXG Aoxing Pharmaceutical Company, Inc. | — | -37.5 | -0.2 | -13.9 | -405.2 | -99.8 | 1 | BEARISH | -69.7 |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -95.0 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -69.6 |
| PBFFF Planet Based Foods Global Inc. | — | -0.7 | 69.6 | 63.1 | — | 100.0 | 2 | BEARISH | -80.8 |
| CTTH CTT Pharmaceutical Holdings, Inc. | — | -40.5 | -272.8 | -210.7 | — | — | 2 | BEARISH | -4.4 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 5806.4 |
| SKVI Skinvisible, Inc. | — | -0.8 | 10.0 | 7.2 | -5110.7 | 0.0 | 2 | BEARISH | -61.0 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| CYIO CYIOS Corporation | — | 1.2 | 60.5 | 46.3 | — | -48.3 | 2 | BEARISH | -86.0 |
| EVAHF EGF Theramed Health Corp. | — | -0.2 | 102.2 | 4.7 | — | — | 2 | BEARISH | -71.0 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.4B | -6.7 | -39.8 | -102.9 | — | — | 3 | BEARISH | -31.3 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $1.0B | 11.3 | 6.5 | -1.9 | 20.2 | 10.7 | 6 | BEARISH | -2.4 |
| XGN Exagen Inc. | $180M | -9.5 | -113.8 | -79.2 | -16.0 | 20.8 | 3 | BEARISH | -35.0 |
| CPIX Cumberland Pharmaceuticals Inc. | $130M | -6.9 | -46.7 | -41.6 | -2472.5 | -25.7 | 3 | BEARISH | 41.8 |
| INBP Integrated BioPharma, Inc. | $10M | -1.9 | -15.0 | -13.1 | -13.9 | -19.3 | 2 | BEARISH | -43.3 |
| IMRN Immuron Limited | $10M | -2.9 | -40.2 | -187.8 | -54.4 | -29.7 | 5 | BEARISH | -56.7 |
| TRUFF Rhelion Life Sciences Corp. | $10M | -2.1 | -37.0 | -58.5 | -804.7 | -34.3 | 3 | BEARISH | -20.4 |
| MDRM Modern Mobility Aids, Inc. | — | -58.8 | 146.1 | 120.5 | — | — | 2 | BEARISH | -47.1 |
| BDPT BioAdaptives Inc. | — | -0.0 | 80.2 | 56.3 | 3009.0 | 169.7 | 3 | BEARISH | -93.4 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BEARISH | -68.2 |
| KHRNF Khiron Life Sciences Corp. | — | -0.2 | -74.7 | -41.4 | -105.6 | 76.2 | 2 | BEARISH | 0.0 |
| EVIO EVIO, Inc. | — | 1.7 | 65.3 | 33.5 | 8.3 | -26.9 | 4 | BEARISH | 0.0 |
| NXL Nexalin Technology, Inc. | — | -0.1 | -240.3 | -1401.4 | -18412.7 | 24.2 | 4 | BEARISH | 13.9 |
| ANRO Alto Neuroscience, Inc. | $860M | -9.4 | -49.2 | -201.4 | — | — | 3 | BEARISH | 110.7 |
| DSGN Design Therapeutics, Inc. | $640M | -9.0 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 85.5 |
| BRIBF Brii Biosciences Limited | $90M | -3.3 | -10.3 | -62.6 | — | 22.5 | 4 | BEARISH | -46.0 |
| ELOX Eloxx Pharmaceuticals, Inc. | $40M | -8.8 | -107.5 | 81.5 | — | — | 4 | BEARISH | 13339900.4 |
| TELA TELA Bio, Inc. | $40M | -1.2 | 1232.5 | -260.3 | -58.4 | 6.1 | 3 | BEARISH | -35.1 |
| IDXG Interpace Biosciences, Inc. | $40M | 0.2 | 221.9 | 123.7 | 1.7 | -20.3 | 6 | BEARISH | 18.0 |
| SGIPF Sugi Holdings Co.,Ltd. | $1.8B | 15.8 | 10.0 | 11.6 | 2.2 | 46.6 | 7 | BEARISH | 0.9 |
| AUTL Autolus Therapeutics plc | $410M | -1.5 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | 1.3 |
| STSN Stemsation International, Inc. | $10M | -4.8 | -2.8 | -1.6 | — | — | 3 | BEARISH | 16.3 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -45.4 |
| IGEX Indo Global Exchange(s) PTE, Ltd. | — | -16.1 | -12.1 | -3.5 | — | -100.0 | 5 | BEARISH | -20.0 |
| HBRM Herborium Group, Inc. | — | -2.3 | 0.6 | 0.6 | 0.7 | -2.7 | 5 | BEARISH | -50.0 |
| AVLN Avalyn Pharma Inc. Common Stock | $1.1B | — | — | — | — | — | — | BEARISH | — |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.1B | -5.6 | -41.0 | 583.9 | — | — | 2 | BEARISH | 2.0 |
| MNKD MannKind Corporation | $1.0B | -23.6 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | BEARISH | -38.0 |
| GLUE Monte Rosa Therapeutics, Inc. | $920M | -4.9 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | -4.3 |
| WVE Wave Life Sciences Ltd. | $630M | -3.2 | -80.0 | -1243.7 | -470.5 | -35.1 | 4 | BEARISH | -51.6 |
| LRMR Larimar Therapeutics, Inc. | $240M | -1.2 | -139.6 | 590.9 | — | — | 2 | BEARISH | -43.2 |
| TSNDF TerrAscend Corp. | $170M | -3.9 | -22.6 | -28.1 | -13.6 | — | 3 | BEARISH | — |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.0 | -80.6 | -851.1 | — | — | 4 | BEARISH | -37.1 |
| OGI Organigram Global Inc. | $130M | 2.1 | 18.4 | -1.3 | 99.8 | 38.1 | 5 | BEARISH | -46.3 |
| HUMA Humacyte, Inc. | $120M | -0.9 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | BEARISH | -73.9 |
| JYNT The Joint Corp. | $100M | 27.2 | 19.4 | -33.1 | 4.3 | 220.6 | 8 | BEARISH | -14.1 |
| IMUX Immunic, Inc. | $100M | -1.6 | -138.2 | 345.6 | — | — | 5 | BEARISH | -0.9 |
| ADAG Adagene Inc. | $90M | -5.5 | -28.6 | 111.8 | -1011.1 | 8927.0 | 5 | BEARISH | 45.8 |
| IMDX Insight Molecular Diagnostics Inc. | $90M | -2.1 | 488.7 | 92.7 | -4711.3 | -60.8 | 2 | BEARISH | -52.3 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -5.8 | 151.4 | 200.5 | — | -100.0 | 2 | BEARISH | -56.0 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $70M | -0.7 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -32.0 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.2 | -59.8 | 1235.8 | — | — | 1 | BEARISH | -76.7 |
| CVM CEL-SCI Corporation | $30M | -0.6 | -252.5 | -142.9 | — | -100.0 | 4 | BEARISH | -82.9 |
| ARTL Artelo Biosciences, Inc. | $10M | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -92.8 |
| NEXI NexImmune, Inc. | — | -0.0 | -230.1 | 1048.5 | — | — | 4 | BEARISH | -0.0 |
| RBOT Vicarious Surgical Inc. | — | -0.0 | -223.8 | -476.5 | — | — | 1 | BEARISH | -99.7 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | BEARISH | -99.6 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| USAQ QHSLab, Inc. | — | 6.8 | 114.6 | 6.2 | 4.5 | 24.6 | 6 | BEARISH | 56.5 |
| BIMI BIMI International Medical Inc. | — | -0.0 | -159.5 | -56.3 | -124.0 | -65.7 | 4 | BEARISH | 300.0 |
| CPYT CarePayment Technologies, Inc. | — | -0.0 | 1607.0 | -66.2 | -585.5 | — | 2 | BEARISH | 0.0 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| YCBD cbdMD, Inc. | — | -1.2 | -40.3 | -27.6 | -20.3 | 10.0 | 2 | BEARISH | -64.3 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| LNDZF Evome Medical Technologies Inc. | — | -2.2 | -294.8 | -10.4 | -11.5 | -15.9 | 4 | BEARISH | -98.3 |
| OHCS Optimus Healthcare Services, Inc. | — | -0.0 | 99.2 | 130.3 | -469.4 | 43.7 | 4 | BEARISH | -99.0 |
| TRGM Targeted Medical Pharma, Inc. | — | -0.0 | 26.6 | 20.9 | -45.1 | -26.0 | 4 | BEARISH | -90.0 |
| NVCR Novocure Ltd | $1.7B | -11.2 | -43.2 | -93.1 | -8.5 | 11.0 | 6 | BEARISH | 6.3 |
| INVA Innoviva, Inc. | $1.5B | 4.3 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | BEARISH | 18.2 |
| LTGO Latigo Biotherapeutics Inc. | $900M | — | — | — | — | — | — | BEARISH | — |
| MTLZF Metall Zug AG | $680M | -34.8 | -2.8 | -1.4 | -5.6 | -0.3 | 6 | BEARISH | 0.0 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.5 | -845.0 | 24.6 | — | — | 2 | BEARISH | 38.6 |
| HELP Helus Pharma Inc. | $630M | -2.5 | -56.3 | -143.0 | — | — | 2 | BEARISH | — |
| IRWD Ironwood Pharmaceuticals, Inc. | $570M | 4.4 | -55.3 | 93.9 | 45.4 | 26.2 | 7 | BEARISH | 111.5 |
| TECX Tectonic Therapeutic, Inc. | $390M | -4.5 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 18.6 |
| EIKN Eikon Therapeutics, Inc. Common Stock | $390M | — | — | — | — | — | — | BEARISH | — |
| VRNO Verano Holdings Corp | $370M | -1.4 | -4.5 | 1.5 | -6.0 | — | 3 | BEARISH | — |
| CLVLF Clinuvel Pharmaceuticals Limited | $250M | 10.6 | 13.2 | 126.7 | 41.1 | -1.1 | 6 | BEARISH | -32.0 |
| ELMD Electromed, Inc. | $220M | 19.5 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | BEARISH | 9.8 |
| EDTXF Spectral Medical Inc. | $210M | -7.5 | 64.9 | 19.4 | 53.3 | 1.5 | 2 | BEARISH | -37.5 |
| PDEX Pro-Dex, Inc. | $200M | 14.8 | 32.4 | 17.5 | 14.0 | 16.4 | 8 | BEARISH | 119.3 |
| RNAC Cartesian Therapeutics, Inc. | $190M | -1.1 | 241.0 | 37.3 | — | 44.0 | 2 | BEARISH | -29.5 |
| NAGE Niagen Bioscience Inc | $190M | 12.9 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -67.0 |
| VRXA Veraxa Biotech Holding AG | $140M | — | — | — | — | — | — | BEARISH | — |
| GNLX Genelux Corporation | $90M | -2.3 | -168.9 | 20537.7 | — | — | 2 | BEARISH | -73.8 |
| TNXP Tonix Pharmaceuticals Holding Corp. | $90M | -0.4 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -72.3 |
| CNXU Conexeu Sciences Inc. | $90M | — | — | — | — | — | — | BEARISH | — |
| SHIEF Shield Therapeutics plc | $80M | -7.4 | 65.2 | 698.4 | -7.4 | 152.4 | 3 | BEARISH | -24.5 |
| INO Inovio Pharmaceuticals, Inc. | $60M | -0.8 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -61.8 |
| ONCY Oncolytics Biotech Inc. | $50M | -1.9 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -61.5 |
| NDTP NDT Pharmaceuticals Inc. | $50M | -39.2 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -83.3 |
| CLCS Cell Source, Inc. | $40M | -4.6 | 27.7 | 34.5 | — | — | 4 | BEARISH | 24.0 |
| BMKDF BioMark Diagnostics Inc. | $40M | -34.8 | -149.8 | -103.7 | -5198.4 | -82.1 | 2 | BEARISH | 39.9 |
| VEXTF Vext Science, Inc. | $40M | -2.3 | -23.2 | -8.7 | -2.6 | 14.2 | 5 | BEARISH | -12.2 |
| INIS Radnostix, Inc. | $30M | -0.0 | -29489557.0 | -23.1 | -33.0 | -23.7 | 1 | BEARISH | -22.0 |
| NSPR InspireMD, Inc. | $20M | -0.9 | -148.8 | -1383.2 | -808.8 | 53.4 | 4 | BEARISH | -79.9 |
| BIAF bioAffinity Technologies, Inc. | $20M | -0.0 | -1860.2 | -352.6 | -222.8 | -23.2 | 4 | BEARISH | -92.5 |
| CNTX Context Therapeutics Inc. | $20M | -0.5 | -76.1 | 841.7 | — | — | 2 | BEARISH | -81.4 |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -45.7 |
| RVXCF Resverlogix Corp. | $20M | -1.5 | 11.5 | 25.3 | — | — | 4 | BEARISH | -30.1 |
| LPCN Lipocine Inc. | $10M | -0.8 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -49.7 |
| ICU SeaStar Medical Holding Corporation | $10M | -0.6 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BEARISH | -59.0 |
| MODD Modular Medical, Inc. | $10M | -0.2 | -247.9 | -302.8 | — | — | 2 | BEARISH | -90.0 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.7 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -57.1 |
| NMTC NeuroOne Medical Technologies Corporation | $10M | -0.9 | -119.7 | -335.0 | -101.7 | 50.8 | 5 | BEARISH | 4.2 |
| BICX BioCorRx Inc. | $10M | -1.7 | 25.4 | 84.3 | -1096.7 | 151.2 | 3 | BEARISH | -47.2 |
| APPB Applied Biosciences Corp. | — | -0.0 | -297.6 | -188.8 | -798.1 | 75.3 | 4 | BEARISH | 0.0 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -97.3 |
| TTOO T2 Biosystems, Inc. | — | -0.0 | 277.6 | -638.9 | -509.7 | -30.2 | 3 | BEARISH | -95.8 |
| PASO Patient Access Solutions, Inc. | — | -0.0 | 540.4 | 691.6 | 0.6 | — | 2 | BEARISH | -99.0 |
| IHGP Jun An Kang Group Inc. | — | 2.0 | 0.5 | 0.5 | 1.0 | 64.0 | 6 | BEARISH | -98.7 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -95.7 |
| BBLG Bone Biologics Corporation | — | -0.2 | -47.5 | 1744.6 | — | — | 2 | BEARISH | -83.6 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | BEARISH | — |
| ICCO InterCare DX, Inc. | — | -0.0 | 16.1 | 3053.3 | — | — | 5 | BEARISH | 0.0 |
| AKAN Akanda Corp. | — | -0.0 | 855.2 | -259.9 | -1532.3 | 84.2 | 3 | BEARISH | -97.5 |
| BRGX BioRegenx, Inc. | — | -0.2 | 0.6 | 1.6 | -6.2 | — | 3 | BEARISH | — |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.1 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BEARISH | -50.5 |
| PMEDF Qscreen Ai Inc. | — | -13.1 | 145.2 | 82.8 | — | — | 3 | BEARISH | -46.7 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | -343.1 | 241.9 | -7433.3 | 202.7 | 2 | BEARISH | -93.5 |
| SYUP Anbc, Inc. | — | — | — | — | — | — | — | BEARISH | 50.0 |
| BMCS BioTech Medics, Inc. | — | -13.9 | -0.0 | -0.0 | — | — | 5 | BEARISH | -97.7 |
| SSKN STRATA Skin Sciences, Inc. | — | -0.0 | -164.6 | -42.5 | 0.6 | -8.5 | 4 | BEARISH | -100.0 |
| YOURF YourWay Cannabis Brands Inc. | — | -0.0 | 19.0 | 18.4 | 3.3 | 253.3 | 8 | BEARISH | 0.0 |
| UDOCF Unidoc Health Corp. | — | -2.4 | 392.6 | 140.6 | -352.4 | 606.8 | 3 | BEARISH | -72.2 |
| LNAI Lunai Bioworks Inc. | — | -0.3 | -21.6 | 30.2 | — | — | 2 | BEARISH | -97.1 |
| POAS Phaos Technology Holdings (Caym | — | — | — | — | — | — | — | BEARISH | — |
| CLABF Core One Labs Inc. | — | -0.3 | -233.7 | -70.3 | -897.6 | -69.3 | 3 | BEARISH | -90.0 |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | BEARISH | -97.2 |
| HLTHQ Cue Health Inc. | — | -0.0 | -90.3 | -100.6 | -789.6 | -85.3 | 1 | BEARISH | 0.0 |
| DRMA Dermata Therapeutics, Inc. | — | -0.2 | -183.9 | 734.5 | — | — | 2 | BEARISH | -80.8 |
| GXXY Galexxy Holdings, Inc. | — | -0.0 | 370.1 | 271.5 | -385.0 | -88.8 | 2 | BEARISH | -98.5 |
| MCIC Multicorp International, Inc. | — | -15.7 | -1.1 | -0.2 | — | — | 3 | BEARISH | -0.0 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | BEARISH | -92.4 |
| VCNX Vaccinex, Inc. | — | -0.4 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BEARISH | -20.1 |
| SPRC SciSparc Ltd. | — | -0.0 | -519.9 | -161.9 | -1891.2 | -26.8 | 5 | BEARISH | -78.9 |
| BMMJ Body and Mind Inc. | — | -0.1 | 267.1 | 411.6 | -58.9 | -48.9 | 2 | BEARISH | -98.0 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -99.5 |
| ENMI DH Enchantment Inc. | — | -0.5 | 52.9 | -49.5 | -32.2 | 26.9 | 5 | BEARISH | 0.0 |
| LVVV LiveWire Ergogenics, Inc. | — | -0.4 | -188.5 | -4.0 | -2585.3 | -89.5 | 3 | BEARISH | -84.6 |
| NPRRF Nipro Corporation | $1.4B | — | — | — | — | — | — | BEARISH | 5.8 |
| LITS Lite Strategy, Inc. | $40M | -0.1 | -170.9 | -28.2 | — | — | 2 | BEARISH | -40.2 |
| AYTU Aytu BioPharma, Inc. | $20M | -1.4 | -52.6 | -24.3 | -0.1 | -13.3 | 4 | BEARISH | -16.3 |
| ETON Eton Pharmaceuticals, Inc. | $1.4B | 110.0 | 36.0 | 33.3 | 30.8 | 81.5 | 7 | BEARISH | 177.1 |
| DRTS Alpha Tau Medical Ltd | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 219.4 |
| SLDB Solid Biosciences Inc. | $630M | -3.2 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 10.1 |
| ORMP Oramed Pharmaceuticals Inc. | $170M | 1.0 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 74.1 |
| AMGXF AnGes, Inc. | $140M | -3.0 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| ANTX AN2 Therapeutics, Inc. | $130M | -3.6 | -50.1 | 1243.3 | — | — | 2 | BEARISH | 229.9 |
| BBIXF Bonus BioGroup Ltd. | $50M | -17.4 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | 13233.3 |
| INTI Inhibitor Therapeutics, Inc. | $10M | -4.2 | 358.8 | 88.0 | — | — | 1 | BEARISH | 59.8 |
| CMHSF Comprehensive Healthcare Systems, Inc. | $10M | -1.8 | 78.3 | 144.6 | -37.9 | -22.6 | 3 | BEARISH | -35.0 |
| XAIR Beyond Air, Inc. | — | -0.0 | -429.9 | 409.7 | -448.8 | 60.7 | 6 | BEARISH | 3.3 |
| IHTI Integrative Health Technologies, Inc. | — | 0.0 | -13.8 | -11.8 | 53.8 | 263.8 | 4 | BEARISH | -95.0 |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.1 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| SLHPF Skylight Health Group Inc. | — | -0.0 | -109.3 | -44.8 | -21.4 | — | 2 | BEARISH | -90.0 |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| IRME IR-Med Inc. | — | -0.1 | 1793.9 | 264.1 | — | -23.5 | 2 | BEARISH | -93.8 |
| NWPHF Newron Pharmaceuticals S.p.A. | $410M | -6.7 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| FOCL EDAP TMS S.A. American Depositary Shares | $160M | — | — | — | — | — | — | BEARISH | — |
| BLEVF Beleave Inc. | — | -0.0 | -105.9 | -25.1 | -653.1 | 117.7 | 4 | BEARISH | -99.0 |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| KKUR ChromoCure, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | BEARISH | -96.7 |
| OLMA Olema Pharmaceuticals, Inc. | $560M | -3.3 | -52.7 | 585.3 | — | — | 2 | BEARISH | -12.3 |
| CBIO Crescent Biopharma, Inc. | $480M | -1.8 | -107.7 | 1928.6 | — | — | 5 | BEARISH | 4.6 |
| BWAY BrainsWay Ltd. | $440M | 46.7 | 13.0 | 31.1 | 15.8 | 32.3 | 5 | BEARISH | 38.3 |
| BLSM BlossomHill Therapeutics, Inc. | $430M | — | — | — | — | — | — | BEARISH | — |
| APYX Apyx Medical Corporation | $100M | -12.1 | -96.4 | -12.3 | -23.4 | 25.6 | 5 | BEARISH | -22.1 |
| MBOT Microbot Medical Inc. | $70M | -4.0 | -32.9 | -600.2 | -2334.9 | — | 3 | BEARISH | -57.4 |
| GOSS Gossamer Bio, Inc. | $60M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | BEARISH | -95.1 |
| CVRX CVRx, Inc. | $40M | -0.7 | -133.4 | -260.4 | -89.4 | 12.0 | 3 | BEARISH | -86.4 |
| ETST Earth Science Tech, Inc. | $30M | 6.8 | 66.8 | 212.2 | 8.0 | 8.0 | 6 | BEARISH | -49.5 |
| IBO Impact BioMedical Inc. | $30M | -2.9 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -50.1 |
| ORXOY Orexo AB (publ) | $20M | -0.5 | 3924.8 | -872.8 | -12050.0 | -97.8 | 4 | BEARISH | -83.4 |
| MEDIF MediPharm Labs Corp. | $20M | -5.6 | -13.2 | -15.4 | 0.0 | -6.7 | 4 | BEARISH | -13.1 |
| NSCIF Nanalysis Scientific Corp. | $10M | -3.5 | -33.5 | -6.2 | -6.9 | -6.2 | 5 | BEARISH | -33.8 |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -93.5 |
| RNVA Rennova Health, Inc. | — | -0.5 | 23.5 | -4.3 | -241.1 | 43.3 | 5 | BEARISH | 0.0 |
| LGVN Longeveron Inc. | — | -0.2 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -81.2 |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| LUDG Ludwig Enterprises, Inc. | — | -0.4 | 43.5 | 103.5 | — | 100.0 | 4 | BEARISH | -94.3 |
| FITY Fifty 1 Labs, Inc. | — | -1.0 | 132.4 | 345.2 | -58137.6 | -75.6 | 4 | BEARISH | -84.6 |
| SHMN SOHM, Inc. | — | 9.0 | -15.3 | -2.9 | -130.8 | -3.6 | 4 | BEARISH | -30.8 |
| ACNV Accelera Innovations, Inc | — | -0.0 | 197.1 | 28.9 | — | -97.0 | 1 | BEARISH | 0.0 |
| SILO Silo Pharma, Inc. | — | -0.2 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 116.9 |
| BFLY Butterfly Network, Inc. | $1.8B | -25.5 | -35.5 | -74.8 | -39.6 | 28.1 | 4 | BEARISH | 231.8 |
| AAPG Ascentage Pharma Group International | $1.4B | -6.1 | -236.8 | -144.8 | -270.2 | 170.9 | 3 | BEARISH | -58.7 |
| OMER Omeros Corporation | $1.2B | 9.2 | -89.2 | 71.8 | 46.4 | — | 5 | BEARISH | 131.7 |
| ASCLF Ascletis Pharma Inc. | $770M | -7.8 | -28.4 | -7144.0 | — | -60.6 | 2 | BEARISH | -40.0 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.1 | -214.6 | 174.4 | — | — | 1 | BEARISH | 197.4 |
| FDMT 4D Molecular Therapeutics, Inc. | $600M | -4.4 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | BEARISH | 5.5 |
| PHAT Phathom Pharmaceuticals, Inc. | $460M | -4.7 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -55.7 |
| EPRX Eupraxia Pharmaceuticals Inc. | $450M | -7.0 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 29.4 |
| AGEN Agenus Inc. | $290M | 2.4 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | BEARISH | 60.6 |
| TLSI TriSalus Life Sciences, Inc. | $220M | -2.9 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -25.8 |
| GALT Galectin Therapeutics Inc. | $210M | -7.9 | 21.9 | 99.4 | — | — | 2 | BEARISH | -35.4 |
| CGEN Compugen Ltd. | $180M | 5.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 9.4 |
| HCAT Health Catalyst, Inc. | $130M | -0.4 | -118.1 | -27.1 | -57.5 | -7.5 | 5 | BEARISH | -51.5 |
| CORBF Global Cord Blood Corporation | $130M | 1.5 | 104.3 | -167.2 | 35.9 | — | 4 | BEARISH | 26.7 |
| SEER Seer, Inc. | $110M | -1.6 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BEARISH | -15.2 |
| VANI Vivani Medical, Inc. | $100M | -3.3 | -220.4 | -127.1 | — | — | 4 | BEARISH | -29.6 |
| COYA Coya Therapeutics, Inc. | $90M | -3.9 | -60.5 | -18820.6 | -2723.4 | 1793.8 | 4 | BEARISH | -34.6 |
| PXMBF Paxman AB (publ) | $80M | -305.7 | -1.2 | -1.7 | 2.4 | 33.5 | 3 | BEARISH | 0.0 |
| MNOV MediciNova, Inc. | $70M | -6.5 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | BEARISH | 14.6 |
| PMVP PMV Pharmaceuticals, Inc. | $70M | -0.9 | -70.9 | 815.8 | — | — | 2 | BEARISH | -19.9 |
| SKIN SkinHealth Systems Inc. | $70M | -2.2 | -43.8 | -1.6 | -3.7 | -6.5 | 4 | BEARISH | -63.6 |
| OSTX OS Therapies Incorporated | $60M | -1.1 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -34.4 |
| SPRO Spero Therapeutics, Inc. | $60M | 8.1 | 19.2 | -128.5 | — | -7.0 | 7 | BEARISH | -48.4 |
| HRTX Heron Therapeutics, Inc. | $60M | -1.6 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | BEARISH | -74.9 |
| ALPS Alps Group Inc | $50M | — | — | — | — | — | — | BEARISH | — |
| XLO Xilio Therapeutics, Inc. | $50M | -5.4 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | BEARISH | 913.9 |
| INCR InterCure Ltd. | $50M | -4.0 | -15.9 | -10.2 | -1.3 | -10.8 | 2 | BEARISH | -40.8 |
| MREO Mereo BioPharma Group plc | $40M | -1.6 | -67.8 | 6194.3 | — | -100.0 | 2 | BEARISH | -85.4 |
| DGNOF DIAGNOS Inc. | $30M | -8.7 | -988.8 | -2061.6 | -7539.8 | -36.9 | 3 | BEARISH | 6.7 |
| CRVO CervoMed Inc. | $30M | -0.7 | -107.6 | 1244.8 | — | — | 2 | BEARISH | -68.6 |
| ITHUF iAnthus Capital Holdings, Inc. | $30M | -0.5 | 53.1 | -9.2 | -40.8 | -9.9 | 1 | BEARISH | -44.8 |
| SCYX SCYNEXIS, Inc. | $20M | -2.1 | -18.4 | -120.7 | 3147.7 | 489.8 | 5 | BEARISH | 393.5 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.2 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -16.9 |
| ASAPF Aurora Spine Corporation | $10M | -5.6 | -35.3 | -14.8 | -22.8 | -4.5 | 5 | BEARISH | -62.9 |
| INNPF InnoCan Pharma Corporation | $10M | -6.5 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -86.2 |
| PHYOF IXICO plc | $10M | -6.0 | -15.8 | -23.6 | -28.5 | 13.2 | 2 | BEARISH | 0.0 |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 181.4 | -1.4 | 155.3 | — | 5 | BEARISH | -79.2 |
| RHEPB Regional Health Properties, Inc. | $10M | 0.5 | -328.8 | -0.6 | -3.2 | 200.4 | 6 | BEARISH | -3.2 |
| RVLWF Revitalist Lifestyle and Wellness Ltd. | $10M | -0.1 | 613.5 | -129.3 | -263.6 | — | 2 | BEARISH | 0.0 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | BEARISH | -16.1 |
| GTHP Guided Therapeutics, Inc. | $10M | -3.6 | 66.3 | 57.9 | — | 450.8 | 3 | BEARISH | -48.2 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -0.9 | -56.4 | -2884.1 | — | — | 2 | BEARISH | -10.2 |
| HLYK HealthLynked Corp. | $10M | -1.4 | 63.5 | -580.7 | -328.1 | -46.7 | 3 | BEARISH | 55.6 |
| PASG Passage Bio, Inc. | $10M | -0.3 | -169.1 | 159.0 | — | — | 3 | BEARISH | -53.1 |
| LUCY Lucyd, Inc | $10M | -0.6 | -84.6 | -209.4 | -165.3 | 72.5 | 4 | BEARISH | -56.0 |
| AMBD American Mobile Dental Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HTPRF HTC Purenergy Inc. | — | -0.0 | 13.4 | -6.6 | — | 100.0 | 5 | BEARISH | -99.8 |
| BBAL New York Health Care, Inc. | — | -0.0 | -9.2 | -21.4 | -1.7 | 3.5 | 6 | BEARISH | 0.0 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| LLBO Lifeline Biotechnologies, Inc. | — | — | — | — | — | — | — | BEARISH | -57.1 |
| WPHM Winston Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | -66.7 |
| PHMB PharmaCom BioVet, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| VSMD Vasamed, Inc. | — | -0.0 | 54566.1 | 395.4 | -334.5 | 70.0 | 4 | BEARISH | 0.0 |
| YECO EV Biologics, Inc. | — | -0.0 | 16.2 | 18.1 | 18.6 | 264.7 | 5 | BEARISH | -99.9 |
| BIGG Big Tree Group, Inc. | — | 0.0 | 0.4 | -0.6 | -0.6 | 55.4 | 5 | BEARISH | 0.0 |
| AZFL Amazonas Florestal, Ltd | — | 3.3 | 19.8 | 13.9 | 13.6 | — | 5 | BEARISH | 0.0 |
| DKSC Dakshidin Corporation | — | -34.4 | -113.2 | -9.1 | — | — | 2 | BEARISH | 200.0 |
| FCHS First Choice Healthcare Solutions, Inc. | — | -0.0 | 61.1 | 51.6 | — | 140.3 | 4 | BEARISH | -33.3 |
| EWLL eWellness Healthcare Corp. | — | -0.2 | 69.3 | 46.3 | — | -99.2 | 1 | BEARISH | 0.0 |
| ISCO International Stem Cell Corporation | — | -2.4 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | 2.4 |
| GPFT Grapefruit USA, Inc. | — | -0.1 | 11.4 | 5.9 | — | — | 2 | BEARISH | -66.7 |
| GREH Green Rain Energy Holdings Inc. | — | 0.4 | 28.6 | -43.9 | -94.2 | — | 3 | BEARISH | 138.8 |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -100.0 |
| IMCC IM Cannabis Corp. | — | -0.0 | 1556.1 | -129.3 | -57.5 | -21.1 | 1 | BEARISH | -98.1 |
| OXIHF Oxford Investments Holdings Inc. | — | -0.2 | 19.5 | 9.8 | 6887.8 | -90.6 | 2 | BEARISH | 0.0 |
| ZCMD Zhongchao Inc. | — | -0.0 | -32.0 | -103.3 | -92.6 | -28.3 | 4 | BEARISH | -99.9 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -93.6 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 655.2 | 80.8 | — | -100.0 | 2 | BEARISH | 0.0 |
| HEMP Hemp, Inc | — | -0.2 | -38.7 | -6.0 | -4131.8 | 333.7 | 4 | BEARISH | 0.0 |
| NHEL Natural Health Farm Holdings Inc. | — | -0.0 | -37.2 | -15.8 | 9.3 | 6892.6 | 4 | BEARISH | 0.0 |
| MAJI Nextel Medical Corp. | — | 0.6 | -2.6 | 42.9 | — | — | 1 | BEARISH | — |
| PTPI Petros Pharmaceuticals, Inc. | — | 0.0 | -124.4 | 96.3 | — | -100.0 | 1 | BEARISH | -90.5 |
| ABTI Alterola Biotech, Inc. | — | -0.1 | -27.4 | 216.7 | — | — | 3 | BEARISH | 0.0 |
| AIMLF AI/ML Innovations Inc. | — | -1.5 | 1433.6 | -1620.8 | -92486.4 | -73.9 | 1 | BEARISH | -32.8 |
| SIGO Sunset Island Group, Inc. | — | -0.0 | 185.8 | 85.4 | — | — | 4 | BEARISH | 0.0 |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.9 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -55.6 |
| CBDL CBD Life Sciences Inc. | — | -57.6 | -79.7 | -382.6 | 45.8 | -47.8 | 3 | BEARISH | -66.7 |
| HIGR Hi-Great Group Holding Company | — | -11.1 | 30.7 | 30.8 | -177.4 | -40.3 | 1 | BEARISH | -93.5 |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.1 | -4165.9 | 252.1 | — | — | 2 | BEARISH | -83.3 |
| BBRRF Blueberries Medical Corp. | — | -7.1 | -218.7 | -2675.7 | -588.1 | -36.9 | 4 | BEARISH | -24.4 |
| CURLF Curaleaf Holdings, Inc. | $1.8B | -62.1 | -4.2 | 0.5 | 3.7 | 2.7 | 7 | BEARISH | -2.1 |
| NUVB Nuvation Bio Inc. | $1.6B | -10.5 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | -6.2 |
| NVAX Novavax, Inc. | $1.6B | -6.6 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BEARISH | 17.6 |
| MEDOF Medios AG | $1.3B | 23.5 | 2.1 | 2.8 | 0.6 | 10.0 | 6 | BEARISH | 0.0 |
| CSBTF Kuros Biosciences AG | $950M | 109.9 | 9.6 | 9.2 | 4.8 | 29.1 | 4 | BEARISH | -39.6 |
| MGTX MeiraGTx Holdings plc | $880M | 12.4 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 7.8 |
| INMD InMode Ltd. | $800M | 10.9 | 12.3 | 44.5 | 17.9 | -6.7 | 5 | BEARISH | -11.3 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.8 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 24.4 |
| CLYM Climb Bio, Inc. | $590M | -11.5 | -27.1 | -88.6 | — | — | 2 | BEARISH | 380.9 |
| MDXG MiMedx Group, Inc. | $570M | 97.5 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | BEARISH | -42.3 |
| AVR Anteris Technologies Global Corp. | $570M | -2.2 | -75.1 | 3136.2 | -2884.3 | 31.1 | 5 | BEARISH | 20.0 |
| MNPR Monopar Therapeutics Inc. | $470M | -30.7 | -19.5 | 523.8 | — | — | 2 | BEARISH | -11.9 |
| AVIR Atea Pharmaceuticals, Inc. | $320M | -2.0 | -58.1 | 974.6 | — | — | 3 | BEARISH | 29.9 |
| SY So-Young International Inc. | $280M | -7.6 | -15.7 | -22.3 | -11.4 | 14.1 | 4 | BEARISH | -29.9 |
| PRQR ProQR Therapeutics N.V. | $180M | -3.0 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -54.0 |
| PFGTF Pacific Edge Limited | $170M | -6.0 | -194.5 | -709.2 | -299.7 | -49.4 | 2 | BEARISH | 36.9 |
| PYXS Pyxis Oncology, Inc. | $110M | -1.3 | -179.1 | 1953.9 | — | 291.4 | 2 | BEARISH | -46.8 |
| RTGN RetinalGenix Technologies Inc. | $80M | -36.0 | 90.4 | -10.3 | — | -100.0 | 4 | BEARISH | 12.7 |
| ECOR electroCore, Inc. | $60M | -4.6 | 1761.5 | 336.0 | -32.4 | 33.5 | 3 | BEARISH | 55.8 |
| INMB INmune Bio, Inc. | $40M | -2.2 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -20.0 |
| BMEA Biomea Fusion, Inc. | $40M | -1.3 | -164.1 | 210.3 | — | — | 2 | BEARISH | -56.0 |
| CELU Celularity Inc. | $30M | -0.4 | 150.9 | 40592.8 | 13.0 | -58.1 | 4 | BEARISH | -61.4 |
| RMTI Rockwell Medical, Inc. | $30M | -4.9 | -15.5 | -14.8 | -6.6 | -21.1 | 6 | BEARISH | 491.4 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.1 | 235.3 | 244.1 | — | — | 5 | BEARISH | 842.5 |
| MLSS Milestone Scientific Inc. | $30M | -6.3 | -121.7 | -160.5 | -37.3 | 3.7 | 4 | BEARISH | -26.6 |
| AVEFF Avecho Biotechnology Limited | $20M | -9.3 | -268.2 | 103.4 | -3227.5 | -46.6 | 3 | BEARISH | 0.0 |
| SER Serina Therapeutics, Inc. | $20M | -0.9 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -67.7 |
| SYBX Synlogic, Inc. | $10M | -19.6 | -5.3 | 306.3 | — | — | 2 | BEARISH | -39.0 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.0 | -82.7 | -314.7 | — | — | 1 | BEARISH | -68.6 |
| BFRI Biofrontera Inc. | $10M | -1.4 | -988.4 | -39.2 | -5.0 | 17.8 | 4 | BEARISH | -23.6 |
| CMPD CompuMed, Inc. | $10M | -28.3 | -8.7 | -11.2 | 1.1 | 22.4 | 6 | BEARISH | 90.0 |
| BNGO Bionano Genomics, Inc. | $10M | -0.3 | -83.6 | -89.6 | -90.8 | 10.0 | 6 | BEARISH | -34.8 |
| PRMD PrimeMD Inc | — | -0.0 | 42.8 | 34.3 | 159.9 | — | 3 | BEARISH | 200.0 |
| XRTX XORTX Therapeutics Inc. | — | -0.4 | -99.1 | -68.5 | — | — | 3 | BEARISH | 66.6 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -0.6 | -26.8 | -38.7 | -88.2 | — | 3 | BEARISH | 47.1 |
| OZYMF Strategic Partners A/S | — | 19.0 | 0.8 | -117.5 | 1019.0 | — | 6 | BEARISH | 0.0 |
| PAIOF Paion AG | — | -0.6 | -385.3 | -130.5 | -98.8 | -18.0 | 1 | BEARISH | 0.0 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -78.3 |
| RXEI RxElite, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| PAVS Paranovus Entertainment Technology Ltd. | — | -0.0 | -25.4 | -20.6 | -5.5 | 3788.4 | 3 | BEARISH | -95.5 |
| IVIXF Invion Limited | — | -0.6 | -83.6 | -69.7 | -537.3 | — | 3 | BEARISH | 0.0 |
| KRSA Korsana Biosciences, Inc. | $150M | — | — | — | — | — | — | BEARISH | — |
| HBMHF HBM Holdings Limited | $1.3B | 12.5 | 24.1 | 53.0 | 53.0 | 54.6 | 4 | BEARISH | -38.1 |
| RAFLF Raffles Medical Group Ltd | $1.2B | 22.0 | 5.8 | 7.3 | 8.2 | -2.8 | 7 | BEARISH | -20.0 |
| MCRPF MicroPort Scientific Corp. | $1.1B | 31.2 | 6.1 | -1.7 | 21.3 | -3.5 | 5 | BEARISH | -63.2 |
| EBOSY EBOS Group Limited | $1.0B | 15.3 | 5.0 | 4.4 | 1.7 | -8.1 | 6 | BEARISH | -47.5 |
| GERN Geron Corporation | $720M | -11.5 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -7.3 |
| XVIPY Xvivo Perfusion AB (publ) | $690M | 49.4 | 5.9 | 4.6 | 17.7 | 17.5 | 6 | BEARISH | — |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| GYRE Gyre Therapeutics, Inc. | $620M | -32.8 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BEARISH | -20.1 |
| ANNX Annexon, Inc. | $610M | -3.2 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 17.1 |
| SSII SS Innovations International, Inc. | $450M | -38.3 | -26.1 | -15.6 | -19.1 | 108.5 | 3 | BEARISH | -72.1 |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $450M | — | — | — | — | — | — | BEARISH | — |
| ASMB Assembly Biosciences, Inc. | $400M | 36.9 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -30.6 |
| SWDCF Swedencare AB (publ) | $370M | 35.2 | 1.2 | 1.7 | 3.9 | 1.4 | 7 | BEARISH | -46.5 |
| RLMD Relmada Therapeutics, Inc. | $350M | -3.5 | -55.7 | 460.5 | — | — | 3 | BEARISH | 52.9 |
| MPLT MapLight Therapeutics, Inc. | $340M | -1.6 | -57.5 | -366.6 | — | — | 2 | BEARISH | — |
| CTNM Contineum Therapeutics, Inc. | $270M | -5.2 | -28.0 | -541.6 | — | — | 4 | BEARISH | -18.6 |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $230M | -2.5 | -46.8 | -249.1 | — | — | 3 | BEARISH | -68.9 |
| BOVNF BioInvent International AB (publ) | $220M | -2.8 | -88.2 | 20101.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| CRLBF Cresco Labs Inc. | $210M | -2.0 | -25.8 | 5.5 | 9.7 | -4.5 | 2 | BEARISH | -49.8 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $210M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -75.5 |
| MFCSF Medical Facilities Corporation | $170M | 8.1 | 46.9 | 50.2 | 2.5 | 3.2 | 7 | BEARISH | -2.4 |
| ONVVF Oneview Healthcare PLC | $130M | -6.9 | -147.3 | -2982.0 | -100.1 | -2.9 | 3 | BEARISH | -6.2 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $130M | — | — | — | — | — | — | BEARISH | -96.9 |
| MIST Milestone Pharmaceuticals Inc. | $80M | -1.0 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -64.0 |
| HYPR Hyperfine, Inc. | $70M | -2.0 | -97.0 | -395.6 | -238.2 | 53.2 | 5 | BEARISH | -41.4 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $70M | -0.3 | -187.1 | 231.9 | — | — | 2 | BEARISH | -79.1 |
| HBPCF Helix BioPharma Corp. | $60M | -23.6 | -50.8 | -21.5 | — | — | 3 | BEARISH | -55.5 |
| IMA ImageneBio Inc | $50M | -0.8 | -40.7 | -594.7 | — | — | 3 | BEARISH | -49.8 |
| RPID Rapid Micro Biosystems, Inc. | $40M | -0.7 | -141.6 | -183.2 | -160.5 | 16.1 | 2 | BEARISH | -73.1 |
| OTCFF Ocumetics Technology Corp. | $40M | -6.8 | 174.3 | 2137.7 | — | — | 1 | BEARISH | -66.1 |
| COSM Cosmos Health Inc. | $30M | -0.4 | -104.0 | -41.2 | -32.1 | 33.8 | 4 | BEARISH | -76.9 |
| LDDD Longduoduo Company Limited | $20M | -26.6 | 47.5 | -421.7 | -13.8 | -36.8 | 5 | BEARISH | -45.4 |
| PRRUF Immutep Limited | $20M | -0.4 | -77.3 | 1092.5 | -328.8 | 255.0 | 3 | BEARISH | -89.5 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.3 | -119.6 | 717.6 | — | — | 3 | BEARISH | -69.8 |
| JMPHF Leveljump Healthcare Corp. | $10M | -1.5 | -21.1 | 0.7 | -9.7 | 5.4 | 3 | BEARISH | 677.3 |
| CNSY Cerenome, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| VYND Vynleads, Inc. | $10M | -27.0 | 74.2 | 89.5 | — | — | 4 | BEARISH | 62.6 |
| AIXN AiXin Life International, Inc. | $10M | -4.9 | 37.6 | 39.5 | -191.9 | -61.1 | 4 | BEARISH | 42.9 |
| TSTTF TripSitter Clinic Ltd. | — | -19.2 | -0.1 | 30.7 | — | 100.0 | 4 | BEARISH | -56.2 |
| RSHN RushNet, Inc. | — | -1.0 | -1202.9 | -22.5 | — | -43.0 | 2 | BEARISH | -98.0 |
| WLSS Welsis Corp. | — | -51.7 | 6.2 | 3.3 | — | — | 1 | BEARISH | -82.9 |
| SCNX Scienture Holdings, Inc. | — | -0.1 | -53.5 | -15.4 | -821.3 | 540.6 | 4 | BEARISH | -91.8 |
| AYURF Ayurcann Holdings Corp. | — | -0.5 | 315.5 | 53.8 | -13.0 | 47.1 | 4 | BEARISH | -98.8 |
| RSLT Resilient Healthcare Corp | — | — | — | — | — | — | — | BEARISH | — |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| STJO St. Joseph, Inc. | — | 0.6 | 9.1 | 6.7 | 89.6 | -23.9 | 7 | BEARISH | -86.0 |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| UNVC Univec, Inc. | — | -3.8 | 6.9 | 5.9 | -1481.4 | 78.3 | 4 | BEARISH | -47.4 |
| ENLV Enlivex Therapeutics Ltd. | — | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -99.0 |
| AQSZF Aequus Pharmaceuticals Inc. | — | 3.1 | 10.0 | 17.6 | 147.2 | 122.3 | 5 | BEARISH | -85.7 |
| ARUXF Acrux Limited | — | -7.1 | -48.5 | -74.2 | -26.5 | 289.9 | 7 | BEARISH | -99.0 |
| SEPSF Asep Medical Holdings Inc | — | -0.3 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| MHUAF Meihua International Medical Technologies Co., Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| IPAH Interpharm Holdings, Inc. | — | -0.0 | -342.5 | -47.0 | -67.2 | -5.1 | 1 | BEARISH | -99.8 |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| ICCM IceCure Medical Ltd | — | -0.2 | -228.3 | 36140.9 | -496.3 | 41.6 | 7 | BEARISH | -95.7 |
| MDXL Medixall Group, Inc. | — | -0.1 | 48.8 | 48.2 | 678.9 | 29.4 | 6 | BEARISH | 3200.0 |
| IRMD IRadimed Corporation | $1.1B | 46.1 | 23.5 | 50.1 | 25.5 | 11.2 | 6 | BEARISH | 7.8 |
| ZVRA Zevra Therapeutics, Inc. | $580M | 10.5 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | -5.2 |
| AQST Aquestive Therapeutics, Inc. | $500M | -6.3 | 121.1 | 43.4 | -165.5 | 22.6 | 5 | BEARISH | -40.5 |
| IRD Opus Genetics, Inc. | $290M | -2.7 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 73.9 |
| ETRA Electra Therapeutics Inc. | $180M | — | — | — | — | — | — | BEARISH | — |
| CUE Cue Biopharma, Inc. | $140M | -0.7 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | -22.2 |
| LOVFF Cannara Biotech Inc. | $140M | 17.6 | 11.4 | 12.2 | 15.2 | 15.4 | 7 | BEARISH | 15.3 |
| MGNX MacroGenics, Inc. | $140M | -11.1 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 32.6 |
| AAWH Ascend Wellness Holdings, Inc. | $80M | -0.7 | 388.6 | 3.1 | -7.8 | -8.4 | 3 | BEARISH | -52.2 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $70M | -0.9 | -64.6 | 5251.5 | — | — | 1 | BEARISH | -15.9 |
| MYO Myomo, Inc. | $50M | -3.4 | -123.8 | -74.2 | -34.4 | 6.1 | 3 | BEARISH | 5.4 |
| LEEEF Leef Brands Inc. | $30M | -1.6 | 222.4 | -39.5 | -17.9 | 8.4 | 5 | BEARISH | -27.5 |
| SKYE Skye Bioscience, Inc. | $10M | -0.1 | -233.9 | 389.5 | — | — | 3 | BEARISH | -5.8 |
| SNOA Sonoma Pharmaceuticals, Inc. | $10M | -0.9 | -41.1 | -55.7 | -5.2 | 47.0 | 4 | BEARISH | -70.2 |
| CHOOF Choom Holdings Inc. | — | -0.0 | 3772.9 | -35.1 | -140.0 | 4.6 | 4 | BEARISH | -90.0 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.2 | -485.4 | -367.8 | — | 100.0 | 6 | BEARISH | -78.7 |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | BEARISH | 292.2 |
| PHRRF PharmaTher Holdings Ltd. | — | -7.6 | -76.9 | 234.4 | — | — | 2 | BEARISH | -56.0 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | BEARISH | 0.0 |
| ESVNF Apptly Health Technologies Corp. | — | -1.5 | -22.3 | -40.4 | — | — | 2 | BEARISH | -33.8 |
| UPC Universe Pharmaceuticals Inc. | — | -0.6 | -3.5 | -4.6 | -17.2 | -8.0 | 2 | BEARISH | -56.2 |
| JUVAF Juva Life Inc. | — | -0.0 | -105.0 | -21.4 | -24.6 | 43.5 | 4 | BEARISH | -90.0 |
| TOMDF Todos Medical Ltd. | — | -0.0 | 89.6 | -253.6 | -355.9 | -37.1 | 3 | BEARISH | -90.0 |
| ARSUF Fagron N.V. | $2.0B | 18.9 | 16.7 | 10.8 | 8.4 | 11.8 | 4 | BEARISH | 9.8 |
| URGN UroGen Pharma Ltd. | $1.7B | -17.1 | 86.5 | 119.0 | -19.8 | 169.5 | 2 | BEARISH | 78.8 |
| SNDA Sonida Senior Living, Inc. | $1.6B | -5.3 | -25.2 | -2.9 | -11.8 | 49.4 | 4 | BEARISH | 23.9 |
| ELEAF EL.En. S.p.A. | $1.4B | 13.7 | 13.2 | 29.1 | 6.0 | 25.8 | 8 | BEARISH | 37.9 |
| MDCLF MedinCell S.A. | $1.1B | -29.2 | 472.2 | 81.6 | -152.1 | -14.8 | 3 | BEARISH | 333.5 |
| IART Integra LifeSciences Holdings Corporation | $930M | 71.5 | 1.2 | 13.4 | 3.6 | 0.8 | 6 | BEARISH | -25.6 |
| IMMX Immix Biopharma, Inc. | $680M | -9.1 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 123.0 |
| CADL Candel Therapeutics, Inc. | $610M | -5.9 | -81.8 | 219.4 | — | — | 2 | BEARISH | 52.8 |
| GNFTF Genfit S.A. | $470M | -5.2 | -5084.0 | -322.7 | -124.0 | 27.5 | 3 | BEARISH | 153.5 |
| VREOF Vireo Growth Inc. | $310M | -4.1 | -4.6 | -0.7 | -0.0 | — | 3 | BEARISH | — |
| IKT Inhibikase Therapeutics, Inc. | $220M | -3.3 | -52.0 | 920.5 | — | — | 3 | BEARISH | 1.9 |
| VMTHF Venus Medtech (Hangzhou) Inc. | $180M | -0.8 | -25.6 | -18.2 | -141.2 | -40.7 | 4 | BEARISH | -57.5 |
| CRDL Cardiol Therapeutics Inc. | $140M | -4.7 | -204.6 | 1592.3 | — | — | 4 | BEARISH | -4.2 |
| TRGNF Transgene S.A. | $120M | -4.1 | -64.1 | -184.9 | -5760.7 | -185.8 | 4 | BEARISH | -53.1 |
| GRUSF Grown Rogue International Inc. | $90M | -22.0 | -5.5 | -18.8 | -14.6 | 31.1 | 6 | BEARISH | -17.3 |
| PRNAF Alterity Therapeutics Limited | $50M | -2.2 | -55.0 | -401.1 | — | -100.0 | 2 | BEARISH | 8233.3 |
| BOLD Boundless Bio, Inc. | $50M | -0.8 | -67.9 | 807.9 | — | — | 2 | BEARISH | 65.1 |
| VRHI Veri Medtech Holdings Inc. | $40M | — | — | — | — | — | — | BEARISH | — |
| PRPO Precipio, Inc. | $40M | -29.1 | -9.0 | -8.1 | -3.1 | 33.5 | 6 | BEARISH | -8.0 |
| CLIFF Cordlife Group Limited | $30M | -2.9 | -9.9 | -15.8 | -11.3 | 11.3 | 5 | BEARISH | 2.6 |
| ABDXF Abingdon Health Plc | $30M | -16.4 | -36.9 | -48.9 | 3.9 | 28.3 | 4 | BEARISH | 83.0 |
| BMNDF Biomind Labs Inc. | $20M | -13.3 | 85.8 | 101.7 | — | — | 2 | BEARISH | 1483.5 |
| PCYN Procyon Corporation | — | 78.3 | -13.9 | -10.8 | 2.7 | 6.4 | 3 | BEARISH | 48.8 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BEARISH | -9.9 |
| ADDLF AddLife AB (publ) | $1.9B | 34.5 | 11.3 | 7.0 | 4.9 | 1.1 | 4 | BEARISH | -62.5 |
| GENSF Genus plc | $1.8B | 5.4 | 45.4 | 9.0 | 80.4 | -3.8 | 5 | BEARISH | -19.4 |
| VIMGF Vimian Group AB (publ) | $1.5B | 48.7 | 5.4 | 6.4 | 7.4 | 8.9 | 7 | BEARISH | -8.0 |
| OCUL Ocular Therapeutix, Inc. | $1.4B | -4.7 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -41.5 |
| GTBIF Green Thumb Industries Inc. | $1.4B | 11.7 | 7.0 | 2.5 | 1.6 | 4.8 | 7 | BEARISH | -16.3 |
| GPCR Structure Therapeutics Inc. | $1.2B | -7.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | -18.3 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.2B | -5.4 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | 1.2 |
| SHPHF Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 18.6 | 5.7 | 8.4 | 19.4 | 24.4 | 6 | BEARISH | 20.0 |
| AKTS Aktis Oncology, Inc. | $850M | -15.7 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 373763.6 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $820M | -4.8 | -4.9 | 0.0 | -14.3 | 5.6 | 6 | BEARISH | -40.3 |
| ARDX Ardelyx, Inc. | $770M | -13.3 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -40.5 |
| TGRNF Tong Ren Tang Technologies Co. Ltd. | $660M | 10.8 | 4.1 | 12.2 | 8.2 | -18.2 | 6 | BEARISH | -43.0 |
| CRWRF Craneware plc | $620M | 25.9 | 6.0 | 6.8 | 9.7 | 4.2 | 7 | BEARISH | -43.9 |
| EVOTF Evotec SE | $590M | -2.6 | -26.1 | -14.9 | -32.5 | -7.7 | 2 | BEARISH | -54.3 |
| CTMX CytomX Therapeutics, Inc. | $510M | -5.1 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -29.1 |
| KSRBF Kossan Rubber Industries Bhd | $480M | 16.9 | 5.0 | 8.5 | 11.3 | 1.0 | 5 | BEARISH | -43.2 |
| PROK ProKidney Corp. | $470M | -2.7 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | BEARISH | -52.5 |
| FTH Faeth Therapeutics, Inc. | $440M | — | — | — | — | — | — | BEARISH | — |
| ALLO Allogene Therapeutics, Inc. | $430M | -1.8 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 2.5 |
| AVCTF Avacta Group Plc | $420M | -6.7 | -2083.2 | -753.6 | -33970.3 | -99.7 | 5 | BEARISH | -18.7 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.7 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -59.1 |
| CAPR Capricor Therapeutics, Inc. | $340M | -2.5 | -73.7 | -107.5 | — | -100.0 | 3 | BEARISH | -1.6 |
| KYTX Kyverna Therapeutics, Inc. | $330M | -1.9 | -87.2 | 14267.8 | — | — | 2 | BEARISH | -24.3 |
| CGC Canopy Growth Corporation | $290M | -1.4 | -40.1 | -11.7 | -18.0 | 6.8 | 4 | BEARISH | -49.3 |
| CLPT ClearPoint Neuro, Inc. | $280M | -8.2 | -226.5 | -54.1 | -104.2 | 25.9 | 3 | BEARISH | -60.8 |
| SPHDF Santhera Pharmaceuticals Holding AG | $280M | -6.6 | 729.6 | 111.3 | -44.5 | 106.3 | 7 | BEARISH | 49.1 |
| ORYZF Oryzon Genomics S.A. | $250M | -80.4 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -14.1 |
| ABEO Abeona Therapeutics Inc. | $250M | -3.9 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -18.8 |
| OCGN Ocugen, Inc. | $250M | -3.0 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -52.4 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $250M | — | — | — | — | — | — | BEARISH | — |
| LAB Standard BioTools Inc. | $240M | -2.7 | -18.1 | -69.4 | -133.1 | -45.2 | 5 | BEARISH | -56.6 |
| VNDA Vanda Pharmaceuticals Inc. | $240M | -0.9 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -27.4 |
| HLOSF Healios K.K. | $240M | 56.3 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -48.6 |
| IPHYF Innate Pharma S.A. | $210M | -2.5 | 267.9 | 119.2 | -343.8 | 32.0 | 3 | BEARISH | -24.5 |
| GLAS Glass House Brands Inc | $190M | — | — | — | — | — | — | BEARISH | — |
| BIOA BioAge Labs Inc. | $190M | -2.3 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | BEARISH | -28.0 |
| EVMN Evommune, Inc. | $190M | -1.5 | -29.6 | -82.4 | — | — | 2 | BEARISH | — |
| NBP NovaBridge Biosciences | $160M | -2.2 | -45.7 | -617.8 | — | — | 1 | BEARISH | -70.4 |
| SION Sionna Therapeutics, Inc. | $160M | -1.8 | -32.3 | -137.7 | — | — | 0 | BEARISH | -90.1 |
| AKBA Akebia Therapeutics, Inc. | $160M | -6.1 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -78.2 |
| ZNTL Zentalis Pharmaceuticals, Inc. | $160M | -0.8 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 15.8 |
| PHCUF Photocure ASA | $150M | 16.9 | 14.5 | 37.4 | -0.5 | 29.5 | 5 | BEARISH | 1.2 |
| CNTN Canton Strategic Holdings Inc | $150M | -1.2 | -14.6 | -7.2 | -1287.2 | — | 2 | BEARISH | — |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| STRO Sutro Biopharma, Inc. | $150M | -0.5 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | -15.5 |
| CDXS Codexis, Inc. | $140M | -3.8 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -52.6 |
| QTRX Quanterix Corporation | $140M | -1.1 | -46.5 | -59.0 | -148.7 | 23.4 | 2 | BEARISH | -49.5 |
| DERM Journey Medical Corporation | $140M | -22.0 | -23.8 | -7.4 | -1.7 | 20.9 | 5 | BEARISH | -33.5 |
| NKTX Nkarta, Inc. | $130M | -1.1 | -38.8 | -75.4 | — | — | 1 | BEARISH | -15.0 |
| OWLT Owlet, Inc. | $120M | -9.7 | 180.6 | -50.5 | -1.8 | 28.0 | 6 | BEARISH | -54.8 |
| AVXL Anavex Life Sciences Corp. | $120M | -5.0 | -23.6 | 411.7 | — | — | 2 | BEARISH | -84.8 |
| CBUS Cibus, Inc. | $110M | -0.8 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | BEARISH | -11.0 |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.2 | -101.1 | 349.9 | — | — | 4 | BEARISH | -29.6 |
| CLLS Cellectis S.A. | $100M | -1.7 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | BEARISH | -69.8 |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| FRNM Freenome, Inc. | $100M | — | — | — | — | — | — | BEARISH | — |
| STXS Stereotaxis, Inc. | $100M | -4.2 | -184.3 | -142.6 | -58.3 | -5.5 | 5 | BEARISH | -66.7 |
| VXRT Vaxart, Inc. | $100M | 2.7 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 10.8 |
| RVRC Revium Recovery Inc. | $90M | -6.4 | -0.0 | 0.0 | — | — | 2 | BEARISH | 175.0 |
| AIRS AirSculpt Technologies, Inc. | $90M | -7.0 | -12.0 | -6.0 | -2.6 | -8.7 | 5 | BEARISH | -88.8 |
| TNYA Tenaya Therapeutics, Inc. | $90M | -0.8 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -75.8 |
| NYXH Nyxoah S.A. | $80M | -0.4 | -125.8 | -181.3 | -429.5 | 359.2 | 2 | BEARISH | -83.8 |
| ABSCF AB Science S.A. | $80M | -6.6 | 21.5 | 34.7 | -1813.1 | 12.3 | 5 | BEARISH | -11.1 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $80M | -0.6 | -95.6 | 738.2 | — | — | 1 | BEARISH | -75.4 |
| EAPIF Euroapi S.A. | $80M | -0.2 | -39.9 | 2.1 | -39.7 | -10.3 | 3 | BEARISH | -76.5 |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.3 | -49.0 | -68.1 | -45.3 | 60.7 | 3 | BEARISH | -55.3 |
| THOXF BioPorto A/S | $70M | 77.4 | 12.3 | 43.6 | 520.6 | 3.4 | 4 | BEARISH | -48.3 |
| CRDF Cardiff Oncology, Inc. | $70M | -1.5 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -60.8 |
| CGTX Cognition Therapeutics, Inc. | $70M | -4.0 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -56.1 |
| LNSR LENSAR Inc | $70M | 4.7 | 1231.0 | -218.4 | 21.4 | 3.3 | 5 | BEARISH | -50.4 |
| LDXHF Lumos Diagnostics Holdings Limited | $60M | -6.5 | -34.8 | -85.3 | -1.0 | 6.4 | 5 | BEARISH | -71.5 |
| CRBU Caribou Biosciences, Inc. | $60M | -0.4 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -81.5 |
| SRTS Sensus Healthcare, Inc. | $50M | -3.0 | -34.8 | -47.6 | -382.1 | -53.4 | 3 | BEARISH | -16.5 |
| IBIO iBio, Inc. | $50M | -2.4 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | -36.6 |
| HYFT MindWalk Holdings Corp. | $50M | -4.5 | -123.5 | -481.3 | -158.7 | -15.9 | 4 | BEARISH | -29.3 |
| DXR Daxor Corporation | $50M | 7.2 | 14.2 | 13.5 | -14382.9 | -78.3 | 3 | BEARISH | -35.4 |
| MDAI Spectral AI, Inc. | $50M | -4.4 | 99.0 | 97.9 | -118.5 | -45.0 | 2 | BEARISH | -31.1 |
| CNTB Connect Biopharma Holdings Limited | $50M | -1.0 | -105.5 | 1034.1 | -1249.0 | 49.8 | 2 | BEARISH | -50.4 |
| MYCOF Noveris Health Sciences Inc. | $50M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 265.0 |
| VTIAF FamiCord AG | $50M | -6.4 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BEARISH | -55.7 |
| EXOZ eXoZymes, Inc. | $40M | -3.2 | -187.2 | 913.0 | — | — | 2 | BEARISH | -68.4 |
| DRIO DarioHealth Corp. | $40M | 5.0 | 113.8 | -93.8 | -153.1 | -22.6 | 3 | BEARISH | -78.5 |
| TIL Instil Bio, Inc. | $40M | -1.3 | -25.3 | -69.1 | — | — | 4 | BEARISH | -69.9 |
| DWTX Dogwood Therapeutics, Inc. | $40M | -0.1 | -47.8 | -39.7 | — | — | 2 | BEARISH | -80.3 |
| SNZZF Senzime AB (publ) | $40M | -4.0 | -35.1 | -36.2 | -86.6 | 27.1 | 3 | BEARISH | -63.8 |
| ANVS Annovis Bio, Inc. | $40M | -0.6 | -703.7 | 170.2 | — | — | 1 | BEARISH | -49.8 |
| EUDA EUDA Health Holdings Limited | $40M | -6.6 | -50.6 | -26.7 | -22.9 | 49.4 | 5 | BEARISH | -68.7 |
| RANI Rani Therapeutics Holdings, Inc. | $40M | -2.3 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | -66.5 |
| ALDX Aldeyra The | $40M | -1.7 | -49.5 | 269.3 | — | — | 4 | BEARISH | -87.8 |
| XTNT Xtant Medical Holdings, Inc. | $40M | -3.4 | -25.2 | -14.8 | -40.9 | -14.3 | 4 | BEARISH | -64.4 |
| IXHL Incannex Healthcare Limited | $30M | -2.3 | -31.9 | 5284.2 | — | -100.0 | 4 | BEARISH | -75.0 |
| FLNA Filana Therapeutics, Inc. | $30M | -0.7 | -13.5 | 38.9 | — | — | 2 | BEARISH | — |
| DCGO DocGo Inc. | $30M | -0.1 | -92.4 | -73.3 | -21.5 | -32.4 | 3 | BEARISH | -77.1 |
| BCTX BriaCell Therapeutics Corp. | $30M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BEARISH | -74.2 |
| IGC IGC Pharma, Inc. | $30M | -3.0 | -129.2 | -127.6 | -1107.9 | -15.4 | 1 | BEARISH | -39.1 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.5 | -38.4 | -58.9 | — | — | 2 | BEARISH | -40.5 |
| AIRDF Rocket Doctor AI Inc. | $30M | -1.7 | -6105.0 | -2497.4 | -909.1 | — | 2 | BEARISH | -49.9 |
| TDMMF Mach7 Technologies Limited | $30M | -6.8 | -22.3 | -41.4 | -22.3 | -17.5 | 3 | BEARISH | -72.0 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $20M | -1.2 | -234.4 | -475.2 | -504.1 | 36.6 | 3 | BEARISH | -34.1 |
| ACH Accendra Health, Inc. | $20M | -0.1 | -1.1 | 4.3 | -14.5 | -99.1 | 3 | BEARISH | -97.9 |
| BYSI BeyondSpring Inc. | $20M | -2.8 | 20.3 | 15.7 | — | 100.0 | 2 | BEARISH | -77.0 |
| ARAY Accuray Incorporated | $20M | -0.3 | -80.1 | -11.3 | -1.9 | -12.3 | 2 | BEARISH | -91.3 |
| ITOC iTonic Holdings Ltd. | $20M | — | — | — | — | — | — | BEARISH | — |
| RVP Retractable Technologies, Inc. | $20M | -4.9 | -4.5 | -53.2 | 39.3 | -11.2 | 4 | BEARISH | -38.1 |
| YI 111, Inc. | $20M | -1.7 | 30.0 | 15.9 | -1.7 | -20.9 | 2 | BEARISH | -33.0 |
| PAVM PAVmed Inc. | $20M | -0.1 | -31.9 | -43.6 | -16315.2 | -89.0 | 3 | BEARISH | 424.0 |
| SCLX Scilex Holding Company | $20M | -0.0 | 160.5 | 105.7 | -1485.2 | -28.5 | 3 | BEARISH | -87.4 |
| ATYR aTyr Pharma, Inc. | $20M | -0.2 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -87.4 |
| MVMDF More Life Company Corp. | $20M | -5.2 | -167.0 | -602.2 | -5006.5 | 43.0 | 4 | BEARISH | 115.8 |
| MDXH MDxHealth S.A. | $20M | -0.3 | 193.7 | -23.4 | -42.4 | -19.1 | 2 | BEARISH | -95.6 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -45.5 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -68.7 |
| GUTS Fractyl Health, Inc. | $10M | -0.1 | 1063.0 | -568.7 | — | -100.0 | 5 | BEARISH | -94.7 |
| TCRX TScan Therapeutics, Inc. | $10M | -0.2 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -91.7 |
| BLRX BioLineRx Ltd. | $10M | -1.1 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -44.6 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.1 | -166.5 | 851.1 | -882.8 | 287.3 | 4 | BEARISH | -95.7 |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| PLSM Pulsenmore Ltd. Ordinary Shares | $10M | — | — | — | — | — | — | BEARISH | — |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 49.3 | 80.2 | -86.2 | 4.3 | 4 | BEARISH | -58.4 |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.6 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | BEARISH | -58.0 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.5 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -62.7 |
| ALRTF ALR Technologies Inc. | $10M | -0.4 | 54.2 | 8.3 | -151734.7 | — | 2 | BEARISH | -16.8 |
| PTN Palatin Technologies, Inc. | $10M | -0.9 | -877.5 | 1176.9 | -1449.1 | — | 5 | BEARISH | -20.5 |
| INAB IN8bio, Inc. | $10M | -0.5 | -111.1 | -576.1 | — | — | 4 | BEARISH | -55.1 |
| IMMVF Immunovia AB | $10M | -0.4 | -425.5 | 808.2 | -5991.9 | 31.4 | 3 | BEARISH | -80.8 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.1 | -931.1 | -564.2 | — | — | 1 | BEARISH | -95.2 |
| IMNN Imunon, Inc. | $10M | -0.2 | -429.7 | -226.7 | — | — | 2 | BEARISH | -81.9 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -67.4 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.3 | -126.2 | 296.9 | — | — | 1 | BEARISH | -82.6 |
| SINT Sintx Technologies, Inc. | $10M | -0.3 | -408.3 | -216.8 | -598.7 | 0.2 | 3 | BEARISH | -54.4 |
| RGNT Regentis Biomaterials Ltd. | $10M | — | — | — | — | — | — | BEARISH | — |
| GSGTF GenSight Biologics S.A. | $10M | -1.0 | 46.5 | 47.3 | 1190.6 | -401.7 | 3 | BEARISH | -57.9 |
| DARE Dare Bioscience, Inc. | $10M | -0.8 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | BEARISH | -68.6 |
| QNTM Quantum BioPharma Ltd. | $10M | -0.4 | -425.3 | 175.1 | — | — | 4 | BEARISH | -83.3 |
| OPTBF OptiBiotix Health Plc | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| PDRX PD-Rx Pharmaceuticals, Inc. | $10M | — | — | — | — | — | — | BEARISH | 6.9 |
| BMRA Biomerica, Inc. | $10M | -1.0 | -113.8 | -132.4 | -97.4 | -11.2 | 1 | BEARISH | -42.2 |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -46.4 |
| MDXHF Medx Health Corp. | $10M | — | 63.5 | 166.6 | -1353.4 | 19.2 | 3 | BEARISH | 150.0 |
| PXXLF Poxel S.A. | $10M | -0.4 | 34.8 | 129.6 | -624.6 | 41.5 | 4 | BEARISH | -12.0 |
| TRAW Traws Pharma, Inc. | $10M | -0.7 | -711.4 | 133.9 | — | -100.0 | 1 | BEARISH | -87.4 |
| MGRX Mangoceuticals, Inc. | $10M | -0.2 | -95.1 | -82.6 | -1909.1 | -38.9 | 4 | BEARISH | -89.4 |
| KTTA Pasithea Therapeutics Corp. | $10M | -0.2 | -65.5 | -453.2 | — | — | 4 | BEARISH | -44.7 |
| VRCDF Verici Dx plc | $10M | -0.6 | -192.7 | -151.0 | -227.8 | 84.7 | 3 | BEARISH | -60.5 |
| AVCNF Avicanna Inc. | $10M | -3.1 | -109.4 | -64.5 | -18.1 | -0.2 | 3 | BEARISH | -62.3 |
| PMSNF Proteome Sciences plc | — | -2.0 | 25.2 | -36.8 | -74.6 | -16.5 | 4 | BEARISH | -66.7 |
| USMJ North American Cannabis Holdings, Inc. | — | -3.5 | 40.1 | 1.5 | — | 14.2 | 2 | BEARISH | 0.0 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | -50.0 |
| NUNZ Nunzia Pharmaceutical Company | — | -0.0 | 69398.6 | 176728.6 | — | — | 2 | BEARISH | 0.0 |
| OJSY OJsys, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -83.1 |
| AMIX Autonomix Medical, Inc. | — | -0.0 | -316.0 | 4343.4 | — | — | 2 | BEARISH | -91.2 |
| AREVF AREV Life Sciences Global Corp | — | -1.9 | 23.9 | 15.1 | — | -96.1 | 2 | BEARISH | -95.0 |
| RPGLF Regent Pacific Group Limited | — | -16.8 | 38.3 | 5.9 | 10.3 | 491.5 | 6 | BEARISH | -94.1 |
| OVATF Ovation Science Inc. | — | -1.7 | 44.0 | 34.6 | -690.6 | -27.1 | 3 | BEARISH | -74.6 |
| MRDH Meridian Holdings, Inc. | — | -0.6 | 29.2 | -2410.8 | — | -100.0 | 1 | BEARISH | -21.3 |
| HRTT Heart Tronics, Inc. | — | -0.0 | -1320.1 | -1322.8 | — | — | 1 | BEARISH | 0.0 |
| AVCRF Avricore Health Inc. | — | -2.6 | -131.4 | -548.9 | -354.9 | -93.8 | 2 | BEARISH | -97.7 |
| AXRX Amexdrug Corporation | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CEVE Ceres Ventures, Inc. | — | -0.0 | 175.9 | 280.3 | — | — | 3 | BEARISH | 0.0 |
| MCOA Marijuana Company of America, Inc. | — | -0.1 | 295.5 | 51.6 | — | -72.4 | 1 | BEARISH | 0.0 |
| PPRG Patient Portal Technologies, Inc. | — | -0.0 | -4.5 | -0.3 | -3.5 | -23.2 | 2 | BEARISH | 0.0 |
| LUFFF Herbal Dispatch Inc. | — | -1.0 | -124.8 | -42.8 | -26.7 | 4.6 | 6 | BEARISH | 46.0 |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| CHALF Chalice Brands Ltd | — | -0.0 | -51.3 | -9.0 | 9.4 | 36.2 | 5 | BEARISH | -99.0 |
| PPII Coenzyme-A Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CYDX CYduct Diagnostics, Inc. | — | -11.1 | 15.8 | 13.7 | -394.2 | -16.3 | 3 | BEARISH | 148.6 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | — | -0.1 | 294.4 | 252.1 | — | — | 4 | BEARISH | -95.3 |
| STLNW Starling Oncology Inc. Wt | — | — | — | — | — | — | — | BEARISH | — |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -99.1 |
| BZYR Burzynski Research Institute, Inc. | — | -0.0 | 2902.9 | 1462.7 | — | — | 4 | BEARISH | -99.4 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -72.3 |
| ISHI Islet Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| KALY Kali, Inc. | — | -8.6 | 32.3 | 47.0 | 20.9 | 28.1 | 4 | BEARISH | -98.0 |
| STMH Stem Holdings, Inc. | — | -0.0 | -274.8 | 873.4 | 98.5 | -100.0 | 3 | BEARISH | 900.0 |
| CBDX Curative Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| AJOY Ayujoy Herbals Ltd. | — | -1.0 | -54.8 | 142.7 | — | -100.0 | 3 | BEARISH | -53.7 |
| GENX Genex Pharmaceutical, Inc. | — | 0.0 | 7.8 | 5.1 | -8.1 | 32.8 | 5 | BEARISH | 0.0 |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -95.2 |
| EDNEF Eden Empire Inc. | — | — | 64.3 | -88.8 | -1382.1 | — | 2 | BEARISH | -90.9 |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| KAPA Kairos Pharma, Ltd. | — | -0.3 | -114.0 | -301.0 | — | — | 3 | BEARISH | -93.0 |
| WOWU WOWI, Inc. | — | 0.0 | 51.5 | 49.7 | -38.1 | — | 4 | BEARISH | -50.0 |
| OMID OMID Holdings, Inc. | — | 25.2 | -127.5 | -314.5 | 40.6 | 57.1 | 5 | BEARISH | -62.9 |
| BUDZ WEED, Inc. | — | -1.7 | 176.9 | 220.9 | — | -100.0 | 1 | BEARISH | -65.2 |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | BEARISH | — |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -95.2 |
| ACUS Acusphere, Inc. | — | -0.0 | -363.3 | -4565.0 | -3033.3 | -5.2 | 2 | BEARISH | 0.0 |
| NGMDF NuGen Medical Devices Inc. | — | -0.3 | 81.2 | -448.2 | -19565.6 | -86.3 | 2 | BEARISH | -70.9 |
| XTXXF Adastra Holdings Ltd. | — | -0.7 | -227.3 | -93.3 | -9.6 | -33.9 | 2 | BEARISH | -98.6 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -27.3 |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -97.3 |
| KALA KALA BIO, Inc. | — | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.6 |
| IBXXF Imagion Biosystems Limited | — | -0.4 | 127.1 | 360.0 | -376.2 | -50.2 | 3 | BEARISH | -86.7 |
| ENZC Enzolytics Inc. | — | -11.2 | 105.9 | 1.4 | — | — | 7 | BEARISH | -25.0 |
| MBIO Mustang Bio, Inc. | — | -0.8 | -58.1 | 36.6 | — | — | 2 | BEARISH | -75.9 |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | -99.0 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -80.1 |
| ETAOF Etao International Co., Ltd. | — | -0.0 | -1369.5 | 4843.5 | -1544.0 | — | 5 | BEARISH | -66.7 |
| HSMD Healthcare Solutions Management Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NCEL NewcelX Ltd. | — | 8.3 | -48.0 | -39.1 | — | — | 2 | BEARISH | -79.5 |
| OVIT OncoVista Innovative Therapies, Inc. | — | -0.0 | 61.2 | 43.6 | — | — | 1 | BEARISH | 0.0 |
| KAYS Kaya Holdings, Inc. | — | -0.0 | 141.1 | -11929.1 | -158865.8 | -102.0 | 3 | BEARISH | -97.1 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SZLSF StageZero Life Sciences Ltd. | — | -0.0 | 23.1 | 18.6 | -79.9 | -29.3 | 2 | BEARISH | -80.4 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | 40.9 | 5 | BEARISH | 0.0 |
| PNDHF Pond Technologies Holdings Inc. | — | -0.4 | 43.2 | 90.7 | -114.9 | -47.3 | 2 | BEARISH | -27.3 |
| AQQRF Aquarius Surgical Technologies Inc. | — | -0.3 | 26.1 | -39.2 | -855.7 | 8.7 | 4 | BEARISH | 0.0 |
| CLCFF Christina Lake Cannabis Corp. | — | -1.6 | -37.8 | -14.8 | -10.0 | -18.1 | 2 | BEARISH | -52.0 |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -99.3 |
| IONKF Ionic Brands Corp. | — | -0.0 | -395.1 | -29.9 | -53.6 | 179.4 | 4 | BEARISH | 0.0 |
| PRFX PRF Technologies Ltd. | — | -0.1 | -57.8 | -88.3 | -19978.6 | 137249010644668.4 | 6 | BEARISH | -42.1 |
| DTMXF Quanta AI Inc. | — | — | 6074.2 | 6923.2 | -413.2 | 15.3 | 3 | BEARISH | -74.8 |
| AMHD HLK Biotech Holding Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | -38.8 |
| USPS Ultimate Sports, Inc. | — | -15.1 | 14.7 | 11.0 | — | — | 1 | BEARISH | -60.4 |
| AYRWF Ayr Wellness Inc. | — | -0.0 | -65.7 | -16.1 | -53.2 | -2.4 | 3 | BEARISH | -100.0 |
| IVF INVO Fertility, Inc. | — | -0.0 | -55.3 | -28.1 | 40.9 | 13.8 | 4 | BEARISH | -97.3 |
| ECIA Encision Inc. | — | -0.7 | -21.1 | -7.4 | 2.0 | -8.7 | 3 | BEARISH | -94.0 |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| MJARF MJardin Group, Inc. | — | -0.0 | 59.5 | -11.0 | -1614.6 | -42.3 | 3 | BEARISH | -99.0 |
| APYI Aspyra Inc. | — | -0.0 | -102.5 | 49.8 | -82.7 | -15.6 | 1 | BEARISH | 0.0 |
| PERCF Percheron Therapeutics Limited | — | — | — | — | — | — | — | BEARISH | — |
| JNHMF Jack Nathan Medical Corp. | — | -0.7 | -152.9 | 25.0 | -471.3 | -108.0 | 4 | BEARISH | -75.0 |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| ALST AllStar Health Brands Inc | — | -0.3 | 12.9 | 2.5 | — | — | 4 | BEARISH | -50.0 |
| WOK WORK Medical Technology Group Ltd. Class A | — | -0.0 | -20.9 | -10.5 | -63.0 | -0.2 | 4 | BEARISH | -64.5 |
| QMDT Quick-Med Technologies, Inc. | — | -0.0 | 8.3 | 3.4 | -78.6 | -6.9 | 5 | BEARISH | 400.0 |
| CHHE China Health Industries Holdings, Inc. | — | -0.0 | -6.9 | -35.0 | -164082.8 | 77.5 | 2 | BEARISH | -0.0 |
| WEQL WellQuest Medical & Wellness Corporation | — | -0.0 | 16.1 | -19.9 | -36.3 | 126.5 | 3 | BEARISH | 100.0 |
| CATV Opus Holdings, Inc. | — | -16.9 | -0.8 | -1.4 | 91.7 | 47.8 | 5 | BEARISH | -99.6 |
| RAFA Rafarma Pharmaceuticals, Inc. | — | 7.6 | 2.9 | 3.4 | 26.6 | -66.0 | 3 | BEARISH | -58.3 |
| MBGNF Many Bright Ideas Technologies Inc. | — | -2.2 | 20.4 | 126.7 | — | — | 2 | BEARISH | 0.0 |
| NNRX Nutranomics, Inc. | — | -0.1 | 58.6 | -70.9 | -150.9 | 46.4 | 4 | BEARISH | -98.0 |
| NSRS Medcann Industries, Inc. | — | -0.0 | -92.1 | -21.1 | — | — | 2 | BEARISH | 0.0 |
| LVCE LiveCare, Inc. | — | — | — | — | — | — | — | BEARISH | -77.2 |
| SVSO SheerVision, Inc. | — | -0.0 | 31.8 | -24.5 | 42.2 | -32.8 | 3 | BEARISH | 0.0 |
| DPAT Dental Patient Care America, Inc. | — | 320.0 | 117.2 | 10.7 | 26.9 | -3.7 | 5 | BEARISH | 64.1 |
| GRPI Grupo International Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ZHCLF Zenith Capital Corp. | — | -0.2 | 35107.2 | 37766.2 | -360.0 | — | 3 | BEARISH | 3233.3 |
| VBIO Valion Bio, Inc. | — | -0.0 | -240.8 | -48.0 | — | -281.4 | 2 | BEARISH | — |
| MDCX Medicus Pharma Ltd. Common Stock | — | -0.0 | -3904.0 | -693.1 | — | — | 3 | BEARISH | -98.2 |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -62.2 |
| GENPF Genix Pharmaceuticals Corporation | — | -5.1 | 19.6 | 11.6 | — | -100.0 | 2 | BEARISH | -20.7 |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -98.6 |
| NEUN Neurogenesis, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MMTC Micro Imaging Technology, Inc. | — | -0.0 | 83.3 | 72.6 | — | — | 1 | BEARISH | 0.0 |
| KLYG Kelyniam Global, Inc. | — | -23.3 | -26.9 | 10.0 | -16.7 | 2.0 | 5 | BEARISH | -24.8 |
| ISPC iSpecimen Inc. | — | -0.0 | -968.5 | 305.3 | -896.9 | -92.1 | 4 | BEARISH | -97.4 |
| ULIHF The United Laboratories International Holdings Limited | $1.9B | 20.6 | 3.3 | 4.4 | 5.6 | -16.6 | 4 | BEARISH | -49.9 |
| FDMDF 4DMedical Limited | $1.6B | -9.6 | -174.5 | 43.4 | -1194.8 | 20.5 | 3 | BEARISH | 94.2 |
| LFTSF LifeTech Scientific Corporation | $1.0B | 103.0 | 7.3 | 6.9 | -5.7 | 103.7 | 4 | BEARISH | -14.3 |
| TTALF Terveystalo Oyj | $910M | 13.3 | 10.3 | 6.3 | 2.1 | -8.7 | 4 | BEARISH | -44.5 |
| IVEVF Inventiva S.A. | $750M | -6.2 | -988.4 | -371.6 | -347346.6 | -99.7 | 3 | BEARISH | -22.8 |
| NNCSF Nanosonics Limited | $620M | 52.8 | 8.3 | 15.6 | 8.1 | 2.4 | 4 | BEARISH | -39.9 |
| RGNX REGENXBIO Inc. | $440M | -1.7 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -49.4 |
| CALZF PolyNovo Limited | $430M | 82.5 | 8.4 | 9.3 | 10.0 | 12.8 | 7 | BEARISH | -38.6 |
| ALT Altimmune, Inc. | $410M | -2.6 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -46.0 |
| NIKA Nika Pharmaceuticals Inc. | $370M | -4711.6 | 26.8 | 18.5 | — | 100.0 | 3 | BEARISH | 8.5 |
| AVTX Avalo Therapeutics, Inc. | $370M | -1.4 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | -61.6 |
| DMTRF 3-D Matrix, Ltd. | $310M | 12.2 | 75.0 | 31.1 | 9.4 | 57.0 | 6 | BEARISH | 61.3 |
| TLRY Tilray Brands, Inc. | $310M | -2.0 | -8.8 | -3.4 | -16.8 | -16.9 | 3 | BEARISH | -81.4 |
| ACIU AC Immune S.A. | $250M | -4.3 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BEARISH | -30.8 |
| CABA Cabaletta Bio, Inc. | $250M | -0.9 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -40.9 |
| SCTX Scribe Therapeutics Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| PALI Palisade Bio, Inc. | $230M | -2.3 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | -31.0 |
| SPOK Spok Holdings, Inc. | $220M | 17.0 | 8.4 | 10.0 | 11.8 | -3.4 | 5 | BEARISH | -36.0 |
| CATX Perspective Therapeutics, Inc. | $180M | -0.8 | -39.5 | -108.8 | -33069.1 | -35.3 | 3 | BEARISH | -60.2 |
| IVVD Invivyd, Inc. | $180M | -1.5 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -73.2 |
| UPB Upstream Bio, Inc. | $150M | -1.0 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -83.0 |
| HWAIF Healwell AI Inc. | $150M | -5.4 | -21.9 | -10.8 | 19.4 | 54.1 | 5 | BEARISH | -55.4 |
| CHHHF CareRx Corporation | $150M | 7.8 | 27.3 | 40.1 | 0.4 | 3.0 | 6 | BEARISH | -10.8 |
| CMPX Compass Therapeutics, Inc. | $140M | -1.8 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -81.2 |
| ORGO Organogenesis Holdings Inc. | $130M | -1.1 | -27.8 | -7.7 | -227.0 | 6.4 | 3 | BEARISH | -78.5 |
| NERV Minerva Neurosciences, Inc. | $110M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | -52.5 |
| VYGR Voyager Therapeutics, Inc. | $110M | -1.0 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -62.8 |
| LENZ LENZ Therapeutics, Inc. | $100M | -0.8 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -90.2 |
| VTVT vTv Therapeutics Inc. | $100M | -233.8 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 23.1 |
| ENGN enGene Holdings Inc. | $100M | -5.5 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -81.3 |
| CCLD CareCloud, Inc. | $80M | 24.9 | 21.8 | 15.7 | 3.5 | 15.1 | 4 | BEARISH | -46.5 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.3 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -54.0 |
| XBIT XBiotech Inc. | $60M | -1.2 | -29.9 | -201.2 | — | — | 2 | BEARISH | -28.0 |
| TLSA Tiziana Life Sciences Ltd | $60M | -4.3 | -780.6 | 375.0 | — | — | 1 | BEARISH | -55.0 |
| VRCA Verrica Pharmaceuticals Inc. | $60M | -2.0 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -9.9 |
| PLRX Pliant Therapeutics, Inc. | $50M | -0.6 | -50.3 | -438.3 | — | — | 3 | BEARISH | -53.6 |
| SOMNF SomnoMed Limited | $50M | -24.0 | -5.6 | 2.2 | -6.4 | 2.6 | 6 | BEARISH | -64.2 |
| GANX Gain Therapeutics, Inc. | $50M | -2.3 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -40.9 |
| KLRS Kalaris Therapeutics Inc | $40M | -0.9 | -79.9 | 109.5 | — | — | 0 | BEARISH | -61.0 |
| ACET Adicet Bio, Inc. | $40M | -0.3 | -78.1 | -553.5 | — | — | 4 | BEARISH | -73.2 |
| EDSA Edesa Biotech, Inc. | $30M | -1.6 | -122.9 | 759.6 | — | — | 1 | BEARISH | -2.5 |
| MDDVF Medical Developments International Limited | $30M | 67.0 | 1.1 | 3.6 | 4.1 | 8.9 | 7 | BEARISH | -15.1 |
| BIOQ Bioqual, Inc. | $30M | -6.2 | -2.8 | -4.3 | -0.8 | -16.6 | 3 | BEARISH | -23.4 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.6 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | BEARISH | -51.1 |
| MIRA MIRA Pharmaceuticals, Inc. | $30M | -0.4 | -710.9 | -15187.8 | — | — | 3 | BEARISH | -63.3 |
| EYPT EyePoint Pharmaceuticals, Inc. | $30M | -0.1 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -97.0 |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| BSEM BioStem Technologies, Inc. | $30M | -0.9 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -69.0 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $30M | -0.4 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -87.8 |
| PLNH Planet 13 Holdings Inc. | $30M | -0.4 | -90.5 | -50.0 | -24.4 | -21.2 | 2 | BEARISH | -65.5 |
| NNOX Nano-X Imaging Ltd. | $30M | -0.2 | -99.0 | -164.5 | -1335.1 | 31.5 | 2 | BEARISH | -92.1 |
| MGX Metagenomi, Inc. Common Stock | $30M | -0.3 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -72.3 |
| OPTH Optimi Health Corp. | $20M | — | — | — | — | — | — | BEARISH | — |
| KYNB Kyntra Bio, Inc. | $20M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| RDGL Vivos Inc. | $20M | -5.7 | -132.5 | -427.2 | -2280.7 | 91.5 | 3 | BEARISH | -39.0 |
| MCRB Seres Therapeutics, Inc. | $20M | -0.8 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -89.9 |
| TELIF Telescope Innovations Corp. | $20M | 5.8 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | -21.7 |
| QUCY Quantum Cyber N.V. | $20M | — | — | — | — | — | — | BEARISH | — |
| BXPHF Botanix Pharmaceuticals Limited | $20M | -0.3 | -96.3 | -131.6 | -203.1 | 495.6 | 4 | BEARISH | -91.5 |
| MRMD MariMed Inc. | $20M | -1.4 | -28.4 | -0.9 | -8.6 | 4.2 | 4 | BEARISH | -66.1 |
| TXMD TherapeuticsMD, Inc. | $20M | -94.7 | -0.8 | -12.9 | 17.8 | 27.8 | 6 | BEARISH | 38.0 |
| ORXOF Orexo AB | $20M | -0.5 | 3924.8 | -872.8 | -12050.0 | -97.8 | 4 | BEARISH | -81.0 |
| SYMQY SymBio Pharmaceuticals Limited | $20M | -0.5 | -334.3 | 639.4 | -515.2 | -54.2 | 1 | BEARISH | -57.1 |
| ACIXF Acarix AB (publ) | $20M | -5.4 | -86.1 | -207.4 | -410.8 | 65.2 | 4 | BEARISH | -33.1 |
| FBLG FibroBiologics, Inc. Common Stock | $10M | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -89.3 |
| FEMY Femasys Inc. | $10M | -0.3 | -443.7 | -188.1 | -1346.8 | 21.9 | 5 | BEARISH | -89.2 |
| AIMD Ainos, Inc. | $10M | -0.3 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -77.5 |
| MDBIF TrivarX Limited | $10M | -0.0 | -61.2 | -48.7 | — | -100.0 | 4 | BEARISH | -70.8 |
| IZOZF Izotropic Corporation | $10M | -4.3 | 40.2 | 39.2 | — | — | 3 | BEARISH | -70.3 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.3 | -128.1 | 241.9 | — | — | 3 | BEARISH | -83.7 |
| BDMD Baird Medical Investment Holdings Limited | $10M | -0.5 | -45.3 | -23.2 | 0.4 | -23.1 | 4 | BEARISH | -79.9 |
| ANPCF CelLBxHealth plc | $10M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -60.8 |
| CNTMF Fluent Corp. | $10M | -0.1 | 119.7 | -49.4 | -65.1 | -34.7 | 4 | BEARISH | -72.8 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | -33.4 |
| BNR Burning Rock Biotech Limited | $10M | -1.2 | -12.8 | -41.7 | -13.7 | -6.6 | 2 | BEARISH | -5.0 |
| IPDQF ImpediMed Limited | $10M | -0.3 | -162.3 | 295.0 | -177.9 | 14.7 | 3 | BEARISH | -67.0 |
| ACON Aclarion, Inc. | $10M | -0.3 | -59.0 | -1069.5 | -10899.5 | 33.1 | 3 | BEARISH | -74.6 |
| MTVA MetaVia Inc. | $10M | -0.3 | -175.7 | 209.3 | — | — | 0 | BEARISH | -89.3 |
| ACTU Actuate Therapeutics Inc | $10M | -0.4 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -94.5 |
| CBSC Cardiac Biotech Solutions Inc. | $10M | -6.8 | 87.3 | 51.1 | -341.6 | 78.5 | 3 | BEARISH | -26.1 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -69.0 |
| UEEC United Health Products, Inc. | $10M | -6.8 | 37.4 | 34.4 | — | — | 4 | BEARISH | -43.3 |
| BCDA BioCardia, Inc. | $10M | -1.2 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -33.7 |
| CODX Co-Diagnostics, Inc. | — | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -95.5 |
| TRLFF Maven Brands Inc. | — | -0.3 | 54.0 | -28.1 | — | -200.0 | 3 | BEARISH | -99.0 |
| LTUS Lotus Pharmaceuticals, Inc. | — | -315.8 | 14.7 | -340.1 | — | — | 3 | BEARISH | -10.0 |
| SCAL Stem Cell Authority, Ltd. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CLRD Clearday, Inc. | — | -0.0 | 41.6 | 33.3 | -296.5 | -39.1 | 3 | BEARISH | -90.0 |
| NUMD Nu-Med Plus, Inc. | — | -24.0 | 8.1 | 29.2 | — | -100.0 | 4 | BEARISH | -76.0 |
| ACAI Safeplus International Holdings Limited | — | -0.3 | -205.0 | -617.4 | -224.7 | -94.2 | 1 | BEARISH | 100.0 |
| FAMDF Futura Medical plc | — | -0.3 | -145.8 | -370.5 | -72.8 | -70.7 | 2 | BEARISH | -86.7 |
| MEDD Medical Imaging Corp. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 56.6 |
| NASC Nascent Pharma Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| TBRIF Therma Bright Inc. | — | -0.4 | 711.8 | 33.4 | -336.3 | 202.0 | 3 | BEARISH | -51.2 |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| CVSI CV Sciences, Inc. | — | -0.9 | -118.9 | -46.0 | -26.0 | -14.9 | 1 | BEARISH | -76.7 |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| NSHSF NanoSphere Health Sciences Inc. | — | 9.5 | 4.6 | 11.1 | — | — | 0 | BEARISH | 0.0 |
| SPLM Sentry Petroleum Ltd | — | -0.1 | -184.2 | -129.4 | — | — | 1 | BEARISH | -99.0 |
| CANF Can-Fite BioPharma Ltd. | — | -0.3 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -81.7 |
| EKGGF CardioComm Solutions, Inc. | — | — | 92.7 | 515.6 | -152.3 | -41.9 | 2 | BEARISH | 51.1 |
| LXGTF Registered Plan Private Investments Inc. | — | -0.0 | 7.6 | 5.5 | — | — | 1 | BEARISH | -99.0 |
| OMRX Orthometrix, Inc. | — | 0.0 | 30.7 | -48.6 | -238.0 | -29.6 | 2 | BEARISH | -99.0 |
| DOSEF Doseology Sciences Inc. | — | -0.7 | -95.4 | -103.8 | -1609.9 | 161.1 | 1 | BEARISH | -90.4 |
| SNNVF Sunniva Inc. | — | -0.2 | -85.4 | -22.5 | -381.7 | 126.7 | 3 | BEARISH | -90.0 |
| ATTBF Abattis Bioceuticals Corp. | — | -0.0 | -27.0 | -30.2 | -400.9 | 4163.2 | 4 | BEARISH | -96.7 |
| NRSN NeuroSense Therapeutics Ltd. | — | -0.3 | 779.3 | 571.3 | — | — | 3 | BEARISH | -90.0 |
| EAPH Parallel Industries Inc. | — | -0.2 | 26.8 | 19.0 | — | 0.0 | 4 | BEARISH | -90.0 |
| DXBRF BellRock Brands Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.1 | -44.0 | 793.8 | — | — | 2 | BEARISH | -64.9 |
| UPDC UPD Holding Corp. | — | -0.0 | 198.3 | 1243.8 | -858.8 | — | 2 | BEARISH | 0.0 |
| VYCO Vycor Medical, Inc. | — | -19.4 | 1.5 | -1.1 | -5.3 | 1.6 | 6 | BEARISH | -76.7 |
| CRIS Curis, Inc. | — | -0.0 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -98.8 |
| BLFE BioLife Sciences Inc. | — | -0.0 | 318059.1 | -92210.0 | — | — | 2 | BEARISH | 0.0 |
| MAHN Mid-Atlantic Home Health Network, Inc. | — | — | — | — | — | — | — | BEARISH | -93.0 |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -214.9 | -155.8 | -649.8 | 33.6 | 3 | BEARISH | -81.1 |
| NVNO enVVeno Medical Corporation | — | -0.0 | -58.5 | 4255.8 | — | — | 4 | BEARISH | 827.2 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | 0.0 |
| AIDX 20/20 Biolabs Inc. | — | — | — | — | — | — | — | BEARISH | — |
| JRSS JRSIS Health Care Corporation | — | -6.8 | -10.1 | -10.3 | 4.5 | -94.6 | 6 | BEARISH | 80.6 |
| MEDVF Medivolve Inc. | — | -0.2 | 149.7 | 23.5 | -322.7 | -93.6 | 3 | BEARISH | -100.0 |
| CXBS Corix Bioscience, Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| MILC Millennium Sustainable Ventures Corp. | — | -0.0 | 763.2 | -36.7 | — | 584982.1 | 2 | BEARISH | -50.0 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.3 | -78.0 | 8335.2 | — | -50.0 | 2 | BEARISH | -85.9 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | 80.8 | 147.8 | -185107971.7 | -99.3 | 1 | BEARISH | -7.8 |
| IAGX Imagenetix, Inc. | — | -0.1 | -88.3 | -8.5 | -12.9 | -69.1 | 4 | BEARISH | 0.0 |
| TWSI Tristar Wellness Solutions Inc. | — | -1.5 | 61.9 | 93.6 | -80.6 | -29.1 | 3 | BEARISH | -99.7 |
| NMLSF Restart Life Sciences Corp. | — | -1.8 | -214.3 | -153.9 | -307.0 | — | 2 | BEARISH | -63.3 |
| CDIX Cardiff Lexington Corporation | — | -0.0 | -481.3 | -3.3 | -114.8 | 0.3 | 2 | BEARISH | -100.0 |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | BEARISH | -66.7 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
KRRO vs Benchmarks
ROIC
Revenue Growth
P/E Ratio
ROE
Piotroski F